index,sex,IBD_type,med_class,antibody_level,seroconversion,age_group,DX_days,vaccine_status,serology_date,vac_date,days_from_vac,vac_type,age_at_collection,decade
1,female,CD,Anti-TNF Only,11594,positive,adult,164,primary,16-Jun-21,15-Mar-21,93,vector,51,50 to 59
2,female,CD,Anti-TNF Only,60224,positive,adult,,booster2,27-Nov-21,20-Aug-21,99,vector,51,50 to 59
3,female,CD,Anti-TNF Only,223,ngative,pediatric,105,booster2,12-Mar-22,17-Oct-21,146,vector,1,00 to 09
4,female,UC,Combination Therapy,89,ngative,pediatric,,primary,28-May-21,24-Dec-20,155,mRNA,11,10 to 17
5,female,UC,Combination Therapy,71999,positive,pediatric,,booster1,09-Jul-21,26-Feb-21,133,mRNA,17,10 to 17
6,female,UC,Combination Therapy,44,ngative,pediatric,,booster2,11-Nov-21,14-Jun-21,150,mRNA,1,00 to 09
7,female,UC,Combination Therapy,230,ngative,adult,,booster2,30-Jan-22,01-Aug-21,182,mRNA,42,40 to 49
8,female,UC,Combination Therapy,62721,positive,adult,,booster2,03-Jun-22,29-Jan-22,125,mRNA,42,40 to 49
9,male,UC,Ustekinumab Only,4029,positive,adult,,primary,15-May-21,29-Dec-20,137,mRNA,37,30 to 39
10,male,UC,Ustekinumab Only,5506,positive,adult,233,booster1,20-Jul-21,05-Feb-21,165,mRNA,37,30 to 39
11,male,UC,Ustekinumab Only,50483,positive,adult,146,booster1,15-Oct-21,30-Mar-21,199,mRNA,37,30 to 39
12,male,UC,Ustekinumab Only,401,positive,adult,120,booster2,10-Nov-21,12-May-21,182,mRNA,37,30 to 39
13,male,UC,Ustekinumab Only,27826,positive,adult,27,booster2,11-Feb-22,23-Oct-21,111,mRNA,38,30 to 39
14,female,CD,No Immunosuppressives,45740,positive,elderly,341,booster1,04-Jun-21,15-Dec-20,171,mRNA,82,70+
15,female,CD,No Immunosuppressives,36504,positive,elderly,194,booster1,29-Oct-21,22-Jul-21,99,mRNA,82,70+
16,female,CD,No Immunosuppressives,8506,positive,elderly,138,booster2,24-Dec-21,25-Sep-21,90,mRNA,83,70+
17,female,CD,Corticosteroids,317,positive,elderly,61,booster2,11-Mar-22,18-Sep-21,174,mRNA,83,70+
18,female,CD,Corticosteroids,390,positive,elderly,30,booster2,10-Jun-22,19-Dec-21,173,mRNA,83,70+
19,female,CD,Corticosteroids,780,positive,adult,164,primary,03-Jun-21,25-Dec-20,160,vector,55,50 to 59
20,female,CD,Corticosteroids,73890,positive,adult,320,booster1,12-Aug-21,22-Mar-21,143,vector,55,50 to 59
21,female,CD,No Immunosuppressives,32508,positive,adult,216,booster1,24-Nov-21,23-Aug-21,93,vector,56,50 to 59
22,female,CD,No Immunosuppressives,46284,positive,adult,140,booster2,08-Feb-22,10-Nov-21,90,vector,56,50 to 59
23,female,CD,No Immunosuppressives,47570,positive,adult,68,booster2,21-Apr-22,23-Jan-22,88,vector,56,50 to 59
24,male,UC,No Immunosuppressives,205,ngative,elderly,205,primary,15-May-21,31-Oct-20,196,mRNA,63,60 to 69
25,male,UC,No Immunosuppressives,10991,positive,elderly,268,booster1,17-Jul-21,29-Apr-21,79,mRNA,63,60 to 69
26,male,UC,No Immunosuppressives,563,positive,elderly,457,booster2,22-Jan-22,24-Aug-21,151,mRNA,63,60 to 69
27,male,UC,No Immunosuppressives,43303,positive,elderly,586,booster2,31-May-22,27-Mar-22,65,mRNA,64,60 to 69
28,female,CD,Ustekinumab Only,73125,positive,adult,,primary,12-Jun-21,16-Apr-21,57,mRNA,17,10 to 17
29,female,UC,Anti-TNF Only,468,positive,adult,,primary,21-May-21,06-Nov-20,196,mRNA,49,40 to 49
30,female,UC,No Immunosuppressives,64508,positive,adult,,booster1,20-Jul-21,07-Feb-21,163,mRNA,49,40 to 49
31,female,UC,Anti-TNF Only,23653,positive,adult,,booster1,16-Oct-21,20-Jul-21,88,mRNA,50,50 to 59
32,female,UC,Anti-TNF Only,315,positive,adult,,booster2,20-Nov-21,15-May-21,189,mRNA,50,50 to 59
33,male,UC,Combination Therapy,16380,positive,adult,,primary,10-Jun-21,08-Mar-21,94,mRNA,42,40 to 49
34,male,UC,Combination Therapy,19630,positive,adult,,booster1,26-Aug-21,22-Feb-21,185,mRNA,42,40 to 49
35,male,UC,Combination Therapy,12341,positive,adult,,booster1,18-Nov-21,07-Sep-21,72,mRNA,42,40 to 49
36,male,UC,Corticosteroids,41089,positive,adult,,booster2,30-Dec-21,27-Aug-21,125,mRNA,42,40 to 49
37,male,UC,Combination Therapy,278,positive,pediatric,,booster2,28-Apr-22,01-Nov-21,178,mRNA,10,10 to 17
38,male,CD,Anti-TNF Only,45050,positive,pediatric,,booster1,09-May-21,11-Mar-21,59,mRNA,10,10 to 17
39,female,CD,No Immunosuppressives,20277,positive,pediatric,105,primary,25-May-21,17-Mar-21,69,vector,11,10 to 17
40,female,CD,No Immunosuppressives,33276,positive,pediatric,187,booster1,17-Jul-21,18-Feb-21,149,vector,17,10 to 17
41,female,CD,No Immunosuppressives,19271,positive,adult,96,booster2,16-Oct-21,30-May-21,139,vector,59,50 to 59
42,female,CD,No Immunosuppressives,208,ngative,adult,9,booster2,29-Jan-22,21-Aug-21,161,vector,59,50 to 59
43,female,CD,Combination Therapy,26350,positive,adult,90,booster1,15-Jun-21,18-Jan-21,148,mRNA,59,50 to 59
44,female,CD,Combination Therapy,48831,positive,pediatric,5,booster1,08-Sep-21,05-Jul-21,65,mRNA,1,00 to 09
45,female,CD,Combination Therapy,688,positive,pediatric,38,booster2,21-Oct-21,24-May-21,150,mRNA,2,00 to 09
46,female,CD,Combination Therapy,48861,positive,pediatric,169,booster2,01-Mar-22,24-Nov-21,97,mRNA,12,10 to 17
47,female,CD,Combination Therapy,73406,positive,pediatric,291,booster2,01-Jul-22,14-Feb-22,137,mRNA,12,10 to 17
48,male,UC,No Immunosuppressives,14904,positive,adult,,primary,20-May-21,13-Feb-21,96,mRNA,36,30 to 39
49,male,UC,No Immunosuppressives,26390,positive,adult,,booster1,29-Jun-21,25-Jan-21,155,mRNA,36,30 to 39
50,male,UC,No Immunosuppressives,4765,ngative,adult,,booster1,02-Nov-21,23-Apr-21,193,mRNA,36,30 to 39
51,male,UC,No Immunosuppressives,200,ngative,adult,,booster2,18-Feb-22,07-Aug-21,195,mRNA,36,30 to 39
52,male,UC,No Immunosuppressives,483,positive,adult,,booster2,11-May-22,20-Nov-21,172,mRNA,37,30 to 39
53,male,UC,Anti-TNF Only,67801,positive,elderly,,primary,14-May-21,21-Mar-21,54,mRNA,70,70+
54,male,UC,Anti-TNF Only,,,elderly,,booster1,03-Aug-21,29-May-21,66,mRNA,70,70+
55,male,UC,Anti-TNF Only,34776,positive,elderly,,booster2,08-Dec-21,18-Sep-21,81,mRNA,71,70+
56,male,UC,Anti-TNF Only,15210,positive,elderly,,booster2,16-Apr-22,25-Feb-22,50,mRNA,71,70+
57,male,UC,Anti-TNF Only,242,ngative,elderly,,booster2,31-May-22,24-Dec-21,158,mRNA,71,70+
58,female,UC,No Immunosuppressives,48,ngative,adult,,primary,26-May-21,31-Dec-20,146,vector,59,50 to 59
59,female,UC,No Immunosuppressives,53455,positive,adult,,booster1,24-Jun-21,19-Apr-21,66,vector,59,50 to 59
60,female,UC,No Immunosuppressives,8165,positive,adult,,booster1,07-Oct-21,28-May-21,132,vector,60,60 to 69
61,female,UC,No Immunosuppressives,305,positive,adult,,booster2,17-Feb-22,06-Sep-21,164,vector,60,60 to 69
62,female,UC,No Immunosuppressives,325,positive,adult,,booster2,04-May-22,15-Nov-21,170,vector,60,60 to 69
63,female,UC,No Immunosuppressives,420,positive,adult,,primary,05-Jun-21,29-Dec-20,158,mRNA,33,30 to 39
64,female,UC,No Immunosuppressives,2788,ngative,adult,,booster1,14-Aug-21,06-Mar-21,161,mRNA,33,30 to 39
65,female,UC,No Immunosuppressives,154,ngative,adult,262,primary,01-Jun-21,07-Mar-21,86,mRNA,36,30 to 39
66,female,UC,No Immunosuppressives,72205,positive,adult,218,booster1,15-Jul-21,15-Apr-21,91,mRNA,37,30 to 39
67,female,UC,No Immunosuppressives,67645,positive,adult,77,booster1,03-Dec-21,02-Oct-21,62,mRNA,37,30 to 39
68,female,UC,No Immunosuppressives,25875,positive,adult,23,booster2,26-Jan-22,07-Nov-21,80,mRNA,37,30 to 39
69,female,UC,No Immunosuppressives,40993,positive,adult,,booster2,14-May-22,04-Jan-22,130,mRNA,37,30 to 39
70,male,UC,Vedolizumab Only,347,positive,adult,401,primary,03-Jun-21,21-Mar-21,74,mRNA,28,18 to 29
71,male,UC,Vedolizumab Only,77398,positive,adult,350,booster1,24-Jul-21,17-Apr-21,98,mRNA,28,18 to 29
72,male,UC,Vedolizumab Only,72424,ngative,adult,210,booster1,11-Dec-21,13-Jun-21,181,mRNA,28,18 to 29
73,male,UC,Vedolizumab Only,56964,positive,adult,39,booster2,31-May-22,11-Mar-22,81,mRNA,29,18 to 29
74,female,CD,Ustekinumab Only,591,positive,adult,,primary,14-Jun-21,23-Feb-21,111,mRNA,46,40 to 49
75,female,CD,Ustekinumab Only,4908,ngative,adult,,booster1,23-Jul-21,06-Jan-21,198,mRNA,46,40 to 49
76,female,CD,Ustekinumab Only,6895,positive,adult,,booster1,18-Jan-22,21-Nov-21,58,mRNA,47,40 to 49
77,female,CD,Ustekinumab Only,201,ngative,adult,,booster2,19-Feb-22,16-Aug-21,187,mRNA,47,40 to 49
78,female,CD,Ustekinumab Only,125,ngative,adult,,booster2,06-Jun-22,25-Nov-21,193,mRNA,47,40 to 49
79,male,CD,Combination Therapy,478,positive,adult,,primary,21-May-21,19-Feb-21,91,mRNA,28,18 to 29
80,male,CD,Combination Therapy,,,adult,,booster1,05-Aug-21,05-Jun-21,61,mRNA,28,18 to 29
81,male,CD,Combination Therapy,16291,positive,adult,,booster2,29-Oct-21,04-Aug-21,86,mRNA,28,18 to 29
82,male,CD,Combination Therapy,671,positive,adult,,booster2,10-Mar-22,18-Oct-21,143,mRNA,28,18 to 29
83,female,CD,Combination Therapy,328,positive,adult,,primary,26-May-21,14-Dec-20,163,mRNA,52,50 to 59
84,female,CD,Combination Therapy,73482,ngative,adult,,booster1,24-Jul-21,30-Jan-21,175,mRNA,52,50 to 59
85,female,CD,Combination Therapy,63749,positive,adult,,booster1,18-Oct-21,07-May-21,164,mRNA,52,50 to 59
86,female,CD,Combination Therapy,37868,positive,adult,,booster2,21-Jan-22,20-Nov-21,62,mRNA,53,50 to 59
87,female,CD,Combination Therapy,77974,positive,adult,,booster2,12-May-22,13-Mar-22,60,mRNA,53,50 to 59
88,male,CD,Corticosteroids,262,positive,elderly,,primary,15-Jun-21,01-Apr-21,75,vector,70,70+
89,male,CD,Corticosteroids,78298,ngative,elderly,,booster1,09-Sep-21,22-Feb-21,199,vector,70,70+
90,male,CD,Corticosteroids,73341,positive,elderly,,booster2,17-Dec-21,26-Aug-21,113,vector,71,70+
91,male,CD,Corticosteroids,56183,positive,elderly,,booster2,17-Mar-22,28-Dec-21,79,vector,71,70+
92,male,CD,Corticosteroids,360,positive,elderly,,booster2,21-Jun-22,18-Dec-21,185,vector,71,70+
93,female,CD,Anti-TNF Only,483,positive,elderly,112,primary,12-May-21,08-Dec-20,155,mRNA,67,60 to 69
94,female,CD,Anti-TNF Only,23528,ngative,elderly,26,booster1,06-Aug-21,05-Feb-21,182,mRNA,67,60 to 69
95,female,CD,Anti-TNF Only,27551,positive,elderly,48,booster1,19-Oct-21,08-Aug-21,72,mRNA,67,60 to 69
96,female,CD,Anti-TNF Only,43093,positive,elderly,162,booster2,10-Feb-22,11-Dec-21,61,mRNA,68,60 to 69
97,female,CD,Anti-TNF Only,94,ngative,elderly,245,booster2,04-May-22,20-Oct-21,196,mRNA,68,60 to 69
98,female,UC,Anti-TNF Only,470,positive,adult,275,primary,25-May-21,13-Mar-21,73,mRNA,28,18 to 29
99,male,UC,No Immunosuppressives,42489,ngative,elderly,,booster1,01-Jun-21,19-Nov-20,194,mRNA,72,70+
100,male,UC,No Immunosuppressives,22813,ngative,elderly,233,booster1,24-Sep-21,01-May-21,146,mRNA,72,70+
101,male,UC,No Immunosuppressives,22633,positive,elderly,146,booster2,23-Mar-22,22-Dec-21,91,mRNA,73,70+
102,male,UC,No Immunosuppressives,27050,positive,elderly,120,booster2,20-May-22,03-Feb-22,106,mRNA,73,70+
103,female,CD,No Immunosuppressives,344,positive,elderly,27,primary,02-Jun-21,01-Jan-21,152,mRNA,68,60 to 69
104,female,CD,No Immunosuppressives,48546,positive,elderly,341,booster1,17-Jul-21,12-May-21,66,mRNA,68,60 to 69
105,female,CD,No Immunosuppressives,61643,positive,elderly,194,booster1,02-Dec-21,28-Jul-21,127,mRNA,68,60 to 69
106,female,CD,No Immunosuppressives,62904,positive,elderly,138,booster2,02-Feb-22,16-Oct-21,109,mRNA,69,60 to 69
107,female,CD,No Immunosuppressives,208,ngative,elderly,61,booster2,19-May-22,06-Nov-21,194,mRNA,69,60 to 69
108,female,CD,No Immunosuppressives,26899,positive,elderly,30,booster2,07-Jul-22,22-Mar-22,107,mRNA,69,60 to 69
109,female,UC,Anti-TNF Only,210,ngative,adult,233,primary,27-May-21,13-Mar-21,75,mRNA,33,30 to 39
110,female,UC,Anti-TNF Only,8421,positive,adult,209,booster1,22-Jul-21,25-Feb-21,147,mRNA,34,30 to 39
111,female,UC,Anti-TNF Only,19640,positive,adult,125,booster2,14-Oct-21,11-Jun-21,125,mRNA,34,30 to 39
112,female,UC,Anti-TNF Only,105,ngative,adult,13,booster2,03-Feb-22,22-Aug-21,165,mRNA,34,30 to 39
113,female,CD,Anti-TNF Only,51762,positive,adult,,booster1,20-Jul-21,18-Mar-21,124,vector,24,18 to 29
114,female,CD,Anti-TNF Only,31685,positive,adult,,booster2,12-Nov-21,14-Jul-21,121,vector,24,18 to 29
115,female,CD,Anti-TNF Only,124,ngative,adult,,booster2,05-Mar-22,05-Sep-21,181,vector,25,18 to 29
116,female,CD,Anti-TNF Only,24688,positive,adult,,booster2,29-Apr-22,05-Mar-22,55,vector,25,18 to 29
117,female,CD,Ustekinumab Only,385,positive,pediatric,,primary,05-Jun-21,17-Feb-21,108,mRNA,12,10 to 17
118,female,CD,Ustekinumab Only,321,positive,pediatric,,primary,29-Jul-21,31-Mar-21,120,mRNA,7,00 to 09
119,female,CD,Ustekinumab Only,218,ngative,pediatric,146,primary,29-Jul-21,19-Feb-21,160,mRNA,12,10 to 17
120,female,CD,Ustekinumab Only,23086,positive,pediatric,,booster1,28-Aug-21,21-May-21,99,mRNA,4,00 to 09
121,male,CD,Anti-TNF Only,180,ngative,adult,,primary,22-May-21,24-Mar-21,59,mRNA,31,30 to 39
122,male,CD,Anti-TNF Only,37957,positive,adult,,booster1,11-Sep-21,08-Apr-21,156,mRNA,32,30 to 39
123,male,CD,Anti-TNF Only,239,ngative,adult,,booster2,06-Nov-21,13-Jun-21,146,mRNA,32,30 to 39
124,male,CD,Corticosteroids,266,positive,adult,,primary,19-May-21,13-Nov-20,187,mRNA,52,50 to 59
125,male,CD,Corticosteroids,5339,positive,adult,,booster1,24-Aug-21,11-May-21,105,mRNA,52,50 to 59
126,male,CD,Corticosteroids,167,ngative,adult,,booster2,29-Oct-21,17-Apr-21,195,mRNA,52,50 to 59
127,male,CD,Corticosteroids,73707,positive,adult,,booster2,02-Mar-22,11-Dec-21,81,mRNA,53,50 to 59
128,male,CD,No Immunosuppressives,369,positive,adult,,primary,09-Jun-21,14-Apr-21,56,vector,50,50 to 59
129,male,CD,No Immunosuppressives,18257,positive,adult,120,booster1,31-Jul-21,23-Apr-21,99,vector,50,50 to 59
130,male,CD,No Immunosuppressives,55318,positive,adult,,booster2,12-Feb-22,18-Nov-21,86,vector,50,50 to 59
131,male,CD,No Immunosuppressives,189,ngative,adult,,booster2,28-Jun-22,07-Jan-22,172,vector,51,50 to 59
132,female,CD,No Immunosuppressives,271,positive,adult,,primary,21-May-21,04-Feb-21,106,vector,62,60 to 69
133,female,CD,No Immunosuppressives,76134,positive,elderly,,booster1,10-Aug-21,07-Jun-21,64,vector,62,60 to 69
134,female,CD,No Immunosuppressives,25297,ngative,elderly,,booster1,25-Nov-21,17-May-21,192,vector,62,60 to 69
135,male,UC,Ustekinumab Only,394,positive,adult,390,primary,09-May-21,23-Dec-20,137,mRNA,39,30 to 39
136,male,UC,Ustekinumab Only,31371,positive,adult,300,booster1,07-Aug-21,05-Jun-21,63,mRNA,39,30 to 39
137,male,UC,Ustekinumab Only,39,ngative,adult,185,booster2,30-Nov-21,26-May-21,188,mRNA,39,30 to 39
138,male,UC,Ustekinumab Only,90,ngative,adult,73,booster2,22-Mar-22,23-Sep-21,180,mRNA,39,30 to 39
139,female,CD,Vedolizumab Only,348,positive,elderly,27,primary,14-May-21,15-Jan-21,119,mRNA,72,70+
140,female,CD,Vedolizumab Only,64099,positive,elderly,,booster1,27-Nov-21,12-Aug-21,107,mRNA,72,70+
141,female,CD,Vedolizumab Only,60522,positive,elderly,,booster2,18-Feb-22,09-Oct-21,132,mRNA,73,70+
142,female,UC,Combination Therapy,229,ngative,adult,237,primary,22-May-21,16-Feb-21,95,mRNA,35,30 to 39
143,female,UC,Combination Therapy,76900,positive,adult,162,booster1,05-Aug-21,28-Jan-21,189,mRNA,35,30 to 39
144,female,UC,Combination Therapy,64764,positive,adult,50,booster2,25-Nov-21,17-Sep-21,69,mRNA,35,30 to 39
145,female,UC,Combination Therapy,615,positive,adult,56,booster2,11-Mar-22,14-Oct-21,148,mRNA,36,30 to 39
146,female,UC,Combination Therapy,257,positive,elderly,,primary,23-Jun-21,16-Dec-20,189,mRNA,71,70+
147,female,UC,Combination Therapy,55989,positive,elderly,,booster1,10-Aug-21,21-Apr-21,111,mRNA,71,70+
148,female,UC,Combination Therapy,74157,positive,elderly,,booster1,23-Dec-21,01-Sep-21,113,mRNA,71,70+
149,female,UC,Combination Therapy,34963,positive,elderly,341,booster2,22-Jun-22,22-Feb-22,120,mRNA,72,70+
150,female,UC,Anti-TNF Only,273,positive,adult,225,primary,01-Jul-21,15-Feb-21,136,mRNA,54,50 to 59
151,female,UC,Anti-TNF Only,64289,positive,adult,169,booster1,26-Aug-21,16-Feb-21,191,mRNA,54,50 to 59
152,female,UC,Anti-TNF Only,12921,positive,adult,8,booster1,03-Feb-22,28-Sep-21,128,mRNA,55,50 to 59
153,male,CD,Anti-TNF Only,279,positive,adult,345,primary,14-May-21,08-Dec-20,157,mRNA,48,40 to 49
154,male,CD,Anti-TNF Only,25956,ngative,adult,302,booster1,26-Jun-21,16-Dec-20,192,mRNA,48,40 to 49
155,male,CD,Anti-TNF Only,100,ngative,adult,187,booster2,19-Oct-21,15-Apr-21,187,mRNA,48,40 to 49
156,male,CD,Anti-TNF Only,67047,positive,adult,36,booster2,19-Mar-22,17-Nov-21,122,mRNA,49,40 to 49
157,female,CD,Vedolizumab Only,295,positive,adult,,primary,26-May-21,06-Feb-21,109,mRNA,46,40 to 49
158,female,CD,Vedolizumab Only,47236,positive,adult,,booster2,17-May-22,29-Jan-22,108,mRNA,47,40 to 49
159,male,UC,No Immunosuppressives,238,ngative,adult,194,primary,13-May-21,03-Jan-21,130,vector,61,60 to 69
160,male,UC,No Immunosuppressives,20557,positive,adult,,booster1,25-Aug-21,12-Apr-21,135,vector,61,60 to 69
161,male,UC,No Immunosuppressives,16687,positive,adult,,booster2,05-Mar-22,13-Jan-22,51,vector,62,60 to 69
162,female,CD,Anti-TNF Only,15578,positive,elderly,,booster1,25-May-21,05-Jan-21,140,mRNA,64,60 to 69
163,female,CD,Anti-TNF Only,46817,positive,elderly,,booster1,16-Sep-21,16-Jun-21,92,mRNA,65,60 to 69
164,female,CD,Anti-TNF Only,17,ngative,elderly,,booster2,02-Feb-22,29-Aug-21,157,mRNA,65,60 to 69
165,female,CD,Anti-TNF Only,48593,positive,elderly,,booster2,31-Mar-22,09-Jan-22,81,mRNA,65,60 to 69
166,female,CD,Anti-TNF Only,13818,positive,elderly,,booster2,18-May-22,04-Mar-22,75,mRNA,65,60 to 69
167,male,UC,Corticosteroids,341,positive,elderly,23,primary,25-May-21,28-Dec-20,148,mRNA,64,60 to 69
168,male,UC,Corticosteroids,36674,positive,elderly,108,booster1,18-Aug-21,22-Jun-21,57,mRNA,65,60 to 69
169,male,UC,Corticosteroids,8827,positive,elderly,138,booster2,31-Dec-21,15-Oct-21,77,mRNA,65,60 to 69
170,male,UC,Corticosteroids,48126,positive,elderly,355,booster2,22-Apr-22,24-Jan-22,88,mRNA,65,60 to 69
171,female,UC,Anti-TNF Only,351,positive,elderly,232,primary,21-May-21,29-Nov-20,173,mRNA,70,70+
172,female,UC,Anti-TNF Only,76563,ngative,elderly,137,booster1,24-Aug-21,02-Apr-21,144,mRNA,70,70+
173,female,UC,Anti-TNF Only,489,positive,elderly,64,booster2,05-Nov-21,23-Apr-21,196,mRNA,70,70+
174,female,UC,Anti-TNF Only,32180,positive,elderly,25,booster2,02-Feb-22,06-Oct-21,119,mRNA,70,70+
175,female,UC,Anti-TNF Only,378,positive,elderly,117,booster2,05-May-22,09-Nov-21,177,mRNA,71,70+
176,female,CD,Immunomodulator Only,353,positive,adult,,primary,14-May-21,09-Mar-21,66,mRNA,51,50 to 59
177,female,CD,Immunomodulator Only,50588,positive,adult,,booster1,07-Jul-21,20-Dec-20,199,mRNA,52,50 to 59
178,female,CD,Immunomodulator Only,26,ngative,adult,,booster2,13-Nov-21,04-Jun-21,162,mRNA,52,50 to 59
179,female,CD,Immunomodulator Only,33421,positive,adult,61,booster2,12-Feb-22,21-Dec-21,53,mRNA,52,50 to 59
180,female,CD,Immunomodulator Only,56286,positive,adult,,booster2,13-May-22,23-Jan-22,110,mRNA,52,50 to 59
181,male,CD,Anti-TNF Only,40390,positive,adult,,booster1,22-Jul-21,21-Feb-21,151,mRNA,53,50 to 59
182,female,CD,Vedolizumab Only,426,positive,adult,,primary,16-Jun-21,01-Jan-21,166,mRNA,57,50 to 59
183,female,CD,Vedolizumab Only,48224,positive,adult,,booster2,26-Mar-22,10-Jan-22,75,mRNA,57,50 to 59
184,male,CD,No Immunosuppressives,391,positive,elderly,,primary,08-May-21,12-Nov-20,177,mRNA,66,60 to 69
185,male,CD,No Immunosuppressives,18403,positive,elderly,,booster1,27-Jul-21,24-Apr-21,94,mRNA,66,60 to 69
186,male,CD,No Immunosuppressives,42021,positive,elderly,,booster1,20-Nov-21,21-Jun-21,152,mRNA,67,60 to 69
187,male,CD,No Immunosuppressives,77836,positive,elderly,,booster2,19-Jan-22,15-Sep-21,126,mRNA,67,60 to 69
188,male,CD,No Immunosuppressives,30350,positive,elderly,,booster2,06-May-22,12-Feb-22,83,mRNA,67,60 to 69
189,female,CD,Vedolizumab Only,7909,ngative,adult,30,booster1,06-Aug-21,31-Jan-21,187,mRNA,56,50 to 59
190,female,CD,Vedolizumab Only,50351,positive,adult,,booster2,27-Nov-21,25-Jul-21,125,mRNA,56,50 to 59
191,female,CD,Vedolizumab Only,77139,positive,adult,,booster2,28-Jan-22,07-Dec-21,52,mRNA,56,50 to 59
192,female,CD,Anti-TNF Only,291,positive,adult,359,primary,19-May-21,26-Mar-21,54,mRNA,47,40 to 49
193,female,CD,Anti-TNF Only,60820,positive,adult,304,booster1,13-Jul-21,08-Feb-21,155,mRNA,47,40 to 49
194,female,CD,Anti-TNF Only,30871,positive,adult,239,booster1,16-Sep-21,27-Jul-21,51,mRNA,47,40 to 49
195,female,CD,Anti-TNF Only,42750,positive,adult,220,booster2,05-Oct-21,26-Jun-21,101,mRNA,47,40 to 49
196,female,CD,Anti-TNF Only,60848,positive,adult,112,booster2,21-Jan-22,15-Sep-21,128,mRNA,48,40 to 49
197,female,CD,Anti-TNF Only,26654,positive,adult,50,booster2,24-Mar-22,20-Jan-22,63,mRNA,48,40 to 49
198,female,CD,Anti-TNF Only,505,positive,adult,40,booster2,22-Jun-22,23-Jan-22,150,mRNA,48,40 to 49
199,female,CD,Combination Therapy,370,positive,adult,164,primary,22-Jun-21,07-Apr-21,76,vector,37,30 to 39
200,female,CD,Combination Therapy,66118,positive,pediatric,320,booster2,18-Nov-21,29-Sep-21,50,vector,1,00 to 09
201,female,CD,Combination Therapy,62131,positive,adult,216,booster2,10-Feb-22,25-Oct-21,108,vector,38,30 to 39
202,male,CD,Anti-TNF Only,305,positive,adult,140,primary,30-May-21,04-Feb-21,115,mRNA,27,18 to 29
203,male,CD,Anti-TNF Only,65659,positive,adult,68,booster1,21-Jul-21,25-Apr-21,87,mRNA,27,18 to 29
204,male,CD,Anti-TNF Only,13423,positive,adult,205,booster2,07-Jan-22,06-Nov-21,62,mRNA,28,18 to 29
205,female,CD,Ustekinumab Only,21688,positive,pediatric,268,booster1,31-Jul-21,04-Mar-21,149,mRNA,17,10 to 17
206,female,CD,Ustekinumab Only,423,positive,adult,457,booster2,25-Feb-22,07-Sep-21,171,mRNA,54,50 to 59
207,female,CD,Ustekinumab Only,164,ngative,adult,586,booster2,14-Jun-22,12-Dec-21,184,mRNA,54,50 to 59
208,male,CD,Immunomodulator Only,175,ngative,adult,,primary,30-Jun-21,14-Dec-20,198,mRNA,43,40 to 49
209,male,CD,Immunomodulator Only,53623,positive,adult,320,booster1,07-Aug-21,21-Apr-21,108,mRNA,43,40 to 49
210,male,CD,Immunomodulator Only,4298,positive,adult,,booster2,15-Jan-22,14-Oct-21,93,mRNA,44,40 to 49
211,female,UC,Vedolizumab Only,274,positive,adult,217,primary,09-Jun-21,14-Jan-21,146,mRNA,34,30 to 39
212,female,UC,Vedolizumab Only,40469,positive,adult,57,booster1,10-Mar-22,07-Sep-21,184,mRNA,35,30 to 39
213,male,UC,Combination Therapy,467,positive,elderly,,primary,23-Jun-21,27-Apr-21,57,mRNA,64,60 to 69
214,male,UC,Combination Therapy,339,positive,elderly,,booster2,12-Nov-21,25-Jun-21,140,mRNA,65,60 to 69
215,male,UC,Combination Therapy,238,ngative,elderly,,booster2,18-Feb-22,28-Aug-21,174,mRNA,65,60 to 69
216,male,UC,Combination Therapy,29235,positive,elderly,,booster2,10-Jun-22,26-Mar-22,76,mRNA,65,60 to 69
217,male,CD,Anti-TNF Only,55063,positive,adult,354,booster1,02-Jul-21,19-Mar-21,105,vector,18,18 to 29
218,male,CD,Anti-TNF Only,11,ngative,adult,230,booster2,03-Nov-21,23-Apr-21,194,vector,19,18 to 29
219,male,CD,Anti-TNF Only,19504,positive,adult,216,booster2,19-Mar-22,19-Jan-22,59,vector,19,18 to 29
220,female,UC,Tofacitinib Only,401,positive,adult,,primary,03-Jul-21,05-Jan-21,179,mRNA,42,40 to 49
221,female,UC,Tofacitinib Only,66323,positive,adult,,booster1,31-Jul-21,31-Mar-21,122,mRNA,42,40 to 49
222,other,UC,Tofacitinib Only,434,positive,pediatric,,booster2,22-Feb-22,23-Aug-21,183,mRNA,2,00 to 09
223,other,UC,Tofacitinib Only,312,positive,adult,,primary,27-May-21,23-Nov-20,185,mRNA,50,50 to 59
224,other,UC,Tofacitinib Only,67266,positive,adult,,booster1,21-Aug-21,10-Mar-21,164,mRNA,50,50 to 59
225,female,UC,Tofacitinib Only,8460,positive,adult,,booster1,09-Dec-21,21-Jun-21,171,mRNA,50,50 to 59
226,female,UC,Tofacitinib Only,65039,positive,adult,,booster2,18-Feb-22,18-Nov-21,92,mRNA,51,50 to 59
227,female,UC,Tofacitinib Only,185,ngative,adult,,booster2,09-Jun-22,07-Dec-21,184,mRNA,51,50 to 59
228,female,UC,Anti-TNF Only,73299,positive,adult,304,booster1,22-Jul-21,19-Apr-21,94,mRNA,37,30 to 39
229,female,UC,Anti-TNF Only,795,positive,adult,140,booster2,07-Jan-22,22-Jul-21,169,mRNA,38,30 to 39
230,female,CD,Anti-TNF Only,48699,positive,elderly,181,booster1,09-Jul-21,24-Feb-21,135,mRNA,63,60 to 69
231,female,CD,Anti-TNF Only,411,positive,elderly,,booster2,06-Jan-22,26-Jun-21,194,mRNA,64,60 to 69
232,female,CD,Anti-TNF Only,375,positive,elderly,91,booster2,07-Apr-22,12-Oct-21,177,mRNA,64,60 to 69
233,male,CD,Immunomodulator Only,45736,positive,adult,,booster1,24-Jul-21,05-Mar-21,141,mRNA,32,30 to 39
234,male,CD,Immunomodulator Only,20606,positive,adult,,booster2,20-Nov-21,24-Jul-21,119,mRNA,32,30 to 39
235,male,CD,Immunomodulator Only,69611,positive,adult,,booster2,21-May-22,05-Jan-22,136,mRNA,33,30 to 39
236,female,UC,Corticosteroids,67269,positive,adult,189,booster1,07-Jul-21,03-Mar-21,126,mRNA,50,50 to 59
237,female,UC,Corticosteroids,52805,ngative,adult,132,booster1,02-Sep-21,17-Mar-21,169,mRNA,50,50 to 59
238,female,UC,Corticosteroids,389,positive,adult,98,booster2,20-Apr-22,19-Oct-21,183,mRNA,51,50 to 59
239,female,CD,No Immunosuppressives,197,ngative,adult,68,primary,03-Jun-21,05-Apr-21,59,vector,58,50 to 59
240,female,CD,No Immunosuppressives,78612,positive,adult,,booster1,22-Aug-21,15-May-21,99,vector,58,50 to 59
241,female,CD,No Immunosuppressives,38462,positive,adult,,booster2,01-Apr-22,20-Jan-22,71,vector,59,50 to 59
242,female,CD,No Immunosuppressives,62052,positive,adult,,booster2,15-Jun-22,24-Apr-22,52,vector,59,50 to 59
243,female,CD,Ustekinumab Only,500,positive,adult,,primary,02-Jun-21,19-Dec-20,165,mRNA,45,40 to 49
244,female,CD,Ustekinumab Only,47039,positive,adult,,booster1,19-Aug-21,22-Jun-21,58,mRNA,45,40 to 49
245,female,CD,Ustekinumab Only,17725,positive,adult,,booster2,14-Oct-21,29-Jul-21,77,mRNA,45,40 to 49
246,female,CD,Ustekinumab Only,57276,positive,adult,,booster2,13-Feb-22,24-Nov-21,81,mRNA,45,40 to 49
247,female,CD,Ustekinumab Only,336,positive,elderly,231,primary,02-Jul-21,24-Dec-20,190,mRNA,64,60 to 69
248,female,CD,Ustekinumab Only,32055,positive,elderly,199,booster1,03-Aug-21,05-Jun-21,59,mRNA,64,60 to 69
249,female,CD,Ustekinumab Only,720,positive,elderly,205,booster2,17-Dec-21,08-Jul-21,162,mRNA,64,60 to 69
250,female,CD,Ustekinumab Only,15142,positive,elderly,49,booster2,08-Apr-22,12-Feb-22,55,mRNA,65,60 to 69
251,female,CD,Ustekinumab Only,39672,positive,elderly,105,booster2,03-Jun-22,30-Mar-22,65,mRNA,65,60 to 69
252,male,CD,No Immunosuppressives,273,positive,adult,,primary,18-May-21,14-Feb-21,93,mRNA,53,50 to 59
253,male,CD,No Immunosuppressives,60661,positive,adult,,booster1,05-Jun-21,08-Apr-21,58,mRNA,53,50 to 59
254,male,CD,No Immunosuppressives,259,positive,adult,,booster2,05-Oct-21,16-Apr-21,172,mRNA,53,50 to 59
255,male,CD,No Immunosuppressives,384,positive,adult,,booster2,26-Jan-22,25-Jul-21,185,mRNA,53,50 to 59
256,male,CD,No Immunosuppressives,333,positive,adult,,booster2,11-Mar-22,29-Sep-21,163,mRNA,53,50 to 59
257,male,CD,No Immunosuppressives,224,ngative,adult,,booster2,08-Jul-22,02-Feb-22,156,mRNA,54,50 to 59
258,male,UC,Anti-TNF Only,246,ngative,elderly,,primary,04-Jun-21,26-Mar-21,70,mRNA,67,60 to 69
259,male,UC,Anti-TNF Only,72040,positive,elderly,268,booster1,10-Aug-21,31-Mar-21,132,mRNA,67,60 to 69
260,male,UC,Anti-TNF Only,551,positive,elderly,,booster2,23-Nov-21,14-Jun-21,162,mRNA,67,60 to 69
261,male,CD,Vedolizumab Only,278,positive,elderly,,primary,27-Jun-21,01-Apr-21,87,vector,68,60 to 69
262,male,CD,Vedolizumab Only,3782,positive,elderly,,booster1,24-Feb-22,25-Dec-21,61,vector,69,60 to 69
263,female,UC,No Immunosuppressives,40553,positive,adult,,booster1,29-Aug-21,18-Apr-21,133,vector,23,18 to 29
264,female,UC,No Immunosuppressives,48622,positive,adult,,booster2,27-Apr-22,03-Feb-22,83,vector,24,18 to 29
265,male,CD,Anti-TNF Only,311,positive,adult,,primary,09-Jun-21,09-Dec-20,182,mRNA,20,18 to 29
266,male,CD,Anti-TNF Only,72488,positive,adult,,booster1,14-Sep-21,09-Jun-21,97,mRNA,20,18 to 29
267,female,CD,Anti-TNF Only,368,positive,adult,205,primary,25-Jun-21,27-Feb-21,118,mRNA,37,30 to 39
268,female,CD,Anti-TNF Only,24122,positive,adult,157,booster1,12-Aug-21,06-Mar-21,159,mRNA,37,30 to 39
269,female,CD,Anti-TNF Only,51174,positive,adult,457,booster1,21-Dec-21,18-Oct-21,64,mRNA,37,30 to 39
270,male,CD,Anti-TNF Only,399,positive,elderly,,primary,09-Jun-21,14-Mar-21,87,mRNA,64,60 to 69
271,male,CD,Anti-TNF Only,255,positive,elderly,,booster2,26-Mar-22,28-Sep-21,179,mRNA,65,60 to 69
272,male,UC,Anti-TNF Only,78686,positive,adult,,booster1,10-Jun-21,22-Mar-21,80,mRNA,40,40 to 49
273,male,UC,Anti-TNF Only,70758,positive,adult,,booster2,23-Jun-22,14-Apr-22,70,mRNA,41,40 to 49
274,male,CD,Anti-TNF Only,406,positive,adult,,primary,04-Jun-21,25-Nov-20,191,mRNA,22,18 to 29
275,male,CD,Anti-TNF Only,55354,positive,adult,,booster1,24-Aug-21,03-Jun-21,82,mRNA,22,18 to 29
276,female,CD,Anti-TNF Only,74085,positive,adult,268,booster1,11-Jun-21,23-Dec-20,170,mRNA,49,40 to 49
277,female,CD,Anti-TNF Only,47358,positive,adult,157,booster1,30-Sep-21,30-Apr-21,153,mRNA,49,40 to 49
278,female,CD,Anti-TNF Only,66970,positive,adult,124,booster2,02-Nov-21,21-Jul-21,104,mRNA,49,40 to 49
279,female,CD,Anti-TNF Only,64977,positive,adult,586,booster2,16-Feb-22,16-Nov-21,92,mRNA,49,40 to 49
280,male,UC,No Immunosuppressives,281,positive,adult,,primary,23-Jun-21,09-Feb-21,134,mRNA,48,40 to 49
281,male,UC,No Immunosuppressives,68851,positive,adult,,booster1,03-Aug-21,17-Mar-21,139,mRNA,48,40 to 49
282,male,UC,No Immunosuppressives,23806,positive,adult,,booster2,31-May-22,05-Mar-22,87,mRNA,49,40 to 49
283,male,UC,Ustekinumab Only,268,positive,adult,,primary,02-Jul-21,29-Apr-21,64,mRNA,54,50 to 59
284,male,UC,Ustekinumab Only,26235,positive,adult,,booster1,01-Aug-21,21-Apr-21,102,mRNA,54,50 to 59
285,male,UC,Ustekinumab Only,13727,ngative,adult,,booster1,15-Dec-21,17-Jun-21,181,mRNA,55,50 to 59
286,male,UC,Ustekinumab Only,41395,positive,adult,,booster2,16-Feb-22,05-Dec-21,73,mRNA,55,50 to 59
287,male,UC,Ustekinumab Only,45987,positive,adult,,booster2,28-May-22,04-Apr-22,54,mRNA,55,50 to 59
288,male,CD,Anti-TNF Only,333,positive,adult,,primary,10-Jun-21,20-Jan-21,141,mRNA,47,40 to 49
289,male,CD,Anti-TNF Only,5657,positive,adult,,booster1,24-Sep-21,29-Jun-21,87,mRNA,47,40 to 49
290,male,CD,Anti-TNF Only,77576,positive,adult,,booster2,30-Dec-21,28-Aug-21,124,mRNA,47,40 to 49
291,male,CD,Anti-TNF Only,9765,positive,adult,,booster2,29-Jan-22,09-Dec-21,51,mRNA,48,40 to 49
292,male,CD,Anti-TNF Only,579,positive,adult,,booster2,15-Mar-22,26-Oct-21,140,mRNA,48,40 to 49
293,male,CD,Anti-TNF Only,41809,positive,adult,,booster2,05-Jul-22,03-Mar-22,124,mRNA,48,40 to 49
294,female,CD,Immunomodulator Only,184,ngative,adult,,primary,25-Jun-21,05-Jan-21,171,mRNA,34,30 to 39
295,female,CD,Immunomodulator Only,47036,positive,adult,,booster1,24-Jul-21,14-May-21,71,mRNA,34,30 to 39
296,female,CD,Immunomodulator Only,254,positive,adult,,booster2,06-Feb-22,12-Sep-21,147,mRNA,34,30 to 39
297,male,CD,Anti-TNF Only,15580,positive,adult,,primary,23-Jun-21,06-Apr-21,78,mRNA,43,40 to 49
298,male,CD,Anti-TNF Only,53312,positive,adult,,booster1,20-Aug-21,22-Apr-21,120,mRNA,44,40 to 49
299,male,CD,Ustekinumab Only,163,ngative,adult,,primary,30-Jun-21,22-Jan-21,159,mRNA,21,18 to 29
300,female,CD,Anti-TNF Only,64269,positive,adult,,booster1,02-Jun-21,03-Apr-21,60,mRNA,62,60 to 69
301,female,CD,Anti-TNF Only,52833,positive,elderly,,booster1,31-Aug-21,15-May-21,108,mRNA,62,60 to 69
302,female,CD,Anti-TNF Only,5876,positive,elderly,,booster2,16-Oct-21,06-May-21,163,mRNA,62,60 to 69
303,female,CD,Anti-TNF Only,748,positive,elderly,,booster2,02-Feb-22,19-Aug-21,167,mRNA,63,60 to 69
304,female,CD,Anti-TNF Only,67788,positive,elderly,,booster2,23-Mar-22,12-Dec-21,101,mRNA,63,60 to 69
305,female,CD,Anti-TNF Only,127,ngative,elderly,,booster2,07-Jul-22,02-Jan-22,186,mRNA,63,60 to 69
306,female,CD,Ustekinumab Only,15003,positive,adult,,primary,17-Jun-21,30-Mar-21,79,vector,41,40 to 49
307,female,CD,Ustekinumab Only,7313,ngative,adult,,booster1,27-Jul-21,05-Mar-21,144,vector,41,40 to 49
308,female,CD,Ustekinumab Only,42951,positive,adult,,booster1,29-Dec-21,20-Jul-21,162,vector,42,40 to 49
309,male,CD,Anti-TNF Only,38249,positive,elderly,,booster1,07-Jul-21,06-May-21,62,mRNA,76,70+
310,male,CD,Vedolizumab Only,5549,positive,adult,39,pre_dose,10-Jun-21,20-Mar-21,82,vector,33,30 to 39
311,female,CD,Combination Therapy,23780,positive,adult,310,primary,24-Jun-21,18-Apr-21,67,mRNA,37,30 to 39
312,male,CD,Immunomodulator Only,874,positive,adult,308,primary,05-Jun-21,27-Dec-20,160,mRNA,52,50 to 59
313,male,CD,Immunomodulator Only,362,positive,pediatric,249,booster1,03-Aug-21,21-Apr-21,104,mRNA,13,10 to 17
314,male,CD,Immunomodulator Only,292,positive,adult,57,booster2,11-Feb-22,05-Sep-21,159,mRNA,52,50 to 59
315,male,CD,Immunomodulator Only,31975,positive,adult,63,booster2,11-Jun-22,29-Jan-22,133,mRNA,53,50 to 59
316,male,UC,No Immunosuppressives,11904,positive,adult,208,primary,15-Jun-21,05-Mar-21,102,vector,33,30 to 39
317,male,UC,No Immunosuppressives,19699,positive,adult,156,booster1,06-Aug-21,11-Jun-21,56,vector,34,30 to 39
318,other ,UC,No Immunosuppressives,24688,ngative,adult,2,booster1,07-Jan-22,01-Jul-21,190,vector,34,30 to 39
319,male,UC,No Immunosuppressives,23395,positive,adult,,booster2,14-Jun-22,23-Apr-22,52,vector,34,30 to 39
320,male,CD,Combination Therapy,13434,positive,adult,,primary,13-Jun-21,19-Mar-21,86,mRNA,49,40 to 49
321,other ,CD,Combination Therapy,74662,positive,adult,,booster1,10-Jul-21,13-Mar-21,119,mRNA,49,40 to 49
322,male,CD,Combination Therapy,68403,positive,adult,,booster2,12-Nov-21,31-Aug-21,73,mRNA,49,40 to 49
323,male,CD,Combination Therapy,583,positive,adult,,booster2,19-Jul-22,09-Feb-22,160,mRNA,50,50 to 59
324,male,CD,No Immunosuppressives,9700,positive,adult,,booster1,25-Aug-21,11-Mar-21,167,mRNA,31,30 to 39
325,male,CD,No Immunosuppressives,67007,positive,adult,,booster2,18-Mar-22,03-Dec-21,105,mRNA,32,30 to 39
326,male,CD,Ustekinumab Only,17341,positive,adult,,primary,09-Jun-21,13-Mar-21,88,mRNA,49,40 to 49
327,male,CD,Ustekinumab Only,36037,positive,adult,,booster1,22-Aug-21,24-Mar-21,151,mRNA,49,40 to 49
328,male,CD,Ustekinumab Only,38438,positive,adult,,booster1,06-Jan-22,10-Oct-21,88,mRNA,50,50 to 59
329,female,UC,Anti-TNF Only,20762,ngative,adult,,booster1,29-Jun-21,14-Dec-20,197,mRNA,28,18 to 29
330,female,UC,Anti-TNF Only,63793,positive,adult,130,booster1,09-Sep-21,21-Jun-21,80,mRNA,28,18 to 29
331,female,UC,Anti-TNF Only,3060,positive,adult,24,booster1,10-Feb-22,03-Oct-21,130,mRNA,29,18 to 29
332,male,UC,No Immunosuppressives,186,ngative,adult,,primary,17-Jun-21,17-Jan-21,151,mRNA,32,30 to 39
333,male,UC,No Immunosuppressives,65603,positive,adult,,booster1,12-Aug-21,02-Apr-21,132,mRNA,32,30 to 39
334,male,UC,No Immunosuppressives,706,positive,adult,,booster2,26-Mar-22,13-Oct-21,164,mRNA,33,30 to 39
335,female,UC,No Immunosuppressives,10935,positive,adult,,primary,01-Jul-21,11-Mar-21,112,mRNA,58,50 to 59
336,female,UC,No Immunosuppressives,16389,ngative,adult,,booster1,07-Oct-21,09-Apr-21,181,mRNA,59,50 to 59
337,female,UC,No Immunosuppressives,60635,positive,adult,,booster2,05-Feb-22,12-Nov-21,85,mRNA,59,50 to 59
338,female,UC,No Immunosuppressives,474,positive,adult,,booster2,14-Jul-22,10-Jan-22,185,mRNA,60,60 to 69
339,female,CD,Ustekinumab Only,76379,positive,adult,,booster1,15-Sep-21,10-Jun-21,97,mRNA,41,40 to 49
340,female,UC,Corticosteroids,693,positive,adult,,primary,17-Jun-21,28-Jan-21,140,mRNA,56,50 to 59
341,female,UC,Corticosteroids,581,positive,adult,,booster1,20-Jul-21,26-May-21,55,mRNA,56,50 to 59
342,female,UC,Corticosteroids,45828,positive,adult,,booster1,24-Aug-21,09-Mar-21,168,mRNA,56,50 to 59
343,female,UC,Corticosteroids,10618,positive,adult,,booster2,01-Feb-22,06-Sep-21,148,mRNA,57,50 to 59
344,female,UC,Corticosteroids,13887,positive,adult,,booster2,24-May-22,25-Feb-22,88,mRNA,57,50 to 59
345,female,CD,Ustekinumab Only,20264,positive,adult,,booster1,24-Jun-21,03-May-21,52,vector,56,50 to 59
346,female,CD,Ustekinumab Only,73620,positive,adult,,booster1,17-Sep-21,14-Jun-21,95,vector,57,50 to 59
347,female,CD,Ustekinumab Only,367,positive,adult,,booster2,09-Dec-21,14-Jun-21,178,vector,57,50 to 59
348,female,CD,Ustekinumab Only,12184,positive,adult,,booster2,23-Feb-22,04-Nov-21,111,vector,57,50 to 59
349,male,CD,Anti-TNF Only,,,adult,,primary,15-Jun-21,08-Apr-21,68,mRNA,62,60 to 69
350,male,CD,Anti-TNF Only,3023,positive,elderly,,booster1,13-Aug-21,19-Jun-21,55,mRNA,62,60 to 69
351,male,CD,Anti-TNF Only,378,positive,elderly,,booster2,27-Nov-21,15-May-21,196,mRNA,62,60 to 69
352,male,CD,Anti-TNF Only,69891,positive,elderly,,booster2,22-Feb-22,14-Nov-21,100,mRNA,63,60 to 69
353,male,CD,Anti-TNF Only,1170,positive,elderly,,booster2,19-Apr-22,12-Jan-22,97,mRNA,63,60 to 69
354,female,UC,No Immunosuppressives,95,ngative,adult,28,pre_dose,11-Jun-21,12-Dec-20,181,mRNA,56,50 to 59
355,female,UC,No Immunosuppressives,47256,positive,adult,69,primary,22-Jul-21,23-May-21,60,mRNA,56,50 to 59
356,female,UC,No Immunosuppressives,8226,positive,adult,84,booster1,06-Aug-21,22-May-21,76,mRNA,56,50 to 59
357,female,UC,No Immunosuppressives,53891,positive,adult,252,booster1,21-Jan-22,16-Sep-21,127,mRNA,56,50 to 59
358,female,UC,No Immunosuppressives,56855,positive,adult,272,booster2,10-Feb-22,09-Nov-21,93,mRNA,56,50 to 59
359,female,UC,No Immunosuppressives,41735,positive,adult,,booster2,01-Jun-22,31-Mar-22,62,mRNA,57,50 to 59
360,male,UC,Combination Therapy,40302,positive,adult,,primary,18-Jun-21,15-Apr-21,64,mRNA,18,18 to 29
361,male,UC,Anti-TNF Only,64211,positive,adult,74,booster1,02-Jul-21,09-Apr-21,84,mRNA,43,40 to 49
362,male,UC,Anti-TNF Only,24245,positive,adult,25,booster1,09-Oct-21,09-Jul-21,92,mRNA,43,40 to 49
363,male,UC,Anti-TNF Only,26254,positive,adult,176,booster2,09-Mar-22,29-Dec-21,70,mRNA,44,40 to 49
364,male,UC,Anti-TNF Only,24570,positive,adult,,booster1,24-Jul-21,21-Jan-21,184,vector,31,30 to 39
365,male,UC,Anti-TNF Only,5086,positive,adult,,booster1,06-Jan-22,02-Oct-21,96,vector,32,30 to 39
366,male,UC,Anti-TNF Only,54597,positive,adult,,booster2,05-Mar-22,21-Oct-21,135,vector,32,30 to 39
367,male,UC,Anti-TNF Only,30590,positive,adult,,booster2,25-Jun-22,07-Mar-22,110,vector,32,30 to 39
368,male,CD,Anti-TNF Only,120,ngative,adult,,primary,23-Jun-21,20-Dec-20,185,vector,36,30 to 39
369,male,CD,Anti-TNF Only,31045,positive,adult,,booster1,13-Jul-21,22-Apr-21,82,vector,36,30 to 39
370,male,CD,Anti-TNF Only,30,ngative,adult,,booster2,07-Apr-22,03-Nov-21,155,vector,37,30 to 39
371,male,CD,Anti-TNF Only,15088,positive,adult,,booster2,30-Jun-22,21-Apr-22,70,vector,37,30 to 39
372,female,CD,Combination Therapy,72473,positive,adult,,primary,30-Jun-21,04-May-21,57,mRNA,24,18 to 29
373,female,CD,Combination Therapy,72114,positive,adult,,booster1,13-Aug-21,12-Jun-21,62,mRNA,24,18 to 29
374,female,CD,Combination Therapy,260,positive,adult,,booster2,02-Dec-21,27-May-21,189,mRNA,24,18 to 29
375,female,CD,Combination Therapy,76822,positive,adult,,booster2,24-Mar-22,25-Dec-21,89,mRNA,24,18 to 29
376,male,CD,Vedolizumab Only,41320,positive,adult,,booster1,13-Jul-21,01-May-21,73,mRNA,37,30 to 39
377,male,CD,Vedolizumab Only,74855,positive,adult,,booster2,03-Dec-21,01-Aug-21,124,mRNA,38,30 to 39
378,male,CD,Combination Therapy,627,positive,adult,36,primary,25-Jun-21,11-Jan-21,165,mRNA,42,40 to 49
379,male,CD,Combination Therapy,,,adult,,booster1,18-Aug-21,28-Jun-21,51,mRNA,42,40 to 49
380,male,CD,Combination Therapy,160,ngative,adult,184,booster2,20-Nov-21,06-May-21,198,mRNA,42,40 to 49
381,male,CD,Combination Therapy,72069,positive,adult,302,booster2,18-Mar-22,21-Oct-21,148,mRNA,43,40 to 49
382,male,CD,Anti-TNF Only,30,ngative,adult,,primary,18-Jun-21,13-Dec-20,187,mRNA,40,40 to 49
383,male,CD,Anti-TNF Only,21689,positive,adult,,booster1,10-Jul-21,10-May-21,61,mRNA,40,40 to 49
384,male,CD,Anti-TNF Only,73310,positive,adult,,booster2,13-Nov-21,13-Aug-21,92,mRNA,40,40 to 49
385,male,CD,Anti-TNF Only,34,ngative,adult,,booster2,04-Mar-22,02-Sep-21,183,mRNA,40,40 to 49
386,male,CD,Anti-TNF Only,199,ngative,adult,,booster2,15-Apr-22,16-Oct-21,181,mRNA,40,40 to 49
387,female,UC,No Immunosuppressives,46550,positive,adult,238,primary,30-Jun-21,30-Apr-21,61,mRNA,40,40 to 49
388,female,UC,No Immunosuppressives,65626,positive,adult,193,booster1,14-Aug-21,16-May-21,90,mRNA,40,40 to 49
389,female,UC,No Immunosuppressives,33608,positive,pediatric,,booster2,13-Nov-21,01-Aug-21,104,mRNA,5,00 to 09
390,female,UC,No Immunosuppressives,67421,positive,pediatric,4,booster2,19-Feb-22,05-Dec-21,76,mRNA,10,10 to 17
391,male,UC,Ustekinumab Only,58264,positive,pediatric,,booster1,17-Jun-21,09-Jan-21,159,mRNA,5,00 to 09
392,male,UC,Ustekinumab Only,79095,positive,pediatric,,booster1,14-Oct-21,02-Aug-21,73,mRNA,11,10 to 17
393,male,UC,Ustekinumab Only,30,ngative,pediatric,,booster2,18-Dec-21,11-Jun-21,190,mRNA,7,00 to 09
394,male,UC,Ustekinumab Only,95,ngative,pediatric,,booster2,01-Apr-22,09-Oct-21,174,mRNA,5,00 to 09
395,male,UC,Ustekinumab Only,54876,positive,pediatric,,booster2,29-Jun-22,05-Apr-22,85,mRNA,1,00 to 09
396,female,CD,Combination Therapy,6015,positive,pediatric,31,primary,23-Jun-21,10-Feb-21,133,mRNA,3,00 to 09
397,female,CD,Ustekinumab Only,484,positive,pediatric,,primary,22-Jul-21,09-Feb-21,163,mRNA,2,00 to 09
398,female,CD,Ustekinumab Only,65685,positive,pediatric,,booster1,17-Sep-21,10-Jul-21,69,mRNA,6,00 to 09
399,female,CD,Ustekinumab Only,992,ngative,pediatric,105,booster1,07-Jan-22,21-Jun-21,200,mRNA,1,00 to 09
400,male,CD,Ustekinumab Only,270,positive,pediatric,187,primary,15-Jun-21,26-Dec-20,171,mRNA,17,10 to 17
401,male,CD,Ustekinumab Only,15806,positive,adult,96,booster1,07-Aug-21,22-Apr-21,107,mRNA,45,40 to 49
402,male,CD,Ustekinumab Only,149,ngative,adult,9,booster2,15-Oct-21,25-May-21,143,mRNA,45,40 to 49
403,male,CD,Ustekinumab Only,61748,positive,adult,90,booster2,22-Jan-22,15-Sep-21,129,mRNA,45,40 to 49
404,male,CD,Ustekinumab Only,9700,positive,adult,5,booster2,14-May-22,05-Jan-22,129,mRNA,46,40 to 49
405,female,UC,Anti-TNF Only,67460,positive,adult,38,booster1,04-Jun-21,31-Jan-21,124,mRNA,62,60 to 69
406,female,UC,Anti-TNF Only,60536,ngative,elderly,169,booster1,22-Sep-21,15-Mar-21,191,mRNA,62,60 to 69
407,female,UC,Anti-TNF Only,9384,positive,elderly,291,booster2,16-Dec-21,15-Sep-21,92,mRNA,62,60 to 69
408,female,UC,Anti-TNF Only,66197,positive,elderly,,booster2,21-Apr-22,15-Feb-22,65,mRNA,63,60 to 69
409,male,CD,Anti-TNF Only,20936,positive,adult,187,primary,13-Jul-21,05-May-21,69,vector,45,40 to 49
410,male,CD,No Immunosuppressives,56287,positive,elderly,,booster1,01-Jul-21,09-Feb-21,142,mRNA,66,60 to 69
411,male,CD,No Immunosuppressives,669,positive,elderly,,booster2,21-Jan-22,19-Aug-21,155,mRNA,67,60 to 69
412,male,CD,Vedolizumab Only,950,positive,adult,,primary,01-Jun-21,19-Dec-20,164,vector,53,50 to 59
413,male,CD,Vedolizumab Only,63218,ngative,adult,,booster1,06-Aug-21,06-Feb-21,181,vector,53,50 to 59
414,male,CD,Vedolizumab Only,36663,positive,adult,,booster2,14-Jan-22,17-Oct-21,89,vector,54,50 to 59
415,male,CD,Vedolizumab Only,262,positive,adult,,booster2,05-Jul-22,30-Dec-21,187,vector,54,50 to 59
416,male,CD,Ustekinumab Only,47109,positive,elderly,,booster1,13-Aug-21,04-May-21,101,mRNA,70,70+
417,male,CD,Ustekinumab Only,9811,positive,elderly,,booster2,10-Mar-22,23-Oct-21,138,mRNA,70,70+
418,male,CD,Ustekinumab Only,77970,positive,elderly,,booster2,28-Jun-22,21-Apr-22,68,mRNA,71,70+
419,male,CD,Anti-TNF Only,62702,positive,adult,96,booster1,05-Aug-21,30-May-21,67,mRNA,40,40 to 49
420,male,CD,Anti-TNF Only,65584,positive,adult,243,booster1,29-Jan-22,04-Nov-21,86,mRNA,41,40 to 49
421,male,CD,Anti-TNF Only,144,ngative,adult,267,booster2,22-Feb-22,14-Aug-21,192,mRNA,41,40 to 49
422,male,CD,Anti-TNF Only,849,positive,adult,386,booster2,21-Jun-22,08-Jan-22,164,mRNA,41,40 to 49
423,female,CD,Anti-TNF Only,19610,positive,adult,,booster1,09-Jun-21,09-Dec-20,182,mRNA,56,50 to 59
424,female,CD,Anti-TNF Only,77328,ngative,adult,,booster1,31-Jul-21,08-Feb-21,173,mRNA,56,50 to 59
425,female,CD,Anti-TNF Only,118,ngative,adult,,booster2,05-Oct-21,01-Apr-21,187,mRNA,56,50 to 59
426,female,CD,Anti-TNF Only,272,positive,adult,,booster2,29-Jan-22,11-Aug-21,171,mRNA,57,50 to 59
427,male,CD,Anti-TNF Only,244,ngative,adult,191,primary,28-Jul-21,18-Jan-21,191,mRNA,43,40 to 49
428,male,CD,Anti-TNF Only,55118,ngative,adult,86,booster1,10-Nov-21,20-May-21,174,mRNA,43,40 to 49
429,male,CD,Anti-TNF Only,56584,positive,adult,9,booster1,12-Feb-22,09-Oct-21,126,mRNA,43,40 to 49
430,male,UC,Anti-TNF Only,12787,positive,adult,,primary,02-Jul-21,18-Apr-21,75,vector,42,40 to 49
431,male,UC,Anti-TNF Only,19634,positive,adult,,booster1,10-Sep-21,16-Apr-21,147,vector,42,40 to 49
432,male,UC,Anti-TNF Only,20315,positive,adult,,booster1,04-Dec-21,10-Oct-21,55,vector,42,40 to 49
433,male,CD,Anti-TNF Only,11803,ngative,elderly,,booster1,22-Jun-21,29-Dec-20,175,mRNA,78,70+
434,male,CD,Anti-TNF Only,31253,positive,elderly,,booster2,13-Oct-21,25-Jul-21,80,mRNA,78,70+
435,male,CD,Anti-TNF Only,860,positive,elderly,,booster2,02-Feb-22,19-Aug-21,167,mRNA,78,70+
436,male,CD,Anti-TNF Only,2578,positive,elderly,,booster2,29-Mar-22,29-Jan-22,59,mRNA,78,70+
437,male,CD,Anti-TNF Only,52306,positive,elderly,,booster2,19-Jul-22,04-May-22,76,mRNA,79,70+
438,female,CD,Combination Therapy,63705,positive,adult,,booster1,26-Sep-21,04-Jun-21,114,mRNA,44,40 to 49
439,male,UC,No Immunosuppressives,17052,positive,adult,90,primary,02-Jul-21,09-Mar-21,115,vector,60,60 to 69
440,male,UC,No Immunosuppressives,76860,positive,adult,,booster1,20-Aug-21,27-Feb-21,174,vector,60,60 to 69
441,male,UC,No Immunosuppressives,53036,positive,adult,,booster2,13-Jan-22,31-Oct-21,74,vector,61,60 to 69
442,male,UC,No Immunosuppressives,184,ngative,adult,,booster2,17-May-22,20-Nov-21,178,vector,61,60 to 69
443,male,UC,Anti-TNF Only,13896,ngative,adult,,booster1,26-Aug-21,19-Feb-21,188,mRNA,38,30 to 39
444,male,UC,Anti-TNF Only,24798,positive,adult,52,booster1,02-Jul-21,19-Mar-21,105,mRNA,38,30 to 39
445,male,UC,Anti-TNF Only,46371,positive,adult,217,booster1,14-Dec-21,08-Sep-21,97,mRNA,38,30 to 39
446,male,UC,Anti-TNF Only,64559,positive,adult,393,booster2,08-Jun-22,16-Apr-22,53,mRNA,39,30 to 39
447,female,UC,No Immunosuppressives,10994,positive,adult,38,pre_dose,30-Jun-21,12-Mar-21,110,mRNA,19,18 to 29
448,female,UC,No Immunosuppressives,450,positive,adult,117,primary,17-Sep-21,20-Mar-21,181,mRNA,19,18 to 29
449,female,UC,No Immunosuppressives,39406,positive,adult,5,booster1,12-Feb-22,16-Nov-21,88,mRNA,20,18 to 29
450,female,CD,Ustekinumab Only,17685,positive,adult,,primary,30-Jun-21,29-Mar-21,93,mRNA,39,30 to 39
451,female,CD,Ustekinumab Only,77025,positive,adult,,booster1,23-Jul-21,08-Feb-21,165,mRNA,39,30 to 39
452,female,CD,Ustekinumab Only,52895,positive,adult,,booster1,16-Nov-21,21-Jul-21,118,mRNA,40,40 to 49
453,female,CD,Ustekinumab Only,34840,positive,adult,,booster2,21-Jan-22,25-Oct-21,88,mRNA,40,40 to 49
454,female,CD,Ustekinumab Only,22612,positive,adult,,booster2,13-May-22,18-Jan-22,115,mRNA,40,40 to 49
455,male,CD,No Immunosuppressives,54960,positive,adult,,primary,15-Jul-21,15-May-21,61,mRNA,51,50 to 59
456,male,CD,No Immunosuppressives,48831,positive,adult,,booster1,20-Aug-21,15-Mar-21,158,mRNA,51,50 to 59
457,male,CD,No Immunosuppressives,7567,positive,adult,,booster1,02-Dec-21,23-Sep-21,70,mRNA,51,50 to 59
458,male,CD,No Immunosuppressives,295,positive,adult,,booster2,25-Feb-22,04-Oct-21,144,mRNA,52,50 to 59
459,other ,CD,No Immunosuppressives,63491,positive,adult,38,booster2,21-May-22,19-Feb-22,91,mRNA,52,50 to 59
460,male,UC,Anti-TNF Only,74139,positive,adult,,booster1,21-Jul-21,31-Jan-21,171,mRNA,25,18 to 29
461,female,CD,Anti-TNF Only,40177,positive,adult,294,booster1,01-Jul-21,14-Feb-21,137,vector,47,40 to 49
462,other ,CD,Anti-TNF Only,37066,ngative,adult,197,booster1,06-Oct-21,12-Apr-21,177,vector,48,40 to 49
463,female,CD,Anti-TNF Only,25745,positive,adult,111,booster2,31-Dec-21,03-Sep-21,119,vector,48,40 to 49
464,female,CD,Anti-TNF Only,40399,positive,adult,34,booster2,18-Mar-22,10-Dec-21,98,vector,48,40 to 49
465,male,UC,No Immunosuppressives,6318,ngative,adult,,booster1,09-Jul-21,28-Dec-20,193,mRNA,54,50 to 59
466,male,UC,No Immunosuppressives,356,positive,adult,,booster2,22-Apr-22,02-Nov-21,171,mRNA,55,50 to 59
467,male,CD,Combination Therapy,59166,positive,adult,,booster1,25-Aug-21,12-Mar-21,166,mRNA,55,50 to 59
468,male,CD,Combination Therapy,13777,positive,adult,,booster2,18-Jun-22,31-Mar-22,79,mRNA,56,50 to 59
469,female,CD,Anti-TNF Only,41039,positive,adult,169,booster1,15-Jul-21,21-Jan-21,175,mRNA,57,50 to 59
470,female,CD,Anti-TNF Only,496,positive,adult,,booster2,09-Oct-21,17-Apr-21,175,mRNA,57,50 to 59
471,female,CD,Anti-TNF Only,76691,positive,adult,,booster2,18-Mar-22,28-Nov-21,110,mRNA,58,50 to 59
472,female,CD,Anti-TNF Only,43097,positive,adult,,booster2,01-Jul-22,04-May-22,58,mRNA,58,50 to 59
473,male,CD,Anti-TNF Only,1353,positive,adult,,booster1,31-Aug-21,17-Apr-21,136,mRNA,58,50 to 59
474,female,CD,Anti-TNF Only,19309,positive,adult,199,booster1,07-Aug-21,16-Jun-21,52,mRNA,61,60 to 69
475,female,CD,Anti-TNF Only,6840,positive,adult,157,booster1,18-Sep-21,13-Apr-21,158,mRNA,61,60 to 69
476,female,CD,Anti-TNF Only,200,ngative,adult,69,booster2,15-Dec-21,13-Jun-21,185,mRNA,61,60 to 69
477,female,CD,Anti-TNF Only,672,positive,adult,11,booster2,05-Mar-22,17-Sep-21,169,mRNA,62,60 to 69
478,male,UC,Tofacitinib Only,69910,positive,elderly,,booster1,04-Aug-21,12-Feb-21,173,vector,62,60 to 69
479,male,UC,Tofacitinib Only,49961,positive,elderly,291,booster2,26-May-22,01-Apr-22,55,vector,63,60 to 69
480,female,CD,Ustekinumab Only,70426,positive,adult,,booster1,24-Jul-21,11-Feb-21,163,mRNA,45,40 to 49
481,male,UC,Vedolizumab Only,37600,positive,adult,,booster1,19-Jun-21,31-Jan-21,139,mRNA,43,40 to 49
482,male,UC,Vedolizumab Only,440,positive,adult,,booster2,10-Dec-21,05-Jun-21,188,mRNA,44,40 to 49
483,male,UC,Vedolizumab Only,5328,positive,adult,,booster2,04-Feb-22,03-Oct-21,124,mRNA,44,40 to 49
484,female,CD,No Immunosuppressives,14104,positive,adult,226,booster1,03-Jul-21,15-Feb-21,138,mRNA,38,30 to 39
485,female,CD,No Immunosuppressives,45189,positive,adult,82,booster1,24-Nov-21,24-Jul-21,123,mRNA,38,30 to 39
486,female,CD,No Immunosuppressives,62802,positive,adult,41,booster2,04-Jan-22,28-Sep-21,98,mRNA,38,30 to 39
487,female,CD,No Immunosuppressives,26483,positive,adult,79,booster2,04-May-22,12-Jan-22,112,mRNA,39,30 to 39
488,male,CD,No Immunosuppressives,25364,positive,elderly,,booster1,04-Aug-21,03-Apr-21,123,mRNA,71,70+
489,male,CD,No Immunosuppressives,55460,positive,elderly,,booster1,15-Oct-21,01-Aug-21,75,mRNA,71,70+
490,male,CD,No Immunosuppressives,15885,positive,elderly,,booster2,28-Dec-21,21-Oct-21,68,mRNA,71,70+
491,male,CD,No Immunosuppressives,27,ngative,elderly,,booster2,19-Apr-22,06-Oct-21,195,mRNA,71,70+
492,female,UC,No Immunosuppressives,53432,positive,adult,,booster1,18-Jul-21,19-May-21,60,vector,54,50 to 59
493,female,UC,No Immunosuppressives,174,ngative,adult,,booster2,06-Feb-22,07-Aug-21,183,vector,55,50 to 59
494,female,UC,Vedolizumab Only,78217,positive,adult,,booster1,29-Jul-21,05-May-21,85,vector,59,50 to 59
495,female,UC,Vedolizumab Only,17001,ngative,adult,,booster1,07-Jan-22,25-Jun-21,196,vector,60,60 to 69
496,female,UC,Vedolizumab Only,56752,positive,adult,,booster2,15-Mar-22,09-Nov-21,126,vector,60,60 to 69
497,female,UC,Vedolizumab Only,67642,positive,adult,,booster2,22-Jul-22,22-Apr-22,91,vector,60,60 to 69
498,male,CD,Anti-TNF Only,55773,positive,elderly,,booster1,07-Jul-21,04-May-21,64,mRNA,71,70+
499,male,CD,Anti-TNF Only,27700,positive,elderly,,booster2,02-Oct-21,13-Jul-21,81,mRNA,71,70+
500,male,CD,Anti-TNF Only,64471,positive,elderly,,booster2,10-Mar-22,05-Jan-22,64,mRNA,72,70+
501,male,CD,Anti-TNF Only,60308,positive,elderly,,booster2,15-Jun-22,07-Apr-22,69,mRNA,72,70+
502,male,CD,Anti-TNF Only,420,positive,elderly,,booster2,26-Jul-22,07-Jan-22,200,mRNA,72,70+
503,male,CD,Anti-TNF Only,12270,positive,adult,,booster1,05-Aug-21,03-Apr-21,124,mRNA,56,50 to 59
504,male,CD,Anti-TNF Only,37815,positive,adult,,booster1,17-Dec-21,23-Aug-21,116,mRNA,56,50 to 59
505,male,CD,Anti-TNF Only,18758,positive,adult,,booster2,11-Mar-22,01-Jan-22,69,mRNA,56,50 to 59
506,male,CD,Anti-TNF Only,47143,positive,adult,,booster2,31-May-22,24-Mar-22,68,mRNA,57,50 to 59
507,male,UC,No Immunosuppressives,60822,ngative,adult,,booster1,14-Jul-21,09-Jan-21,186,vector,59,50 to 59
508,male,UC,No Immunosuppressives,26051,positive,adult,,booster1,22-Dec-21,01-Aug-21,143,vector,60,60 to 69
509,male,CD,Anti-TNF Only,17895,positive,elderly,,primary,30-Jun-21,23-Mar-21,99,mRNA,69,60 to 69
510,male,CD,Anti-TNF Only,42006,positive,elderly,,booster1,25-Aug-21,16-May-21,101,mRNA,69,60 to 69
511,male,CD,Anti-TNF Only,47564,positive,elderly,,booster1,15-Dec-21,23-Oct-21,53,mRNA,69,60 to 69
512,male,CD,Anti-TNF Only,12521,positive,elderly,,booster1,29-Jul-22,17-Mar-22,134,mRNA,70,70+
513,female,UC,No Immunosuppressives,33367,positive,adult,,booster1,20-Jul-21,13-Apr-21,98,mRNA,50,50 to 59
514,male,UC,Tofacitinib Only,34491,positive,adult,,booster1,10-Jul-21,29-Apr-21,72,vector,34,30 to 39
515,male,UC,Tofacitinib Only,8528,positive,adult,,booster2,09-Apr-22,01-Dec-21,129,vector,35,30 to 39
516,female,CD,Anti-TNF Only,78460,positive,adult,,booster1,15-Jul-21,31-Mar-21,106,mRNA,41,40 to 49
517,female,CD,Anti-TNF Only,70111,positive,adult,,booster2,07-Oct-21,14-Jul-21,85,mRNA,41,40 to 49
518,female,CD,Anti-TNF Only,6937,positive,adult,,booster2,08-Feb-22,13-Oct-21,118,mRNA,42,40 to 49
519,female,CD,Anti-TNF Only,23910,positive,adult,,booster2,03-Apr-22,18-Nov-21,136,mRNA,42,40 to 49
520,male,CD,Ustekinumab Only,18613,positive,adult,,booster1,10-Aug-21,10-Mar-21,153,mRNA,53,50 to 59
521,male,CD,Ustekinumab Only,33255,positive,adult,,booster1,25-Jan-22,05-Aug-21,173,mRNA,53,50 to 59
522,female,CD,Ustekinumab Only,43071,positive,adult,,booster1,30-Jul-21,13-Jan-21,198,mRNA,43,40 to 49
523,female,CD,Ustekinumab Only,69412,positive,adult,,booster2,30-Sep-21,31-May-21,122,mRNA,43,40 to 49
524,female,CD,Ustekinumab Only,79215,positive,adult,,booster2,27-Jan-22,11-Sep-21,138,mRNA,43,40 to 49
525,female,CD,Ustekinumab Only,77325,positive,adult,,booster2,29-Jan-22,12-Nov-21,78,mRNA,43,40 to 49
526,male,UC,Corticosteroids,15183,positive,adult,,primary,07-Aug-21,15-Apr-21,114,mRNA,21,18 to 29
527,male,UC,Corticosteroids,44200,positive,adult,,booster1,24-Sep-21,12-Jul-21,74,mRNA,21,18 to 29
528,male,UC,Corticosteroids,71,ngative,adult,,booster2,20-Nov-21,29-May-21,175,mRNA,21,18 to 29
529,male,UC,Corticosteroids,688,positive,adult,,booster2,10-Mar-22,23-Sep-21,168,mRNA,21,18 to 29
530,male,UC,Corticosteroids,317,positive,adult,,booster2,30-Jun-22,04-Jan-22,177,mRNA,21,18 to 29
531,female,CD,Immunomodulator Only,3510,ngative,adult,,booster1,06-Aug-21,25-Feb-21,162,vector,38,30 to 39
532,female,CD,Immunomodulator Only,69515,positive,adult,,booster2,13-Nov-21,31-Jul-21,105,vector,39,30 to 39
533,female,CD,Immunomodulator Only,210,ngative,adult,,booster2,23-Feb-22,17-Aug-21,190,vector,39,30 to 39
534,female,CD,Anti-TNF Only,688,positive,adult,98,primary,09-Oct-21,44320,158,vector,39,30 to 39
535,male,CD,Combination Therapy,194,ngative,adult,,primary,03-Sep-21,11-Mar-21,176,mRNA,60,60 to 69
536,male,CD,Combination Therapy,2963,positive,adult,,booster1,01-Oct-21,23-Jul-21,70,mRNA,60,60 to 69
537,male,CD,Combination Therapy,74896,positive,adult,,booster1,11-Feb-22,26-Sep-21,138,mRNA,61,60 to 69
538,female,CD,Anti-TNF Only,74000,positive,adult,135,booster1,29-Sep-21,28-Jun-21,93,vector,59,50 to 59
539,female,CD,Anti-TNF Only,24270,positive,adult,,booster2,19-Nov-21,30-Jul-21,112,vector,59,50 to 59
540,female,CD,Anti-TNF Only,30141,positive,adult,40,booster2,23-Mar-22,28-Jan-22,54,vector,60,60 to 69
541,male,CD,Anti-TNF Only,63907,positive,adult,,booster1,18-Sep-21,17-Jul-21,63,mRNA,55,50 to 59
542,male,CD,Anti-TNF Only,413,positive,adult,,booster2,15-Mar-22,26-Sep-21,170,mRNA,56,50 to 59
543,female,CD,Combination Therapy,10915,positive,adult,,booster1,13-Oct-21,19-Jun-21,116,mRNA,28,18 to 29
544,female,CD,Combination Therapy,66982,positive,adult,,booster2,27-Nov-21,24-Jul-21,126,mRNA,28,18 to 29
545,female,CD,Combination Therapy,54718,positive,adult,,booster2,22-Apr-22,28-Dec-21,115,mRNA,28,18 to 29
546,female,CD,Combination Therapy,2429,positive,adult,,booster2,27-May-22,05-Apr-22,52,mRNA,29,18 to 29
547,female,CD,Vedolizumab Only,38421,positive,adult,,booster1,17-Sep-21,10-Jul-21,69,mRNA,54,50 to 59
548,female,CD,Vedolizumab Only,887,positive,adult,,booster2,03-Nov-21,28-May-21,159,mRNA,54,50 to 59
549,female,CD,Vedolizumab Only,670,positive,adult,,booster2,12-May-22,14-Dec-21,149,mRNA,55,50 to 59
550,female,CD,Combination Therapy,5111,positive,adult,21,booster1,06-Oct-21,17-Apr-21,172,mRNA,21,18 to 29
551,female,CD,Combination Therapy,31516,positive,adult,62,booster2,16-Nov-21,11-Jul-21,128,mRNA,21,18 to 29
552,female,CD,Combination Therapy,58633,positive,adult,181,booster2,15-Mar-22,02-Jan-22,72,mRNA,21,18 to 29
553,female,CD,Anti-TNF Only,15224,positive,elderly,,booster1,30-Sep-21,24-May-21,129,vector,72,70+
554,male,UC,Immunomodulator Only,60629,positive,adult,36,booster1,01-Dec-21,22-Jul-21,132,mRNA,26,18 to 29
555,female,CD,Anti-TNF Only,256,positive,adult,,booster2,11-Feb-22,14-Aug-21,181,mRNA,50,50 to 59
556,male,UC,Vedolizumab Only,227,ngative,elderly,,primary,26-May-21,11-Nov-20,196,mRNA,66,60 to 69
557,male,UC,Vedolizumab Only,6957,positive,elderly,,booster1,26-Jun-21,09-Jan-21,168,mRNA,66,60 to 69
558,male,UC,Vedolizumab Only,70663,positive,elderly,,booster2,14-Oct-21,31-Jul-21,75,mRNA,66,60 to 69
559,male,UC,Vedolizumab Only,69402,positive,elderly,,booster2,28-Jan-22,21-Nov-21,68,mRNA,67,60 to 69
560,female,UC,Combination Therapy,14158,positive,adult,357,primary,19-May-21,02-Feb-21,106,vector,46,40 to 49
561,female,UC,Combination Therapy,7828,positive,adult,306,booster1,09-Jul-21,05-May-21,65,vector,46,40 to 49
562,female,UC,Combination Therapy,114,ngative,adult,94,booster2,06-Feb-22,12-Aug-21,178,vector,47,40 to 49
563,female,UC,Combination Therapy,585,positive,adult,56,booster2,16-Mar-22,30-Sep-21,167,vector,47,40 to 49
564,other,UC,Combination Therapy,10873,positive,adult,55,booster2,05-Jul-22,15-Mar-22,112,vector,47,40 to 49
565,female,CD,Anti-TNF Only,13201,positive,adult,30,pre_dose,21-Apr-21,26-Jan-21,85,mRNA,32,30 to 39
566,female,CD,Anti-TNF Only,52373,positive,adult,395,booster2,21-Apr-22,07-Jan-22,104,mRNA,33,30 to 39
567,male,CD,Ustekinumab Only,74277,positive,adult,,primary,25-Sep-21,04-Aug-21,52,vector,60,60 to 69
568,male,CD,Ustekinumab Only,79702,ngative,adult,,booster1,23-Oct-21,26-May-21,150,vector,60,60 to 69
569,female,CD,Vedolizumab Only,15425,positive,adult,,booster1,03-Aug-21,07-Jun-21,57,mRNA,29,18 to 29
570,female,CD,Vedolizumab Only,7234,positive,adult,259,primary,22-May-21,13-Feb-21,98,mRNA,39,30 to 39
571,female,CD,Vedolizumab Only,46821,positive,adult,212,booster1,08-Jul-21,05-Apr-21,94,mRNA,39,30 to 39
572,female,CD,Vedolizumab Only,4047,positive,adult,135,booster1,23-Sep-21,12-Jul-21,73,mRNA,39,30 to 39
573,female,CD,Vedolizumab Only,16295,positive,adult,4,booster2,01-Feb-22,25-Aug-21,160,mRNA,39,30 to 39
574,female,CD,Vedolizumab Only,20,ngative,adult,18,booster2,23-Feb-22,17-Aug-21,190,mRNA,40,40 to 49
575,male,UC,Anti-TNF Only,450,positive,adult,271,pre_dose,24-Apr-21,22-Oct-20,184,mRNA,27,18 to 29
576,female,CD,Vedolizumab Only,9380,positive,adult,,primary,22-Jun-21,16-Feb-21,126,vector,36,30 to 39
577,female,CD,Vedolizumab Only,41243,positive,adult,,booster1,04-Sep-21,10-Jun-21,86,vector,36,30 to 39
578,female,CD,Vedolizumab Only,13604,positive,adult,,booster1,16-Dec-21,18-Aug-21,120,vector,37,30 to 39
579,female,CD,Vedolizumab Only,51376,positive,adult,,booster2,30-Mar-22,06-Feb-22,52,vector,37,30 to 39
580,female,CD,Vedolizumab Only,58758,positive,adult,,booster2,23-Jun-22,16-Jan-22,158,vector,37,30 to 39
581,male,UC,Anti-TNF Only,63062,ngative,adult,,booster1,22-Jul-21,06-Feb-21,166,mRNA,51,50 to 59
582,male,UC,Anti-TNF Only,28381,positive,adult,,booster1,06-Jan-22,26-Jul-21,164,mRNA,51,50 to 59
583,female,CD,Vedolizumab Only,5122,positive,adult,,primary,14-Apr-21,09-Dec-20,126,mRNA,35,30 to 39
584,female,CD,Vedolizumab Only,25836,positive,adult,,booster1,10-Jun-21,01-Apr-21,70,mRNA,35,30 to 39
585,female,CD,Vedolizumab Only,75797,ngative,adult,,booster1,30-Sep-21,23-Mar-21,191,mRNA,35,30 to 39
586,female,CD,Vedolizumab Only,6,ngative,adult,,booster2,29-Mar-22,26-Oct-21,154,mRNA,36,30 to 39
587,female,CD,Anti-TNF Only,46410,positive,adult,,booster1,19-Sep-21,27-Apr-21,145,mRNA,57,50 to 59
588,female,CD,Anti-TNF Only,26346,positive,adult,,booster2,30-Jan-22,10-Dec-21,51,mRNA,57,50 to 59
589,female,CD,Anti-TNF Only,10376,positive,adult,,booster2,24-Apr-22,02-Jan-22,112,mRNA,57,50 to 59
590,female,CD,Anti-TNF Only,79051,positive,adult,,booster1,20-Jul-21,05-May-21,76,mRNA,58,50 to 59
591,female,CD,Anti-TNF Only,72840,positive,adult,,booster2,18-Nov-21,26-Jun-21,145,mRNA,58,50 to 59
592,female,CD,Anti-TNF Only,58652,positive,adult,,booster2,01-Mar-22,27-Dec-21,64,mRNA,58,50 to 59
593,female,CD,Vedolizumab Only,64971,positive,adult,,booster1,14-Dec-21,12-Oct-21,63,mRNA,32,30 to 39
594,female,CD,Vedolizumab Only,38668,positive,adult,,booster2,25-Mar-22,14-Jan-22,70,mRNA,33,30 to 39
595,male,CD,Anti-TNF Only,23041,positive,adult,,booster1,07-Jul-21,18-Feb-21,139,mRNA,42,40 to 49
596,male,CD,Anti-TNF Only,13296,positive,adult,,booster1,01-Sep-21,27-May-21,97,mRNA,42,40 to 49
597,male,CD,Anti-TNF Only,623,positive,adult,,booster2,22-Dec-21,31-Jul-21,144,mRNA,42,40 to 49
598,male,CD,Anti-TNF Only,825,positive,adult,,booster2,08-Jun-22,18-Jan-22,141,mRNA,43,40 to 49
599,female,CD,Vedolizumab Only,69970,positive,elderly,,primary,18-May-21,25-Mar-21,54,mRNA,67,60 to 69
600,female,CD,Vedolizumab Only,42492,positive,elderly,,booster1,13-Jul-21,10-Mar-21,125,mRNA,67,60 to 69
601,female,CD,Vedolizumab Only,14424,positive,elderly,,booster1,06-Jan-22,02-Nov-21,65,mRNA,67,60 to 69
602,female,CD,Vedolizumab Only,181,ngative,elderly,,booster2,03-Feb-22,07-Aug-21,180,mRNA,67,60 to 69
603,male,UC,Anti-TNF Only,67005,positive,adult,,booster1,15-Jul-21,24-Feb-21,141,mRNA,28,18 to 29
604,female,CD,Ustekinumab Only,48715,positive,adult,,booster1,27-May-21,06-Dec-20,172,mRNA,35,30 to 39
605,female,CD,Ustekinumab Only,41666,positive,adult,262,booster1,21-Aug-21,20-Mar-21,154,mRNA,36,30 to 39
606,female,CD,Ustekinumab Only,229,ngative,adult,218,booster2,12-Mar-22,24-Sep-21,169,mRNA,36,30 to 39
607,female,CD,Ustekinumab Only,3234,positive,adult,77,primary,02-Jun-21,21-Jan-21,132,mRNA,48,40 to 49
608,female,CD,Ustekinumab Only,48604,positive,adult,23,booster1,04-Aug-21,17-Apr-21,109,mRNA,48,40 to 49
609,female,CD,Ustekinumab Only,69541,ngative,adult,,booster1,19-Jan-22,19-Jul-21,184,mRNA,49,40 to 49
610,female,CD,Ustekinumab Only,70251,positive,adult,,booster2,17-Jun-22,06-Apr-22,72,mRNA,49,40 to 49
611,female,CD,Vedolizumab Only,23227,positive,adult,220,booster1,06-Jul-21,28-Feb-21,128,vector,40,40 to 49
612,female,CD,Vedolizumab Only,52284,positive,adult,71,booster2,02-Dec-21,12-Oct-21,51,vector,41,40 to 49
613,female,CD,Vedolizumab Only,93,ngative,adult,41,booster2,24-Mar-22,08-Sep-21,197,vector,41,40 to 49
614,female,CD,Anti-TNF Only,47536,positive,elderly,,booster1,10-Aug-21,08-Apr-21,124,mRNA,67,60 to 69
615,female,CD,Anti-TNF Only,453,positive,elderly,,booster2,25-Jan-22,04-Sep-21,143,mRNA,67,60 to 69
616,female,CD,Anti-TNF Only,291,positive,elderly,,booster2,04-Jun-22,17-Nov-21,199,mRNA,68,60 to 69
617,female,CD,Ustekinumab Only,596,positive,adult,18,pre_dose,09-Jun-21,05-Jan-21,155,vector,58,50 to 59
618,female,CD,Ustekinumab Only,6808,positive,adult,59,primary,20-Jul-21,28-Apr-21,83,vector,58,50 to 59
619,female,CD,Ustekinumab Only,259,positive,adult,,booster1,12-Aug-21,08-Mar-21,157,vector,58,50 to 59
620,female,CD,Ustekinumab Only,44903,positive,adult,294,booster2,12-Mar-22,17-Jan-22,54,vector,59,50 to 59
621,female,CD,Ustekinumab Only,39376,positive,adult,405,booster2,01-Jul-22,11-May-22,51,vector,59,50 to 59
622,female,CD,Combination Therapy,301,positive,adult,,primary,04-Jun-21,03-Dec-20,183,mRNA,36,30 to 39
623,female,CD,Combination Therapy,2759,positive,adult,,booster1,29-Jul-21,19-Feb-21,160,mRNA,36,30 to 39
624,female,CD,Combination Therapy,415,positive,adult,,booster2,11-Mar-22,05-Sep-21,187,mRNA,37,30 to 39
625,female,CD,Anti-TNF Only,27826,positive,elderly,40,primary,05-Mar-21,30-Dec-20,65,mRNA,64,60 to 69
626,female,CD,Anti-TNF Only,12756,positive,elderly,265,primary,16-Oct-21,15-Jun-21,123,mRNA,64,60 to 69
627,female,CD,Anti-TNF Only,27039,positive,elderly,331,booster1,21-Dec-21,27-Jul-21,147,mRNA,65,60 to 69
628,female,UC,Vedolizumab Only,46194,ngative,adult,,booster1,06-Aug-21,14-Feb-21,173,mRNA,24,18 to 29
629,female,UC,Vedolizumab Only,296,positive,adult,,booster2,26-Jan-22,09-Aug-21,170,mRNA,25,18 to 29
630,female,UC,Vedolizumab Only,158,ngative,adult,,booster2,22-May-22,09-Nov-21,194,mRNA,25,18 to 29
631,female,CD,Combination Therapy,63336,positive,adult,218,booster1,16-Sep-21,26-Jun-21,82,vector,35,30 to 39
632,female,CD,Combination Therapy,53232,positive,adult,135,booster2,08-Dec-21,11-Oct-21,58,vector,35,30 to 39
633,female,CD,Ustekinumab Only,34668,positive,adult,,booster1,15-Jul-21,13-Feb-21,152,mRNA,43,40 to 49
634,male,CD,Vedolizumab Only,53250,positive,adult,290,booster1,22-Jul-21,06-Mar-21,138,mRNA,41,40 to 49
635,male,CD,Vedolizumab Only,61,ngative,adult,177,booster2,12-Nov-21,26-Apr-21,200,mRNA,41,40 to 49
636,male,CD,Vedolizumab Only,454,positive,adult,92,booster2,05-Feb-22,26-Jul-21,194,mRNA,42,40 to 49
637,male,CD,Anti-TNF Only,40785,positive,adult,,booster1,22-Aug-21,13-Apr-21,131,mRNA,32,30 to 39
638,male,CD,Anti-TNF Only,68581,positive,adult,,booster2,18-Dec-21,19-Sep-21,90,mRNA,33,30 to 39
639,female,CD,Anti-TNF Only,74796,positive,adult,,booster1,19-Aug-21,27-May-21,84,mRNA,54,50 to 59
640,female,CD,Vedolizumab Only,15771,positive,adult,,booster1,24-Jul-21,20-May-21,65,vector,53,50 to 59
641,female,CD,Vedolizumab Only,213,ngative,adult,,booster2,11-Nov-21,26-Apr-21,199,vector,54,50 to 59
642,female,CD,Vedolizumab Only,35506,positive,adult,,booster2,18-Feb-22,19-Oct-21,122,vector,54,50 to 59
643,female,CD,Vedolizumab Only,10519,positive,adult,,booster2,18-Mar-22,13-Dec-21,95,vector,54,50 to 59
644,female,CD,Vedolizumab Only,853,positive,adult,,booster2,09-Jul-22,11-Feb-22,148,vector,54,50 to 59
645,female,CD,Vedolizumab Only,6854,positive,adult,,booster1,25-Aug-21,19-Feb-21,187,mRNA,36,30 to 39
646,female,CD,Vedolizumab Only,59810,positive,adult,,booster2,24-Dec-21,23-Aug-21,123,mRNA,36,30 to 39
647,female,UC,No Immunosuppressives,497,positive,adult,203,pre_dose,30-Mar-21,10-Oct-20,171,vector,26,18 to 29
648,female,UC,No Immunosuppressives,71594,positive,adult,522,booster2,12-Feb-22,08-Dec-21,66,vector,27,18 to 29
649,male,CD,Ustekinumab Only,17756,positive,adult,,pre_dose,25-Feb-21,25-Oct-20,123,mRNA,54,50 to 59
650,female,CD,Anti-TNF Only,5,ngative,adult,142,pre_dose,12-Mar-21,21-Sep-20,172,mRNA,50,50 to 59
651,female,CD,Anti-TNF Only,17458,positive,adult,225,primary,03-Jun-21,07-Feb-21,116,mRNA,50,50 to 59
652,female,CD,Anti-TNF Only,38065,positive,adult,282,booster1,30-Jul-21,07-Apr-21,114,mRNA,50,50 to 59
653,female,CD,Anti-TNF Only,11999,positive,adult,444,booster1,08-Jan-22,01-Oct-21,99,mRNA,50,50 to 59
654,female,CD,Anti-TNF Only,267,positive,adult,470,booster2,03-Feb-22,28-Jul-21,190,mRNA,50,50 to 59
655,female,CD,Anti-TNF Only,7506,positive,adult,582,booster2,26-May-22,12-Feb-22,103,mRNA,51,50 to 59
656,male,UC,Tofacitinib Only,3688,positive,adult,,booster2,21-Jul-22,06-Apr-22,106,vector,38,30 to 39
657,female,CD,Vedolizumab Only,27205,positive,adult,259,booster1,08-Aug-21,05-May-21,95,mRNA,52,50 to 59
658,female,CD,Vedolizumab Only,71909,positive,adult,18,booster2,12-May-22,01-Feb-22,100,mRNA,53,50 to 59
659,female,CD,Anti-TNF Only,628,positive,adult,262,primary,28-Apr-21,11-Nov-20,168,mRNA,49,40 to 49
660,female,CD,Anti-TNF Only,32,ngative,adult,124,booster2,22-Oct-21,03-May-21,172,mRNA,49,40 to 49
661,female,CD,Combination Therapy,13459,positive,adult,224,booster1,09-Jul-21,06-Mar-21,125,mRNA,23,18 to 29
662,female,CD,Combination Therapy,46086,positive,adult,43,booster2,02-Apr-22,28-Nov-21,125,mRNA,24,18 to 29
663,female,CD,Vedolizumab Only,40977,positive,adult,294,primary,27-Feb-21,26-Dec-20,63,mRNA,37,30 to 39
664,female,CD,Vedolizumab Only,1981,positive,adult,287,booster1,06-Mar-21,25-Aug-20,193,mRNA,37,30 to 39
665,female,CD,Vedolizumab Only,10118,positive,adult,,booster1,18-Dec-21,16-Oct-21,63,mRNA,38,30 to 39
666,female,CD,Vedolizumab Only,67618,positive,adult,5,booster1,23-Dec-21,28-Oct-21,56,mRNA,38,30 to 39
667,female,CD,Anti-TNF Only,6742,positive,adult,25,pre_dose,24-Dec-20,03-Oct-20,82,vector,41,40 to 49
668,female,CD,Anti-TNF Only,10773,positive,adult,304,primary,29-Sep-21,12-Jun-21,109,vector,42,40 to 49
669,male,CD,Anti-TNF Only,18458,positive,adult,218,pre_dose,02-Feb-21,29-Oct-20,96,mRNA,48,40 to 49
670,male,CD,Anti-TNF Only,54013,positive,adult,408,booster1,22-Jul-21,25-May-21,58,mRNA,48,40 to 49
671,male,CD,Anti-TNF Only,6807,positive,adult,590,booster2,20-Jan-22,28-Nov-21,53,mRNA,48,40 to 49
672,male,CD,Anti-TNF Only,465,positive,adult,696,booster2,06-May-22,20-Nov-21,167,mRNA,49,40 to 49
673,male,CD,Anti-TNF Only,59873,positive,adult,738,booster2,17-Jun-22,22-Feb-22,115,mRNA,49,40 to 49
674,female,CD,Anti-TNF Only,18183,positive,adult,101,pre_dose,13-Mar-21,23-Dec-20,80,mRNA,29,18 to 29
675,female,CD,Anti-TNF Only,6192,positive,adult,273,booster1,01-Sep-21,19-Apr-21,135,mRNA,29,18 to 29
676,male,UC,Combination Therapy,824,positive,adult,119,pre_dose,08-Apr-21,28-Oct-20,162,mRNA,44,40 to 49
677,male,UC,Combination Therapy,281,positive,adult,199,primary,27-Jun-21,25-Jan-21,153,mRNA,44,40 to 49
678,male,UC,Combination Therapy,7361,positive,adult,238,booster1,05-Aug-21,14-Jun-21,52,mRNA,44,40 to 49
679,male,UC,Combination Therapy,3332,positive,adult,77,booster1,23-Dec-21,21-Oct-21,63,mRNA,45,40 to 49
680,female,UC,Anti-TNF Only,65272,positive,adult,359,primary,27-May-21,05-Apr-21,52,mRNA,30,30 to 39
681,female,UC,Anti-TNF Only,18129,positive,adult,319,booster1,06-Jul-21,31-Jan-21,156,mRNA,30,30 to 39
682,female,UC,Anti-TNF Only,26027,positive,adult,239,booster1,24-Sep-21,08-Jul-21,78,mRNA,30,30 to 39
683,female,UC,Anti-TNF Only,20864,positive,adult,105,booster2,05-Feb-22,30-Nov-21,67,mRNA,30,30 to 39
684,female,CD,Combination Therapy,7551,ngative,adult,236,booster1,06-Aug-21,21-Jan-21,197,mRNA,48,40 to 49
685,female,CD,Combination Therapy,62088,positive,adult,98,booster1,22-Dec-21,06-Sep-21,107,mRNA,49,40 to 49
686,female,CD,Combination Therapy,47974,positive,adult,32,booster2,26-Feb-22,28-Dec-21,60,mRNA,49,40 to 49
687,female,CD,Combination Therapy,273,positive,adult,73,booster2,11-Jun-22,28-Nov-21,195,mRNA,49,40 to 49
688,female,CD,Anti-TNF Only,17763,positive,adult,,pre_dose,16-Mar-21,12-Nov-20,124,vector,61,60 to 69
689,female,CD,Anti-TNF Only,423,positive,adult,23,primary,18-May-21,19-Nov-20,180,vector,61,60 to 69
690,female,CD,Anti-TNF Only,42298,positive,adult,,booster1,20-Jul-21,24-Mar-21,118,vector,61,60 to 69
691,female,CD,Anti-TNF Only,45441,positive,adult,,booster1,18-Sep-21,25-May-21,116,vector,61,60 to 69
692,female,CD,Anti-TNF Only,6435,positive,adult,,booster2,27-Oct-21,23-Aug-21,65,vector,61,60 to 69
693,female,CD,Anti-TNF Only,42713,positive,adult,,booster2,02-Mar-22,16-Sep-21,167,vector,62,60 to 69
694,other,CD,Anti-TNF Only,528,positive,elderly,,booster2,25-Jun-22,18-Jan-22,158,vector,62,60 to 69
695,female,CD,Anti-TNF Only,76028,positive,adult,198,booster1,19-Aug-21,27-May-21,84,vector,48,40 to 49
696,female,CD,Anti-TNF Only,44399,positive,adult,21,booster1,26-Mar-22,16-Jan-22,69,vector,49,40 to 49
697,female,CD,Combination Therapy,75373,positive,adult,,booster1,23-Jul-21,17-Mar-21,128,mRNA,55,50 to 59
698,female,CD,Combination Therapy,73143,positive,adult,,booster2,23-Nov-21,19-Sep-21,65,mRNA,56,50 to 59
699,female,CD,Combination Therapy,76481,positive,adult,,booster2,18-Feb-22,29-Nov-21,81,mRNA,56,50 to 59
700,female,CD,Combination Therapy,16200,positive,adult,401,booster2,19-Apr-22,09-Dec-21,131,mRNA,56,50 to 59
701,female,CD,Combination Therapy,2671,positive,adult,350,booster2,04-Aug-22,04-Apr-22,122,mRNA,57,50 to 59
702,male,UC,Anti-TNF Only,522,positive,adult,210,pre_dose,29-Dec-20,20-Jul-20,162,mRNA,59,50 to 59
703,male,UC,Anti-TNF Only,11369,positive,adult,39,primary,27-May-21,10-Feb-21,106,mRNA,59,50 to 59
704,male,UC,Anti-TNF Only,58343,ngative,adult,,booster1,06-Aug-21,22-Jan-21,196,mRNA,59,50 to 59
705,male,UC,Anti-TNF Only,259,positive,adult,,booster2,07-Nov-21,07-May-21,184,mRNA,59,50 to 59
706,female,CD,Anti-TNF Only,495,positive,adult,,pre_dose,21-Jan-21,06-Jul-20,199,mRNA,56,50 to 59
707,female,CD,Anti-TNF Only,19931,positive,adult,,primary,24-Feb-21,19-Dec-20,67,mRNA,57,50 to 59
708,female,CD,Anti-TNF Only,998,positive,adult,,booster1,16-Jun-21,24-Apr-21,53,mRNA,57,50 to 59
709,female,CD,Anti-TNF Only,17636,positive,adult,401,booster1,05-Aug-21,22-Feb-21,164,mRNA,57,50 to 59
710,female,CD,Anti-TNF Only,69996,positive,adult,291,booster1,02-Oct-21,23-Apr-21,162,mRNA,57,50 to 59
711,female,CD,Anti-TNF Only,22247,positive,adult,395,booster2,14-Jan-22,06-Nov-21,69,mRNA,57,50 to 59
712,female,CD,Anti-TNF Only,252,positive,adult,540,booster2,08-Jun-22,17-Dec-21,173,mRNA,58,50 to 59
713,female,CD,Anti-TNF Only,65351,positive,elderly,321,booster1,22-Jul-21,26-Feb-21,146,mRNA,66,60 to 69
714,female,CD,Anti-TNF Only,65852,positive,elderly,197,booster2,23-Nov-21,28-Aug-21,87,mRNA,66,60 to 69
715,male,CD,Combination Therapy,4338,positive,adult,210,pre_dose,29-Jul-21,23-Mar-21,128,vector,56,50 to 59
716,male,CD,Vedolizumab Only,16953,positive,adult,,booster1,27-Jul-21,31-May-21,57,mRNA,46,40 to 49
717,male,CD,Vedolizumab Only,19182,positive,adult,,booster2,18-Nov-21,12-Aug-21,98,mRNA,46,40 to 49
718,male,CD,Vedolizumab Only,42166,positive,adult,,booster2,02-Feb-22,28-Oct-21,97,mRNA,46,40 to 49
719,female,CD,Anti-TNF Only,7604,positive,elderly,350,primary,09-May-21,02-Feb-21,96,mRNA,63,60 to 69
720,female,CD,Anti-TNF Only,63641,positive,elderly,203,booster1,25-Jul-21,03-May-21,83,mRNA,63,60 to 69
721,female,CD,Anti-TNF Only,20772,ngative,elderly,75,booster1,30-Nov-21,15-May-21,199,mRNA,64,60 to 69
722,female,CD,Anti-TNF Only,17886,positive,elderly,158,booster1,21-Jul-22,23-Feb-22,148,mRNA,64,60 to 69
723,male,CD,Combination Therapy,55136,positive,adult,,booster1,24-Aug-21,28-Apr-21,118,mRNA,37,30 to 39
724,male,CD,Combination Therapy,52919,positive,adult,,booster2,23-Feb-22,11-Nov-21,104,mRNA,37,30 to 39
725,male,CD,Combination Therapy,58012,positive,adult,185,booster1,13-Aug-21,03-May-21,102,vector,59,50 to 59
726,male,CD,Combination Therapy,68517,positive,adult,93,booster2,13-Nov-21,25-Aug-21,80,vector,59,50 to 59
727,male,CD,Combination Therapy,21039,positive,adult,10,booster2,04-Feb-22,17-Nov-21,79,vector,59,50 to 59
728,male,CD,Anti-TNF Only,69147,positive,adult,,primary,31-Mar-21,08-Feb-21,51,mRNA,61,60 to 69
729,male,CD,Anti-TNF Only,36476,positive,adult,210,booster2,11-Nov-21,18-Jul-21,116,mRNA,61,60 to 69
730,male,CD,Anti-TNF Only,29562,positive,adult,,booster2,09-Mar-22,24-Nov-21,105,mRNA,62,60 to 69
731,male,CD,Anti-TNF Only,869,positive,adult,,booster2,04-May-22,14-Dec-21,141,mRNA,62,60 to 69
732,male,CD,Anti-TNF Only,63054,positive,adult,,booster2,05-Aug-22,20-May-22,77,mRNA,62,60 to 69
733,female,CD,Anti-TNF Only,37169,ngative,adult,243,booster1,18-Aug-21,12-Feb-21,187,mRNA,40,40 to 49
734,female,CD,Anti-TNF Only,51016,positive,adult,137,booster2,02-Dec-21,24-Sep-21,69,mRNA,40,40 to 49
735,female,CD,Anti-TNF Only,965,positive,adult,159,pre_dose,28-May-21,13-Dec-20,166,mRNA,42,40 to 49
736,female,CD,Anti-TNF Only,21619,positive,adult,256,booster1,02-Sep-21,11-Jul-21,53,mRNA,42,40 to 49
737,female,CD,Anti-TNF Only,41355,positive,adult,414,booster2,07-Feb-22,06-Oct-21,124,mRNA,43,40 to 49
738,female,CD,Anti-TNF Only,35943,positive,adult,,booster1,01-Aug-21,20-Mar-21,134,mRNA,48,40 to 49
739,female,CD,Anti-TNF Only,53310,ngative,adult,39,booster1,07-Aug-21,17-Feb-21,171,mRNA,51,50 to 59
740,female,CD,Anti-TNF Only,403,positive,adult,,booster2,26-Nov-21,06-Jul-21,143,mRNA,51,50 to 59
741,female,CD,Anti-TNF Only,4317,positive,adult,,booster2,24-Feb-22,02-Nov-21,114,mRNA,52,50 to 59
742,male,CD,Anti-TNF Only,50939,positive,adult,211,booster1,03-Jul-21,28-Feb-21,125,vector,58,50 to 59
743,male,CD,Anti-TNF Only,24893,positive,adult,133,booster1,19-Sep-21,29-Jul-21,52,vector,58,50 to 59
744,male,CD,Anti-TNF Only,411,positive,adult,69,booster2,22-Nov-21,29-Jun-21,146,vector,59,50 to 59
745,male,CD,Anti-TNF Only,405,positive,adult,9,booster2,21-Jan-22,26-Aug-21,148,vector,59,50 to 59
746,female,CD,Combination Therapy,34,ngative,adult,292,primary,04-Jul-21,08-Feb-21,146,mRNA,47,40 to 49
747,female,CD,Combination Therapy,17534,positive,adult,251,booster1,14-Aug-21,04-Mar-21,163,mRNA,47,40 to 49
748,female,CD,Combination Therapy,47979,positive,adult,133,booster2,10-Dec-21,25-Aug-21,107,mRNA,47,40 to 49
749,female,CD,Combination Therapy,70130,positive,adult,,booster2,05-Apr-22,06-Jan-22,89,mRNA,47,40 to 49
750,female,UC,No Immunosuppressives,14128,positive,adult,83,pre_dose,02-Jan-21,30-Sep-20,94,mRNA,34,30 to 39
751,female,UC,No Immunosuppressives,23862,positive,adult,293,booster1,31-Jul-21,22-Mar-21,131,mRNA,35,30 to 39
752,female,UC,No Immunosuppressives,61429,positive,adult,607,booster2,10-Jun-22,27-Mar-22,75,mRNA,35,30 to 39
753,male,CD,Combination Therapy,49,ngative,adult,57,pre_dose,10-Feb-21,31-Aug-20,163,mRNA,33,30 to 39
754,male,CD,Combination Therapy,4817,positive,adult,226,booster1,29-Jul-21,04-Feb-21,175,mRNA,33,30 to 39
755,female,UC,Anti-TNF Only,203,ngative,adult,73,pre_dose,19-Feb-21,18-Sep-20,154,vector,47,40 to 49
756,female,UC,Anti-TNF Only,907,positive,adult,217,primary,13-Jul-21,29-Jan-21,165,vector,48,40 to 49
757,female,UC,Anti-TNF Only,13129,positive,adult,240,booster1,05-Aug-21,23-May-21,74,vector,48,40 to 49
758,female,UC,Anti-TNF Only,2469,positive,adult,336,booster1,09-Nov-21,25-Apr-21,198,vector,48,40 to 49
759,female,UC,No Immunosuppressives,269,positive,adult,,pre_dose,16-Feb-21,04-Sep-20,165,mRNA,51,50 to 59
760,female,UC,No Immunosuppressives,42090,positive,adult,257,booster1,14-Aug-21,11-Feb-21,184,mRNA,51,50 to 59
761,female,UC,No Immunosuppressives,884,positive,adult,347,booster2,12-Nov-21,24-Jun-21,141,mRNA,51,50 to 59
762,female,UC,No Immunosuppressives,65705,positive,adult,491,booster2,05-Apr-22,10-Feb-22,54,mRNA,52,50 to 59
763,female,CD,Ustekinumab Only,35752,positive,adult,,booster1,29-Oct-21,27-Jun-21,124,mRNA,56,50 to 59
764,female,CD,Combination Therapy,517,positive,adult,,pre_dose,14-Jan-21,22-Aug-20,145,mRNA,52,50 to 59
765,female,CD,Combination Therapy,44686,positive,adult,,booster1,29-Jul-21,22-Feb-21,157,mRNA,53,50 to 59
766,female,CD,Combination Therapy,6488,positive,adult,,booster2,03-Feb-22,01-Sep-21,155,mRNA,53,50 to 59
767,female,CD,Combination Therapy,2229,positive,adult,,booster2,03-Jun-22,20-Jan-22,134,mRNA,53,50 to 59
768,female,CD,Anti-TNF Only,77249,positive,adult,64,booster2,03-Feb-22,04-Dec-21,61,vector,29,18 to 29
769,female,UC,Anti-TNF Only,67103,positive,adult,,booster1,14-Aug-21,05-May-21,101,vector,39,30 to 39
770,female,UC,Anti-TNF Only,317,positive,adult,10,booster2,16-Feb-22,12-Aug-21,188,vector,40,40 to 49
771,female,CD,Anti-TNF Only,178,ngative,elderly,,primary,13-May-21,08-Nov-20,186,mRNA,66,60 to 69
772,female,CD,Anti-TNF Only,8289,positive,elderly,,booster1,12-Aug-21,26-Mar-21,139,mRNA,66,60 to 69
773,female,CD,Anti-TNF Only,9397,positive,elderly,,booster2,12-Nov-21,28-Aug-21,76,mRNA,67,60 to 69
774,female,CD,Anti-TNF Only,186,ngative,elderly,,booster2,11-Mar-22,11-Sep-21,181,mRNA,67,60 to 69
775,female,CD,Anti-TNF Only,53668,positive,elderly,,booster2,05-May-22,30-Dec-21,126,mRNA,67,60 to 69
776,male,CD,Combination Therapy,2752,positive,adult,,primary,03-Jul-21,20-Feb-21,133,vector,33,30 to 39
777,male,CD,Combination Therapy,25293,ngative,adult,,booster1,23-Oct-21,04-May-21,172,vector,33,30 to 39
778,male,CD,Anti-TNF Only,27159,positive,adult,368,booster1,29-Jul-21,13-Apr-21,107,mRNA,55,50 to 59
779,male,CD,Anti-TNF Only,32616,positive,adult,,booster2,12-Nov-21,04-Aug-21,100,mRNA,55,50 to 59
780,male,CD,Anti-TNF Only,45406,positive,adult,165,booster2,17-Feb-22,27-Nov-21,82,mRNA,56,50 to 59
781,female,CD,Anti-TNF Only,7392,positive,adult,259,primary,29-Jun-21,12-Feb-21,137,mRNA,47,40 to 49
782,female,CD,Anti-TNF Only,17470,positive,adult,238,booster1,20-Jul-21,10-May-21,71,mRNA,47,40 to 49
783,female,CD,Anti-TNF Only,72144,positive,adult,101,booster1,04-Dec-21,12-Aug-21,114,mRNA,47,40 to 49
784,female,CD,Anti-TNF Only,710,positive,adult,68,booster2,06-Jan-22,08-Aug-21,151,mRNA,47,40 to 49
785,female,CD,Anti-TNF Only,502,positive,adult,63,booster2,17-May-22,20-Dec-21,148,mRNA,48,40 to 49
786,male,UC,Anti-TNF Only,56449,positive,adult,173,booster1,26-Aug-21,03-Jun-21,84,mRNA,34,30 to 39
787,male,UC,Anti-TNF Only,48348,positive,adult,89,booster2,18-Nov-21,17-Sep-21,62,mRNA,34,30 to 39
788,male,UC,Anti-TNF Only,19,ngative,adult,14,booster2,01-Mar-22,06-Sep-21,176,mRNA,35,30 to 39
789,female,CD,Anti-TNF Only,15408,positive,adult,,pre_dose,07-Apr-21,14-Jan-21,83,mRNA,51,50 to 59
790,female,CD,Anti-TNF Only,6813,positive,adult,,primary,01-Jun-21,23-Feb-21,98,mRNA,51,50 to 59
791,female,UC,Anti-TNF Only,38201,positive,adult,,booster1,27-Jul-22,19-Feb-22,158,mRNA,54,50 to 59
792,male,CD,Vedolizumab Only,408,positive,elderly,,primary,11-May-21,17-Dec-20,145,mRNA,68,60 to 69
793,male,CD,Vedolizumab Only,55522,positive,elderly,,booster1,06-Jul-21,11-May-21,56,mRNA,68,60 to 69
794,male,CD,Vedolizumab Only,7428,ngative,elderly,,booster1,28-Oct-21,30-May-21,151,mRNA,68,60 to 69
795,male,CD,Vedolizumab Only,47,ngative,elderly,,booster2,28-Dec-21,08-Jul-21,173,mRNA,69,60 to 69
796,male,CD,Vedolizumab Only,8,ngative,elderly,,booster2,14-Jun-22,21-Dec-21,175,mRNA,69,60 to 69
797,female,CD,Corticosteroids,317,positive,elderly,,primary,20-May-21,03-Nov-20,198,mRNA,66,60 to 69
798,female,CD,Corticosteroids,29863,positive,elderly,,booster1,24-Jul-21,23-Apr-21,92,mRNA,66,60 to 69
799,female,CD,Corticosteroids,194,ngative,elderly,,booster2,03-Mar-22,29-Aug-21,186,mRNA,67,60 to 69
800,female,CD,Corticosteroids,16245,positive,elderly,,booster2,14-Jul-22,26-Mar-22,110,mRNA,67,60 to 69
801,female,CD,Anti-TNF Only,12163,positive,adult,,booster1,04-Aug-21,29-Mar-21,128,mRNA,49,40 to 49
802,female,CD,Anti-TNF Only,844,positive,adult,,booster2,13-Apr-22,06-Nov-21,158,mRNA,50,50 to 59
803,female,CD,Anti-TNF Only,3359,positive,adult,,primary,03-Mar-21,20-Oct-20,134,vector,32,30 to 39
804,female,CD,Anti-TNF Only,5097,positive,adult,,booster1,27-Jul-21,10-Feb-21,167,vector,32,30 to 39
805,female,CD,Anti-TNF Only,34419,positive,adult,,booster2,13-Apr-22,02-Jan-22,101,vector,33,30 to 39
806,male,UC,Vedolizumab Only,456,positive,adult,,pre_dose,22-Apr-21,17-Oct-20,187,mRNA,54,50 to 59
807,male,UC,Vedolizumab Only,343,positive,adult,,booster2,19-May-22,11-Nov-21,189,mRNA,55,50 to 59
808,female,UC,Combination Therapy,5911,positive,adult,,pre_dose,30-Apr-21,03-Jan-21,117,mRNA,41,40 to 49
809,female,UC,Combination Therapy,72297,ngative,adult,,booster1,23-Jul-21,19-Feb-21,154,mRNA,41,40 to 49
810,female,UC,Combination Therapy,70842,ngative,adult,30,booster1,06-Jan-22,10-Aug-21,149,mRNA,41,40 to 49
811,female,UC,Combination Therapy,38040,positive,adult,7,booster1,12-Feb-22,20-Sep-21,145,mRNA,41,40 to 49
812,male,UC,Tofacitinib Only,40556,positive,adult,,booster1,29-Aug-21,24-May-21,97,mRNA,32,30 to 39
813,male,UC,Tofacitinib Only,406,positive,adult,,booster2,13-Feb-22,04-Aug-21,193,mRNA,32,30 to 39
814,female,UC,Anti-TNF Only,425,positive,adult,31,primary,31-Dec-20,44010,186,vector,34,30 to 39
815,male,UC,Ustekinumab Only,29422,ngative,adult,173,booster1,12-Aug-21,17-Mar-21,148,mRNA,22,18 to 29
816,male,UC,Ustekinumab Only,52645,positive,adult,6,booster1,26-Jan-22,06-Nov-21,81,mRNA,23,18 to 29
817,male,CD,Ustekinumab Only,50608,positive,elderly,,booster1,23-Jul-21,11-Jan-21,193,mRNA,66,60 to 69
818,female,CD,Anti-TNF Only,11885,positive,adult,37,pre_dose,13-Jan-21,27-Oct-20,78,mRNA,36,30 to 39
819,female,CD,Anti-TNF Only,3147,positive,adult,,pre_dose,01-Sep-21,19-Apr-21,135,mRNA,37,30 to 39
820,female,CD,Anti-TNF Only,36751,positive,adult,13,booster1,02-Feb-22,24-Nov-21,70,mRNA,47,40 to 49
821,female,CD,Anti-TNF Only,187,ngative,adult,145,booster2,14-Jun-22,13-Jan-22,152,mRNA,48,40 to 49
822,female,CD,Combination Therapy,,,adult,,primary,22-Oct-21,44427,64,vector,53,50 to 59
823,male,CD,Anti-TNF Only,16152,positive,adult,,primary,20-Apr-21,44202,104,vector,43,40 to 49
824,male,CD,Combination Therapy,49096,positive,adult,221,booster1,30-Jun-21,07-May-21,54,mRNA,25,18 to 29
825,male,CD,Combination Therapy,33273,positive,adult,127,booster1,02-Oct-21,02-Aug-21,61,mRNA,26,18 to 29
826,male,CD,Combination Therapy,51179,positive,adult,32,booster2,10-Mar-22,23-Nov-21,107,mRNA,26,18 to 29
827,male,CD,Combination Therapy,1406,positive,adult,151,booster2,07-Jul-22,01-Mar-22,128,mRNA,26,18 to 29
828,male,CD,Ustekinumab Only,6853,positive,elderly,,primary,01-Jun-21,14-Jan-21,138,mRNA,64,60 to 69
829,male,CD,Ustekinumab Only,5582,positive,elderly,,booster1,11-Aug-21,18-May-21,85,mRNA,64,60 to 69
830,male,CD,Ustekinumab Only,593,positive,elderly,,booster2,10-Feb-22,04-Sep-21,159,mRNA,64,60 to 69
831,male,CD,Ustekinumab Only,1822,positive,elderly,,booster2,05-May-22,18-Feb-22,76,mRNA,65,60 to 69
832,male,CD,Ustekinumab Only,137,ngative,adult,60,pre_dose,23-Apr-21,18-Oct-20,187,mRNA,53,50 to 59
833,male,CD,Ustekinumab Only,141,ngative,adult,93,primary,26-May-21,25-Nov-20,182,mRNA,53,50 to 59
834,male,CD,Ustekinumab Only,46871,positive,adult,166,booster1,07-Aug-21,09-May-21,90,mRNA,53,50 to 59
835,male,CD,Ustekinumab Only,3674,positive,adult,331,booster1,19-Jan-22,28-Oct-21,83,mRNA,54,50 to 59
836,male,CD,Ustekinumab Only,61408,positive,adult,370,booster2,27-Feb-22,03-Jan-22,55,mRNA,54,50 to 59
837,male,CD,Ustekinumab Only,73933,positive,adult,484,booster2,21-Jun-22,20-Mar-22,93,mRNA,54,50 to 59
838,male,CD,Combination Therapy,889,positive,adult,,pre_dose,07-Aug-21,08-Mar-21,152,mRNA,46,40 to 49
839,male,CD,Anti-TNF Only,66936,ngative,adult,,booster1,05-Aug-21,17-Jan-21,200,vector,35,30 to 39
840,male,CD,Anti-TNF Only,75615,positive,adult,400,booster1,28-Jan-22,29-Nov-21,60,vector,36,30 to 39
841,male,CD,Anti-TNF Only,14650,positive,adult,567,booster1,14-Jul-22,08-Mar-22,128,vector,36,30 to 39
842,male,CD,Ustekinumab Only,514,positive,elderly,,primary,29-Apr-21,10-Dec-20,140,mRNA,76,70+
843,male,CD,Ustekinumab Only,9865,ngative,elderly,,booster1,10-Jun-21,19-Dec-20,173,mRNA,76,70+
844,male,CD,Ustekinumab Only,56686,positive,elderly,,booster1,16-Sep-21,13-May-21,126,mRNA,76,70+
845,male,CD,Ustekinumab Only,136,ngative,elderly,,booster2,22-Jan-22,29-Aug-21,146,mRNA,77,70+
846,male,CD,Ustekinumab Only,19592,positive,elderly,,primary,20-Apr-21,10-Jan-21,100,mRNA,73,70+
847,male,CD,Ustekinumab Only,76681,positive,elderly,,booster1,11-Jun-21,14-Apr-21,58,mRNA,73,70+
848,male,CD,Ustekinumab Only,649,positive,elderly,,booster1,14-Sep-21,20-Jul-21,56,mRNA,74,70+
849,male,CD,Ustekinumab Only,693,positive,elderly,,booster2,19-Jan-22,10-Aug-21,162,mRNA,74,70+
850,female,CD,Combination Therapy,60978,positive,adult,335,booster1,25-Jun-21,15-Mar-21,102,mRNA,26,18 to 29
851,female,CD,Combination Therapy,61322,positive,adult,251,booster1,17-Sep-21,04-Apr-21,166,mRNA,27,18 to 29
852,female,CD,Combination Therapy,57379,positive,adult,190,booster2,17-Nov-21,30-Jul-21,110,mRNA,27,18 to 29
853,female,CD,Combination Therapy,66227,positive,adult,41,booster2,15-Apr-22,27-Jan-22,78,mRNA,27,18 to 29
854,male,CD,Vedolizumab Only,15681,positive,elderly,,booster1,10-Jun-21,28-Mar-21,74,mRNA,77,70+
855,male,CD,Vedolizumab Only,13902,positive,elderly,,booster1,08-Sep-21,01-Jun-21,99,mRNA,78,70+
856,male,CD,Vedolizumab Only,76,ngative,elderly,,booster2,18-Feb-22,15-Sep-21,156,mRNA,78,70+
857,female,UC,No Immunosuppressives,16115,positive,elderly,,primary,14-May-21,24-Feb-21,79,mRNA,72,70+
858,female,UC,No Immunosuppressives,26068,positive,elderly,,booster1,30-Jul-21,26-Apr-21,95,mRNA,72,70+
859,female,UC,No Immunosuppressives,9000,positive,elderly,,booster2,18-Mar-22,17-Jan-22,60,mRNA,73,70+
860,female,UC,No Immunosuppressives,34327,positive,elderly,,booster2,27-May-22,12-Jan-22,135,mRNA,73,70+
861,male,CD,Ustekinumab Only,7620,positive,adult,,primary,27-Jul-21,20-Apr-21,98,mRNA,56,50 to 59
862,male,CD,Ustekinumab Only,9342,ngative,adult,,booster1,08-Jan-22,13-Jul-21,179,mRNA,57,50 to 59
863,female,CD,Ustekinumab Only,40254,positive,elderly,,booster1,04-Aug-21,03-Jun-21,62,mRNA,64,60 to 69
864,female,CD,Ustekinumab Only,56052,positive,elderly,,booster2,11-Nov-21,12-Sep-21,60,mRNA,64,60 to 69
865,female,CD,Ustekinumab Only,84,ngative,elderly,,booster2,13-Feb-22,09-Sep-21,157,mRNA,64,60 to 69
866,female,CD,Ustekinumab Only,79825,positive,elderly,,booster2,21-Apr-22,19-Dec-21,123,mRNA,65,60 to 69
867,female,CD,Ustekinumab Only,18636,positive,elderly,,booster2,04-Aug-22,03-Apr-22,123,mRNA,65,60 to 69
868,female,CD,Corticosteroids,44395,positive,adult,,booster1,07-Sep-21,22-May-21,108,mRNA,49,40 to 49
869,female,CD,Corticosteroids,32783,positive,adult,,booster2,07-Oct-21,29-Jul-21,70,mRNA,49,40 to 49
870,female,CD,Corticosteroids,223,ngative,adult,,booster2,05-Feb-22,23-Jul-21,197,mRNA,49,40 to 49
871,female,CD,Corticosteroids,44316,positive,adult,,booster2,11-Jul-22,14-Apr-22,88,mRNA,50,50 to 59
872,male,CD,Ustekinumab Only,66460,positive,adult,215,booster1,26-Aug-21,07-Jul-21,50,mRNA,50,50 to 59
873,female,CD,Ustekinumab Only,40462,positive,adult,,booster1,29-Jul-21,16-Feb-21,163,vector,43,40 to 49
874,female,CD,Ustekinumab Only,37790,positive,adult,,booster2,26-Jan-22,30-Sep-21,118,vector,44,40 to 49
875,female,CD,Ustekinumab Only,609,positive,adult,,booster2,09-Apr-22,06-Nov-21,154,vector,44,40 to 49
876,female,CD,Ustekinumab Only,77368,positive,adult,,booster2,07-Jul-22,31-Mar-22,98,vector,44,40 to 49
877,female,UC,Anti-TNF Only,53507,positive,adult,190,booster1,04-Aug-21,22-Feb-21,163,mRNA,41,40 to 49
878,female,UC,Anti-TNF Only,75929,positive,adult,13,booster2,23-Feb-22,27-Dec-21,58,mRNA,41,40 to 49
879,male,CD,Anti-TNF Only,13810,positive,adult,,pre_dose,03-Apr-21,15-Dec-20,109,mRNA,25,18 to 29
880,male,CD,Anti-TNF Only,462,positive,adult,371,primary,29-May-21,07-Dec-20,173,mRNA,25,18 to 29
881,male,UC,Anti-TNF Only,120,ngative,adult,,primary,27-Jul-21,44204,200,vector,34,30 to 39
882,male,CD,Corticosteroids,40515,positive,elderly,,booster1,14-May-21,11-Dec-20,154,mRNA,82,70+
883,male,CD,Corticosteroids,58054,positive,elderly,,booster1,11-Jun-21,12-Jan-21,150,mRNA,82,70+
884,male,CD,Corticosteroids,33732,positive,elderly,,booster1,04-Sep-21,28-Jun-21,68,mRNA,82,70+
885,male,CD,Corticosteroids,579,positive,elderly,,booster2,08-Apr-22,22-Oct-21,168,mRNA,83,70+
886,male,CD,Corticosteroids,644,positive,elderly,,booster2,30-Jul-22,06-Mar-22,146,mRNA,83,70+
887,female,CD,Ustekinumab Only,19373,positive,elderly,,primary,01-May-21,09-Jan-21,112,mRNA,66,60 to 69
888,female,CD,Ustekinumab Only,22026,positive,elderly,,booster1,10-Jun-21,30-Jan-21,131,mRNA,66,60 to 69
889,female,CD,Ustekinumab Only,35906,positive,elderly,,booster1,30-Sep-21,24-Apr-21,159,mRNA,66,60 to 69
890,female,CD,Ustekinumab Only,12969,positive,elderly,,booster2,05-Jan-22,10-Sep-21,117,mRNA,67,60 to 69
891,female,UC,Anti-TNF Only,79621,positive,adult,272,booster1,10-Sep-21,23-Mar-21,171,mRNA,46,40 to 49
892,female,UC,Anti-TNF Only,29,ngative,adult,216,booster2,05-Nov-21,08-May-21,181,mRNA,46,40 to 49
893,female,UC,Anti-TNF Only,65786,positive,adult,104,booster2,25-Feb-22,27-Nov-21,90,mRNA,47,40 to 49
894,female,UC,Anti-TNF Only,27262,positive,adult,48,booster2,22-Apr-22,26-Dec-21,117,mRNA,47,40 to 49
895,male,CD,Anti-TNF Only,55071,positive,adult,,booster1,24-Sep-21,23-Apr-21,154,mRNA,54,50 to 59
896,male,CD,Anti-TNF Only,288,positive,adult,,booster2,01-Mar-22,25-Aug-21,188,mRNA,54,50 to 59
897,male,CD,Anti-TNF Only,20002,positive,adult,,booster1,03-Jul-21,28-Mar-21,97,mRNA,39,30 to 39
898,male,CD,Anti-TNF Only,76977,positive,adult,,booster1,28-Aug-21,02-Jul-21,57,mRNA,39,30 to 39
899,male,CD,Anti-TNF Only,9375,positive,adult,,booster2,30-Nov-21,10-Sep-21,81,mRNA,39,30 to 39
900,male,CD,Anti-TNF Only,115,ngative,adult,,booster2,12-Feb-22,24-Aug-21,172,mRNA,39,30 to 39
901,female,CD,Combination Therapy,7545,positive,adult,,pre_dose,24-Mar-21,15-Dec-20,99,mRNA,31,30 to 39
902,female,CD,Combination Therapy,17305,positive,adult,,primary,18-May-21,12-Feb-21,95,mRNA,31,30 to 39
903,female,CD,Combination Therapy,64040,positive,adult,112,booster1,16-Jun-21,02-Dec-20,196,mRNA,31,30 to 39
904,female,CD,Combination Therapy,43168,positive,adult,26,booster2,03-Feb-22,04-Oct-21,122,mRNA,32,30 to 39
905,male,CD,Anti-TNF Only,65120,positive,adult,48,booster1,08-Sep-21,19-Jul-21,51,mRNA,28,18 to 29
906,male,CD,Anti-TNF Only,22823,positive,adult,162,booster2,17-Nov-21,05-Jul-21,135,mRNA,28,18 to 29
907,male,CD,Ustekinumab Only,824,positive,adult,245,pre_dose,30-Apr-21,25-Nov-20,156,vector,56,50 to 59
908,male,CD,Ustekinumab Only,9885,positive,adult,275,primary,10-Jun-21,18-Feb-21,112,vector,56,50 to 59
909,male,CD,Ustekinumab Only,31076,positive,adult,,booster1,05-Aug-21,25-Apr-21,102,vector,56,50 to 59
910,male,CD,Ustekinumab Only,736,positive,adult,,booster2,06-Nov-21,27-May-21,163,vector,57,50 to 59
911,male,CD,Ustekinumab Only,32395,positive,adult,,booster2,03-Mar-22,08-Dec-21,85,vector,57,50 to 59
912,male,CD,Combination Therapy,16583,positive,adult,280,pre_dose,27-Mar-21,31-Dec-20,86,mRNA,45,40 to 49
913,male,CD,Combination Therapy,34864,positive,adult,141,booster1,13-Aug-21,27-Mar-21,139,mRNA,45,40 to 49
914,male,CD,Combination Therapy,50389,positive,adult,,booster2,01-Jan-22,29-Sep-21,94,mRNA,46,40 to 49
915,male,CD,Combination Therapy,22437,positive,adult,56,booster2,26-Feb-22,23-Nov-21,95,mRNA,46,40 to 49
916,male,CD,Combination Therapy,398,positive,adult,194,booster2,14-Jul-22,01-Feb-22,163,mRNA,46,40 to 49
917,male,CD,Corticosteroids,5601,positive,adult,,booster1,31-Jul-21,06-Jun-21,55,vector,45,40 to 49
918,male,CD,Combination Therapy,159,ngative,adult,,booster2,04-Dec-21,25-May-21,193,vector,45,40 to 49
919,male,CD,Combination Therapy,745,positive,adult,,booster2,09-Mar-22,28-Sep-21,162,vector,46,40 to 49
920,female,CD,Combination Therapy,762,positive,elderly,,pre_dose,23-Mar-21,27-Oct-20,147,mRNA,63,60 to 69
921,female,CD,Combination Therapy,2757,positive,elderly,,booster2,26-Nov-21,26-Aug-21,92,mRNA,64,60 to 69
922,female,CD,Combination Therapy,45221,positive,elderly,,booster2,08-Feb-22,18-Oct-21,113,mRNA,64,60 to 69
923,male,UC,Ustekinumab Only,9792,positive,adult,,booster1,03-Aug-21,19-May-21,76,mRNA,37,30 to 39
924,male,UC,Ustekinumab Only,74625,positive,adult,,booster2,03-Feb-22,30-Sep-21,126,mRNA,37,30 to 39
925,male,CD,Anti-TNF Only,789,positive,elderly,380,primary,01-Jun-21,21-Dec-20,162,vector,65,60 to 69
926,male,CD,Anti-TNF Only,62254,positive,elderly,337,booster1,14-Jul-21,20-Mar-21,116,vector,65,60 to 69
927,male,CD,Anti-TNF Only,74,ngative,elderly,135,booster2,01-Feb-22,28-Jul-21,188,vector,66,60 to 69
928,male,CD,Anti-TNF Only,651,positive,elderly,36,booster2,11-May-22,11-Dec-21,151,vector,66,60 to 69
929,male,UC,Ustekinumab Only,656,positive,adult,,pre_dose,19-Mar-21,28-Oct-20,142,mRNA,54,50 to 59
930,male,UC,Ustekinumab Only,33402,positive,adult,,booster1,24-Nov-21,22-Jul-21,125,mRNA,55,50 to 59
931,male,UC,Ustekinumab Only,37,ngative,adult,,booster2,02-Feb-22,21-Aug-21,165,mRNA,55,50 to 59
932,female,CD,Ustekinumab Only,12265,positive,adult,,primary,23-Jun-21,28-Mar-21,87,mRNA,41,40 to 49
933,female,CD,Ustekinumab Only,46951,positive,adult,,booster1,15-Jul-21,12-Apr-21,94,mRNA,41,40 to 49
934,female,CD,Ustekinumab Only,2685,positive,adult,,booster2,30-Jan-22,08-Oct-21,114,mRNA,41,40 to 49
935,female,CD,Ustekinumab Only,47718,positive,adult,,booster2,17-May-22,06-Feb-22,100,mRNA,41,40 to 49
936,female,CD,Anti-TNF Only,74420,positive,adult,226,booster1,18-Sep-21,16-Jun-21,94,mRNA,35,30 to 39
937,female,CD,Anti-TNF Only,51098,positive,adult,212,booster2,02-Oct-21,05-Aug-21,58,mRNA,35,30 to 39
938,female,CD,Anti-TNF Only,23808,positive,adult,100,booster2,22-Jan-22,18-Oct-21,96,mRNA,35,30 to 39
939,male,CD,Anti-TNF Only,278,positive,elderly,112,pre_dose,20-Mar-21,24-Sep-20,177,vector,70,70+
940,male,CD,Anti-TNF Only,404,positive,elderly,,primary,14-May-21,11-Nov-20,184,vector,70,70+
941,male,CD,Anti-TNF Only,77649,positive,elderly,,booster1,08-Jul-21,16-Feb-21,142,vector,70,70+
942,male,CD,Anti-TNF Only,331,positive,elderly,,booster1,29-Sep-21,28-May-21,124,vector,70,70+
943,male,CD,Anti-TNF Only,241,ngative,elderly,,booster2,29-Oct-21,20-Apr-21,192,vector,70,70+
944,male,CD,Anti-TNF Only,13864,positive,elderly,,booster2,28-Jan-22,21-Oct-21,99,vector,70,70+
945,male,CD,Ustekinumab Only,21864,positive,elderly,,booster2,20-Apr-22,04-Jan-22,106,vector,71,70+
946,male,CD,Ustekinumab Only,29745,positive,elderly,,booster2,20-Jul-22,03-Apr-22,108,vector,71,70+
947,female,CD,Combination Therapy,65900,positive,adult,223,primary,18-Mar-21,22-Jan-21,55,mRNA,22,18 to 29
948,female,CD,Combination Therapy,63300,positive,adult,89,booster1,30-Jul-21,24-Apr-21,97,mRNA,22,18 to 29
949,female,CD,Combination Therapy,732,positive,adult,26,booster2,27-Oct-21,31-May-21,149,mRNA,23,18 to 29
950,female,CD,Combination Therapy,47166,positive,adult,112,booster2,16-Feb-22,16-Oct-21,123,mRNA,23,18 to 29
951,male,UC,Combination Therapy,19745,positive,adult,,primary,19-May-21,28-Jan-21,111,mRNA,49,40 to 49
952,male,UC,Combination Therapy,20297,positive,adult,,booster1,15-Jun-21,13-Dec-20,184,mRNA,49,40 to 49
953,male,UC,Combination Therapy,51658,positive,adult,,booster2,12-Nov-21,17-Aug-21,87,mRNA,49,40 to 49
954,male,UC,Combination Therapy,436,positive,adult,,booster2,11-Feb-22,21-Aug-21,174,mRNA,50,50 to 59
955,male,CD,Ustekinumab Only,9694,positive,adult,224,booster1,03-Jul-21,21-Mar-21,104,mRNA,55,50 to 59
956,male,CD,Ustekinumab Only,74,ngative,adult,113,booster2,22-Oct-21,14-Apr-21,191,mRNA,56,50 to 59
957,male,CD,Ustekinumab Only,26087,positive,adult,20,booster2,04-Mar-22,29-Dec-21,65,mRNA,56,50 to 59
958,male,CD,Ustekinumab Only,60594,positive,adult,216,booster1,28-Jul-21,16-Mar-21,134,mRNA,53,50 to 59
959,male,CD,Ustekinumab Only,9225,positive,adult,48,booster2,17-Nov-21,22-Jul-21,118,mRNA,53,50 to 59
960,male,CD,Ustekinumab Only,28253,positive,adult,25,booster2,26-Mar-22,13-Nov-21,133,mRNA,54,50 to 59
961,male,CD,Anti-TNF Only,66223,ngative,elderly,,booster1,12-Aug-21,07-Feb-21,186,vector,69,60 to 69
962,male,CD,Anti-TNF Only,3619,positive,elderly,,booster1,07-Oct-21,13-Aug-21,55,vector,69,60 to 69
963,male,CD,Anti-TNF Only,51214,positive,elderly,,booster2,27-Jan-22,13-Oct-21,106,vector,69,60 to 69
964,male,CD,Ustekinumab Only,37640,positive,adult,,booster1,12-Aug-21,08-May-21,96,mRNA,50,50 to 59
965,male,CD,Ustekinumab Only,324,positive,adult,,pre_dose,24-Mar-21,30-Sep-20,175,vector,29,18 to 29
966,male,CD,Ustekinumab Only,1934,positive,adult,,primary,02-Jun-21,24-Jan-21,129,vector,30,30 to 39
967,male,CD,Ustekinumab Only,77400,positive,adult,,booster2,15-Jun-22,10-Feb-22,125,vector,31,30 to 39
968,male,CD,Ustekinumab Only,21278,positive,adult,,booster1,30-Jun-21,18-Feb-21,132,mRNA,59,50 to 59
969,male,CD,Ustekinumab Only,5489,positive,adult,162,booster2,28-Jul-21,27-Apr-21,92,mRNA,59,50 to 59
970,male,CD,Ustekinumab Only,531,positive,adult,,booster2,21-Oct-21,16-May-21,158,mRNA,59,50 to 59
971,male,CD,Ustekinumab Only,465,positive,adult,,booster2,10-Feb-22,26-Jul-21,199,mRNA,60,60 to 69
972,male,UC,Combination Therapy,65,ngative,adult,,primary,05-May-21,23-Oct-20,194,vector,60,60 to 69
973,male,UC,Combination Therapy,12029,ngative,adult,,booster1,30-Jul-21,15-Feb-21,165,vector,61,60 to 69
974,male,UC,Combination Therapy,407,positive,adult,,booster2,31-May-22,22-Dec-21,160,vector,61,60 to 69
975,female,UC,Combination Therapy,17165,positive,adult,,pre_dose,16-Mar-21,14-Dec-20,92,mRNA,50,50 to 59
976,female,UC,Combination Therapy,8335,positive,adult,,booster1,11-Aug-21,10-May-21,93,mRNA,51,50 to 59
977,female,UC,Combination Therapy,30644,positive,adult,,booster2,18-Nov-21,04-Aug-21,106,mRNA,51,50 to 59
978,female,UC,Combination Therapy,295,positive,adult,,booster2,02-Mar-22,13-Sep-21,170,mRNA,51,50 to 59
979,female,UC,Combination Therapy,597,positive,adult,245,booster2,16-Apr-22,11-Nov-21,156,mRNA,51,50 to 59
980,female,CD,Ustekinumab Only,35611,positive,elderly,,booster1,27-Jul-21,17-May-21,71,mRNA,64,60 to 69
981,female,CD,Ustekinumab Only,9464,positive,elderly,,booster2,14-Oct-21,07-Aug-21,68,mRNA,64,60 to 69
982,female,CD,Ustekinumab Only,296,positive,elderly,,booster2,18-Feb-22,05-Aug-21,197,mRNA,64,60 to 69
983,female,CD,Ustekinumab Only,27027,positive,elderly,,booster2,08-May-22,02-Feb-22,95,mRNA,64,60 to 69
984,female,CD,Ustekinumab Only,46811,positive,elderly,,booster2,06-Jul-22,20-Jan-22,167,mRNA,65,60 to 69
985,female,CD,Combination Therapy,92,ngative,adult,,primary,04-Jun-21,13-Dec-20,173,mRNA,33,30 to 39
986,female,CD,Combination Therapy,65040,positive,adult,,booster1,03-Jul-21,08-Feb-21,145,mRNA,33,30 to 39
987,female,CD,Combination Therapy,67204,positive,adult,,booster2,16-Nov-21,21-Aug-21,87,mRNA,33,30 to 39
988,female,CD,Combination Therapy,32022,positive,adult,,booster2,25-Jan-22,13-Oct-21,104,mRNA,34,30 to 39
989,female,CD,Combination Therapy,54531,positive,adult,275,booster2,09-Mar-22,14-Nov-21,115,mRNA,34,30 to 39
990,male,CD,Vedolizumab Only,396,positive,adult,263,pre_dose,23-Jan-21,11-Aug-20,165,mRNA,48,40 to 49
991,male,CD,Vedolizumab Only,57920,positive,adult,490,booster1,07-Sep-21,02-Jun-21,97,mRNA,48,40 to 49
992,male,CD,Vedolizumab Only,30495,positive,adult,634,booster1,29-Jan-22,30-Aug-21,152,mRNA,49,40 to 49
993,female,CD,Ustekinumab Only,5059,positive,adult,,pre_dose,17-Mar-21,08-Dec-20,99,mRNA,55,50 to 59
994,female,CD,Ustekinumab Only,64315,positive,adult,,booster1,05-Aug-21,03-May-21,94,mRNA,55,50 to 59
995,female,CD,Ustekinumab Only,8329,positive,adult,,booster2,26-Feb-22,09-Dec-21,79,mRNA,56,50 to 59
996,female,CD,Ustekinumab Only,52681,positive,adult,,booster2,28-Jul-22,21-May-22,68,mRNA,56,50 to 59
997,female,UC,Anti-TNF Only,19585,positive,adult,,booster2,23-Oct-21,29-Jun-21,116,mRNA,35,30 to 39
998,female,UC,Anti-TNF Only,389,positive,adult,,booster2,24-Feb-22,24-Sep-21,153,mRNA,35,30 to 39
999,female,CD,Ustekinumab Only,66368,positive,adult,,primary,05-Jun-21,12-Apr-21,54,vector,47,40 to 49
1000,female,CD,Ustekinumab Only,45151,ngative,adult,233,booster1,02-Jul-21,02-Feb-21,150,vector,47,40 to 49
1001,female,CD,Ustekinumab Only,70906,positive,adult,146,booster1,31-Dec-21,21-Oct-21,71,vector,48,40 to 49
1002,female,CD,Ustekinumab Only,33926,positive,adult,120,booster2,12-Feb-22,13-Dec-21,61,vector,48,40 to 49
1003,female,CD,Ustekinumab Only,20983,positive,adult,27,booster2,24-May-22,08-Jan-22,136,vector,48,40 to 49
1004,male,CD,Anti-TNF Only,19079,positive,adult,341,pre_dose,16-Mar-21,18-Dec-20,88,vector,41,40 to 49
1005,male,CD,Anti-TNF Only,7239,positive,adult,194,pre_dose,23-Apr-21,10-Dec-20,134,vector,41,40 to 49
1006,male,CD,Anti-TNF Only,344,positive,adult,138,pre_dose,12-Feb-22,18-Aug-21,178,vector,42,40 to 49
1007,male,CD,Ustekinumab Only,33518,positive,adult,61,booster1,05-Aug-21,15-Apr-21,112,mRNA,34,30 to 39
1008,male,CD,Ustekinumab Only,43315,positive,adult,30,booster2,03-Nov-21,22-Aug-21,73,mRNA,34,30 to 39
1009,male,CD,Ustekinumab Only,850,positive,adult,233,booster2,08-Feb-22,26-Aug-21,166,mRNA,34,30 to 39
1010,male,CD,Ustekinumab Only,267,positive,adult,209,booster2,01-Apr-22,20-Sep-21,193,mRNA,35,30 to 39
1011,male,CD,Combination Therapy,62724,ngative,adult,125,booster1,15-Aug-21,28-Jan-21,199,mRNA,59,50 to 59
1012,male,CD,Combination Therapy,213,ngative,adult,13,booster2,06-Feb-22,04-Sep-21,155,mRNA,60,60 to 69
1013,male,CD,Combination Therapy,29281,positive,adult,,booster2,14-Jun-22,14-Mar-22,92,mRNA,60,60 to 69
1014,female,CD,Ustekinumab Only,2918,positive,adult,,pre_dose,16-Mar-21,31-Oct-20,136,mRNA,52,50 to 59
1015,female,CD,Ustekinumab Only,71768,positive,adult,,booster1,08-Oct-21,15-May-21,146,mRNA,53,50 to 59
1016,female,CD,Ustekinumab Only,45729,positive,adult,,booster2,12-Nov-21,19-Aug-21,85,mRNA,53,50 to 59
1017,female,CD,Ustekinumab Only,15768,positive,adult,,booster2,22-Feb-22,18-Nov-21,96,mRNA,53,50 to 59
1018,male,UC,Corticosteroids,69278,positive,adult,,booster1,01-Sep-21,29-May-21,95,mRNA,61,60 to 69
1019,male,UC,Corticosteroids,41444,positive,adult,146,booster2,01-Dec-21,15-Sep-21,77,mRNA,61,60 to 69
1020,male,UC,Corticosteroids,30826,positive,adult,,booster2,23-Mar-22,19-Dec-21,94,mRNA,61,60 to 69
1021,female,CD,Anti-TNF Only,10025,positive,adult,,booster1,10-Jul-21,04-Apr-21,97,vector,40,40 to 49
1022,female,CD,Anti-TNF Only,315,positive,adult,,booster2,29-Jan-22,08-Sep-21,143,vector,41,40 to 49
1023,female,CD,Anti-TNF Only,444,positive,adult,,booster2,04-Jun-22,13-Dec-21,173,vector,41,40 to 49
1024,female,CD,Ustekinumab Only,17894,positive,adult,,pre_dose,30-Apr-21,22-Jan-21,98,mRNA,46,40 to 49
1025,female,CD,Ustekinumab Only,8951,positive,adult,,primary,04-Jun-21,01-Feb-21,123,mRNA,46,40 to 49
1026,female,CD,Ustekinumab Only,14676,positive,adult,,booster1,06-Jul-21,14-Mar-21,114,mRNA,46,40 to 49
1027,female,CD,Ustekinumab Only,39068,positive,adult,,booster2,13-Oct-21,20-Jul-21,85,mRNA,46,40 to 49
1028,female,CD,Ustekinumab Only,192,ngative,adult,,booster2,01-Feb-22,12-Sep-21,142,mRNA,47,40 to 49
1029,female,CD,Ustekinumab Only,3993,positive,adult,120,booster2,23-Mar-22,20-Jan-22,62,mRNA,47,40 to 49
1030,female,CD,Ustekinumab Only,72504,positive,adult,,booster2,01-Jul-22,08-May-22,54,mRNA,47,40 to 49
1031,female,CD,Combination Therapy,5492,positive,adult,,pre_dose,31-Mar-21,24-Dec-20,97,mRNA,21,18 to 29
1032,female,CD,Combination Therapy,21874,positive,adult,,booster1,26-May-21,14-Jan-21,132,mRNA,21,18 to 29
1033,female,CD,Combination Therapy,77592,positive,adult,,booster2,06-Jan-22,14-Oct-21,84,mRNA,22,18 to 29
1034,female,CD,Anti-TNF Only,15,ngative,adult,,pre_dose,14-Apr-21,02-Oct-20,194,vector,56,50 to 59
1035,female,CD,Anti-TNF Only,572,positive,adult,390,primary,26-May-21,03-Jan-21,143,vector,56,50 to 59
1036,female,CD,Anti-TNF Only,42310,positive,adult,300,booster1,12-Aug-21,23-Apr-21,111,vector,56,50 to 59
1037,female,CD,Anti-TNF Only,64089,positive,adult,185,booster1,02-Sep-21,25-Apr-21,130,vector,56,50 to 59
1038,female,CD,Anti-TNF Only,227,ngative,adult,73,booster2,14-Oct-21,22-Apr-21,175,vector,56,50 to 59
1039,female,CD,Anti-TNF Only,52222,positive,adult,27,booster2,09-Mar-22,09-Nov-21,120,vector,57,50 to 59
1040,female,CD,Anti-TNF Only,258,positive,adult,,booster2,01-Jun-22,18-Dec-21,165,vector,57,50 to 59
1041,female,CD,Ustekinumab Only,14656,positive,adult,,booster1,01-Aug-21,07-May-21,86,vector,59,50 to 59
1042,female,CD,Ustekinumab Only,60464,positive,adult,237,booster2,12-Nov-21,25-Jul-21,110,vector,59,50 to 59
1043,female,CD,Ustekinumab Only,38,ngative,adult,162,booster2,10-Mar-22,11-Sep-21,180,vector,60,60 to 69
1044,female,CD,Anti-TNF Only,20586,positive,adult,50,primary,20-Mar-21,09-Jan-21,70,mRNA,48,40 to 49
1045,female,CD,Anti-TNF Only,78556,ngative,adult,56,booster1,09-Jun-21,01-Dec-20,190,mRNA,48,40 to 49
1046,female,CD,Anti-TNF Only,53087,positive,adult,,booster1,09-Oct-21,28-Jul-21,73,mRNA,48,40 to 49
1047,female,CD,Anti-TNF Only,64076,positive,adult,,booster2,20-Nov-21,31-Aug-21,81,mRNA,48,40 to 49
1048,female,CD,Anti-TNF Only,609,positive,adult,,booster2,22-Mar-22,04-Nov-21,138,mRNA,49,40 to 49
1049,female,CD,Anti-TNF Only,149,ngative,adult,341,primary,13-May-21,12-Nov-20,182,vector,58,50 to 59
1050,female,CD,Anti-TNF Only,56726,positive,adult,225,booster2,28-Oct-21,23-Jul-21,97,vector,59,50 to 59
1051,female,CD,Anti-TNF Only,296,positive,adult,169,booster2,26-May-22,03-Jan-22,143,vector,59,50 to 59
1052,female,CD,Ustekinumab Only,184,ngative,adult,8,pre_dose,31-Aug-21,24-Feb-21,188,mRNA,50,50 to 59
1053,female,CD,Combination Therapy,22473,positive,adult,345,primary,30-Jan-21,24-Nov-20,67,mRNA,54,50 to 59
1054,female,CD,Combination Therapy,12548,positive,adult,302,pre_dose,20-Mar-21,22-Nov-20,118,mRNA,54,50 to 59
1055,female,CD,Combination Therapy,18559,positive,adult,187,primary,05-Jun-21,05-Mar-21,92,mRNA,54,50 to 59
1056,female,CD,Combination Therapy,36279,positive,adult,36,booster1,10-Jul-21,04-May-21,67,mRNA,55,50 to 59
1057,female,CD,Combination Therapy,62110,ngative,adult,,booster1,28-Sep-21,12-May-21,139,mRNA,55,50 to 59
1058,female,CD,Combination Therapy,29919,positive,adult,,booster2,09-Nov-21,01-Jul-21,131,mRNA,55,50 to 59
1059,female,CD,Combination Therapy,21732,positive,adult,194,booster2,15-Mar-22,03-Dec-21,102,mRNA,55,50 to 59
1060,female,CD,Combination Therapy,274,positive,adult,,booster2,17-Apr-22,24-Oct-21,175,mRNA,55,50 to 59
1061,female,UC,Combination Therapy,10697,positive,adult,,booster1,21-Aug-21,08-Jun-21,74,mRNA,43,40 to 49
1062,female,UC,Combination Therapy,21342,positive,adult,,booster2,16-Feb-22,15-Dec-21,63,mRNA,43,40 to 49
1063,female,CD,Ustekinumab Only,6030,positive,adult,,pre_dose,24-Jan-21,17-Sep-20,129,mRNA,37,30 to 39
1064,female,CD,Ustekinumab Only,17027,positive,adult,,pre_dose,24-Jul-21,07-May-21,78,mRNA,38,30 to 39
1065,female,CD,Ustekinumab Only,16201,positive,adult,,primary,27-Jun-21,05-Apr-21,83,mRNA,37,30 to 39
1066,female,CD,Ustekinumab Only,24138,positive,adult,,booster1,20-Aug-21,11-Mar-21,162,mRNA,38,30 to 39
1067,female,CD,Ustekinumab Only,50093,positive,adult,23,booster2,12-Nov-21,11-Aug-21,93,mRNA,38,30 to 39
1068,female,CD,Ustekinumab Only,8553,positive,adult,108,booster2,03-Feb-22,28-Nov-21,67,mRNA,38,30 to 39
1069,female,CD,Anti-TNF Only,74110,positive,adult,138,booster1,12-Aug-21,15-May-21,89,mRNA,29,18 to 29
1070,female,CD,Anti-TNF Only,36957,positive,adult,355,booster1,23-Sep-21,10-May-21,136,mRNA,29,18 to 29
1071,female,CD,Anti-TNF Only,56112,positive,adult,232,booster2,30-Jan-22,18-Nov-21,73,mRNA,29,18 to 29
1072,female,CD,Combination Therapy,184,ngative,adult,137,pre_dose,31-Mar-21,27-Sep-20,185,mRNA,38,30 to 39
1073,female,CD,Combination Therapy,11062,positive,adult,64,primary,27-Jun-21,07-Apr-21,81,mRNA,39,30 to 39
1074,female,CD,Combination Therapy,59652,ngative,adult,,booster1,24-Jul-21,06-Jan-21,199,mRNA,39,30 to 39
1075,female,CD,Combination Therapy,53738,positive,adult,117,booster2,14-Oct-21,12-Aug-21,63,mRNA,39,30 to 39
1076,female,CD,Combination Therapy,27645,positive,adult,,booster2,04-Feb-22,12-Dec-21,54,mRNA,39,30 to 39
1077,female,CD,Combination Therapy,705,positive,adult,,booster2,01-Apr-22,03-Nov-21,149,mRNA,39,30 to 39
1078,male,UC,Ustekinumab Only,11,ngative,elderly,,primary,08-May-21,24-Oct-20,196,mRNA,68,60 to 69
1079,male,UC,Ustekinumab Only,76136,positive,elderly,61,booster2,22-Feb-22,28-Sep-21,147,mRNA,69,60 to 69
1080,female,CD,Anti-TNF Only,118,ngative,adult,,primary,26-Feb-21,26-Aug-20,184,mRNA,48,40 to 49
1081,female,CD,Anti-TNF Only,16865,positive,adult,,booster1,30-Mar-21,23-Dec-20,97,mRNA,48,40 to 49
1082,female,CD,Anti-TNF Only,357,positive,adult,,booster2,28-Dec-21,25-Jul-21,156,mRNA,48,40 to 49
1083,female,CD,Anti-TNF Only,130,ngative,adult,,booster2,09-Apr-22,05-Nov-21,155,mRNA,49,40 to 49
1084,female,CD,Ustekinumab Only,4910,positive,adult,,pre_dose,16-Apr-21,06-Dec-20,131,mRNA,57,50 to 59
1085,female,CD,Ustekinumab Only,48443,ngative,adult,,booster1,01-Sep-21,20-Mar-21,165,mRNA,57,50 to 59
1086,female,CD,Ustekinumab Only,35335,positive,adult,,booster2,29-Jan-22,20-Oct-21,101,mRNA,58,50 to 59
1087,female,CD,Ustekinumab Only,1444,positive,adult,,booster2,11-Jun-22,11-Apr-22,61,mRNA,58,50 to 59
1088,male,CD,Ustekinumab Only,507,positive,adult,,pre_dose,07-Apr-21,20-Nov-20,138,vector,52,50 to 59
1089,male,CD,Ustekinumab Only,36560,positive,adult,30,booster2,12-Oct-21,24-Jul-21,80,vector,53,50 to 59
1090,male,CD,Ustekinumab Only,541,positive,adult,,booster2,08-Dec-21,26-Jun-21,165,vector,53,50 to 59
1091,male,CD,Ustekinumab Only,142,ngative,elderly,,primary,21-May-21,29-Nov-20,173,mRNA,66,60 to 69
1092,male,CD,Ustekinumab Only,61058,positive,elderly,359,booster1,11-Aug-21,19-Feb-21,173,mRNA,67,60 to 69
1093,male,CD,Ustekinumab Only,44264,positive,elderly,304,booster2,04-May-22,23-Jan-22,101,mRNA,67,60 to 69
1094,male,UC,Anti-TNF Only,132,ngative,elderly,239,pre_dose,27-Mar-21,24-Oct-20,154,mRNA,72,70+
1095,male,UC,Anti-TNF Only,46323,positive,elderly,220,booster2,25-Feb-22,16-Oct-21,132,mRNA,73,70+
1096,male,UC,Anti-TNF Only,77573,positive,elderly,112,booster2,04-May-22,05-Jan-22,119,mRNA,73,70+
1097,male,UC,Anti-TNF Only,70101,positive,elderly,50,booster2,19-May-22,04-Jan-22,135,mRNA,73,70+
1098,female,CD,Combination Therapy,5301,positive,adult,40,primary,29-May-21,23-Jan-21,126,vector,44,40 to 49
1099,female,CD,Combination Therapy,47862,positive,adult,233,booster1,08-Sep-21,28-Apr-21,133,vector,44,40 to 49
1100,female,CD,Combination Therapy,60187,positive,adult,209,booster2,18-Nov-21,18-Sep-21,61,vector,45,40 to 49
1101,female,CD,Combination Therapy,51059,positive,adult,125,booster2,04-Feb-22,21-Sep-21,136,vector,45,40 to 49
1102,female,CD,Combination Therapy,380,positive,adult,13,booster2,05-Jul-22,12-Jan-22,174,vector,45,40 to 49
1103,male,CD,Anti-TNF Only,16016,positive,adult,,primary,26-May-21,18-Mar-21,69,mRNA,59,50 to 59
1104,male,CD,Anti-TNF Only,75571,positive,adult,,booster1,10-Aug-21,12-Feb-21,179,mRNA,59,50 to 59
1105,male,CD,Anti-TNF Only,332,positive,adult,,booster2,10-Nov-21,15-May-21,179,mRNA,60,60 to 69
1106,male,CD,Anti-TNF Only,60458,positive,adult,,booster2,01-Mar-22,29-Nov-21,92,mRNA,60,60 to 69
1107,male,UC,Combination Therapy,13067,positive,adult,,booster1,07-Aug-21,16-Mar-21,144,mRNA,48,40 to 49
1108,female,UC,No Immunosuppressives,26909,positive,adult,,booster1,28-Apr-21,29-Dec-20,120,mRNA,47,40 to 49
1109,female,CD,Ustekinumab Only,19593,positive,elderly,209,primary,28-Apr-21,18-Feb-21,69,mRNA,72,70+
1110,female,CD,Ustekinumab Only,19525,positive,elderly,,booster1,19-May-21,28-Jan-21,111,mRNA,72,70+
1111,female,CD,Ustekinumab Only,14730,positive,elderly,,booster1,04-Aug-21,05-Apr-21,121,mRNA,72,70+
1112,female,CD,Ustekinumab Only,34098,positive,elderly,,booster2,01-Dec-21,25-Sep-21,67,mRNA,72,70+
1113,female,CD,Ustekinumab Only,38605,positive,elderly,,booster2,17-Mar-22,10-Dec-21,97,mRNA,72,70+
1114,female,CD,Ustekinumab Only,405,positive,elderly,,booster2,06-May-22,16-Nov-21,171,mRNA,73,70+
1115,female,CD,Anti-TNF Only,73679,ngative,adult,,booster1,06-Aug-21,05-Feb-21,182,mRNA,59,50 to 59
1116,female,CD,Anti-TNF Only,68115,positive,adult,,booster1,02-Oct-21,06-May-21,149,mRNA,59,50 to 59
1117,female,CD,Anti-TNF Only,315,positive,adult,,booster2,22-Jan-22,22-Aug-21,153,mRNA,60,60 to 69
1118,female,CD,Anti-TNF Only,49324,positive,adult,,booster2,17-May-22,12-Jan-22,125,mRNA,60,60 to 69
1119,female,CD,Combination Therapy,13923,positive,adult,125,pre_dose,02-May-21,30-Jan-21,92,mRNA,35,30 to 39
1120,female,CD,Combination Therapy,21,ngative,adult,,primary,25-Jun-21,03-Feb-21,142,mRNA,35,30 to 39
1121,female,CD,Combination Therapy,18778,ngative,adult,,booster1,05-Sep-21,29-Mar-21,160,mRNA,35,30 to 39
1122,female,CD,Combination Therapy,2546,positive,adult,,booster2,18-Feb-22,23-Nov-21,87,mRNA,36,30 to 39
1123,female,CD,Combination Therapy,63815,positive,adult,,booster2,25-Jun-22,18-Apr-22,68,mRNA,36,30 to 39
1124,male,CD,Ustekinumab Only,589,positive,adult,,primary,19-May-21,07-Dec-20,163,vector,56,50 to 59
1125,male,CD,Ustekinumab Only,24666,positive,adult,,booster1,03-Sep-21,27-Mar-21,160,vector,56,50 to 59
1126,male,CD,Ustekinumab Only,67495,positive,adult,,booster1,04-Mar-22,08-Jan-22,55,vector,56,50 to 59
1127,female,CD,Combination Therapy,8333,positive,adult,43,pre_dose,20-Feb-21,27-Oct-20,116,mRNA,42,40 to 49
1128,female,CD,Combination Therapy,330,positive,adult,159,primary,16-Jun-21,12-Dec-20,186,mRNA,42,40 to 49
1129,female,CD,Vedolizumab Only,5536,positive,adult,13,booster1,24-Jul-21,12-Mar-21,134,mRNA,42,40 to 49
1130,female,CD,Combination Therapy,41961,positive,adult,302,booster2,06-Nov-21,05-Aug-21,93,mRNA,42,40 to 49
1131,female,CD,Combination Therapy,72662,positive,adult,411,booster2,23-Feb-22,22-Nov-21,93,mRNA,43,40 to 49
1132,female,CD,Combination Therapy,721,positive,adult,464,booster2,17-Apr-22,14-Nov-21,154,mRNA,43,40 to 49
1133,female,CD,Combination Therapy,129,ngative,adult,566,booster2,28-Jul-22,27-Jan-22,182,mRNA,43,40 to 49
1134,female,CD,Anti-TNF Only,52937,positive,adult,,booster1,11-Sep-21,11-May-21,123,mRNA,33,30 to 39
1135,female,CD,Anti-TNF Only,48283,positive,adult,,booster2,04-Feb-22,12-Nov-21,84,mRNA,34,30 to 39
1136,female,CD,Anti-TNF Only,72530,positive,adult,,booster2,13-May-22,01-Feb-22,101,mRNA,34,30 to 39
1137,male,UC,Anti-TNF Only,267,positive,adult,,pre_dose,16-Apr-21,22-Nov-20,145,vector,34,30 to 39
1138,male,UC,Anti-TNF Only,18894,positive,adult,,primary,10-Jun-21,21-Mar-21,81,vector,34,30 to 39
1139,male,UC,Vedolizumab Only,78528,ngative,adult,,booster1,30-Jul-21,18-Jan-21,193,vector,34,30 to 39
1140,male,UC,Vedolizumab Only,35755,positive,adult,,booster2,13-Nov-21,22-Sep-21,52,vector,34,30 to 39
1141,male,UC,Anti-TNF Only,155,ngative,adult,,booster2,12-Apr-22,18-Nov-21,145,vector,35,30 to 39
1142,female,CD,Anti-TNF Only,61587,positive,adult,,primary,26-Feb-21,44193,60,vector,32,30 to 39
1143,female,CD,Anti-TNF Only,3893,positive,adult,,primary,10-Sep-21,44322,127,vector,33,30 to 39
1144,female,CD,Combination Therapy,15951,positive,adult,,pre_dose,22-Apr-21,22-Dec-20,121,mRNA,48,40 to 49
1145,female,CD,Vedolizumab Only,38354,positive,adult,352,primary,07-May-21,05-Mar-21,63,vector,42,40 to 49
1146,male,CD,Vedolizumab Only,13090,positive,adult,,pre_dose,23-Mar-21,27-Dec-20,86,mRNA,53,50 to 59
1147,male,CD,Vedolizumab Only,18966,positive,adult,,primary,22-May-21,05-Feb-21,106,mRNA,54,50 to 59
1148,female,UC,Anti-TNF Only,15826,positive,adult,,pre_dose,23-Mar-21,17-Dec-20,96,mRNA,45,40 to 49
1149,female,UC,Anti-TNF Only,25389,positive,adult,,booster1,22-Jun-21,03-Feb-21,139,mRNA,45,40 to 49
1150,female,UC,Anti-TNF Only,24480,positive,adult,,booster2,08-Oct-21,31-Jul-21,69,mRNA,45,40 to 49
1151,female,UC,Anti-TNF Only,32504,positive,adult,,booster2,24-Mar-22,28-Dec-21,86,mRNA,46,40 to 49
1152,female,UC,Anti-TNF Only,11372,positive,adult,,booster2,24-Jun-22,09-Mar-22,107,mRNA,46,40 to 49
1153,male,CD,Ustekinumab Only,8105,positive,adult,,pre_dose,18-Mar-21,17-Dec-20,91,mRNA,37,30 to 39
1154,male,CD,Ustekinumab Only,69120,positive,adult,,booster1,11-Aug-21,11-May-21,92,mRNA,37,30 to 39
1155,male,CD,Ustekinumab Only,46231,positive,adult,,booster2,26-Jan-22,13-Sep-21,135,mRNA,38,30 to 39
1156,male,CD,Ustekinumab Only,472,positive,adult,,booster2,19-Apr-22,10-Oct-21,191,mRNA,38,30 to 39
1157,male,UC,Combination Therapy,467,positive,adult,,pre_dose,20-Mar-21,09-Sep-20,192,mRNA,32,30 to 39
1158,male,UC,Combination Therapy,34677,positive,adult,,booster1,02-Sep-21,22-Mar-21,164,mRNA,33,30 to 39
1159,male,UC,Combination Therapy,21806,positive,adult,,booster2,18-Feb-22,29-Nov-21,81,mRNA,33,30 to 39
1160,male,UC,Combination Therapy,30068,positive,adult,,booster2,09-Jun-22,23-Feb-22,106,mRNA,33,30 to 39
1161,male,CD,Anti-TNF Only,70416,positive,adult,,primary,20-Mar-21,25-Jan-21,54,mRNA,37,30 to 39
1162,male,CD,Anti-TNF Only,19145,positive,adult,44,pre_dose,13-Apr-21,02-Feb-21,70,mRNA,51,50 to 59
1163,male,CD,Anti-TNF Only,181,ngative,adult,,primary,27-May-21,15-Nov-20,193,mRNA,51,50 to 59
1164,male,CD,Anti-TNF Only,45542,positive,adult,96,booster1,31-Aug-21,22-Mar-21,162,mRNA,51,50 to 59
1165,male,CD,Anti-TNF Only,32575,positive,adult,142,booster1,16-Oct-21,06-Apr-21,193,mRNA,51,50 to 59
1166,male,CD,Anti-TNF Only,1,ngative,adult,265,booster2,16-Feb-22,26-Aug-21,174,mRNA,52,50 to 59
1167,male,CD,Anti-TNF Only,34325,positive,adult,331,booster2,23-Apr-22,27-Jan-22,86,mRNA,52,50 to 59
1168,male,CD,Anti-TNF Only,360,positive,adult,404,booster2,05-Jul-22,04-Jan-22,182,mRNA,52,50 to 59
1169,male,UC,Vedolizumab Only,205,ngative,elderly,,primary,03-Jun-21,12-Jan-21,142,mRNA,67,60 to 69
1170,male,CD,Combination Therapy,13641,positive,adult,93,pre_dose,21-Apr-21,26-Dec-20,116,mRNA,21,18 to 29
1171,male,CD,Combination Therapy,6183,positive,adult,206,booster1,12-Aug-21,24-May-21,80,mRNA,21,18 to 29
1172,male,UC,Combination Therapy,21708,positive,adult,148,booster1,09-Sep-21,22-Feb-21,199,mRNA,41,40 to 49
1173,male,UC,Combination Therapy,415,positive,adult,132,booster2,16-Jun-22,18-Jan-22,149,mRNA,41,40 to 49
1174,female,UC,Anti-TNF Only,15587,positive,adult,,pre_dose,24-Mar-21,04-Jan-21,79,mRNA,34,30 to 39
1175,female,UC,Anti-TNF Only,45308,positive,adult,,booster2,02-Nov-21,24-Jul-21,101,mRNA,35,30 to 39
1176,female,UC,Anti-TNF Only,1110,positive,adult,,booster2,23-Feb-22,22-Oct-21,124,mRNA,35,30 to 39
1177,female,CD,Anti-TNF Only,420,positive,adult,232,primary,09-Mar-21,30-Aug-20,191,mRNA,53,50 to 59
1178,male,UC,Anti-TNF Only,316,positive,adult,227,primary,06-Jun-21,01-Dec-20,187,mRNA,33,30 to 39
1179,male,UC,Anti-TNF Only,35532,positive,adult,,booster1,18-Aug-21,05-Apr-21,135,mRNA,33,30 to 39
1180,male,UC,Anti-TNF Only,65043,positive,adult,5,booster1,14-Jan-22,01-Nov-21,74,mRNA,33,30 to 39
1181,male,UC,Anti-TNF Only,65201,positive,adult,129,booster2,28-May-22,27-Jan-22,121,mRNA,34,30 to 39
1182,male,CD,Anti-TNF Only,72544,positive,adult,102,primary,29-Sep-21,44410,58,vector,45,40 to 49
1183,male,UC,Anti-TNF Only,309,positive,adult,164,pre_dose,12-Feb-21,06-Aug-20,190,mRNA,29,18 to 29
1184,male,UC,Anti-TNF Only,22384,positive,adult,682,booster1,15-Jul-22,30-Apr-22,76,mRNA,30,30 to 39
1185,female,CD,Anti-TNF Only,72264,positive,adult,223,booster1,27-Aug-21,16-Jun-21,72,mRNA,52,50 to 59
1186,female,CD,Anti-TNF Only,13798,positive,adult,125,booster2,03-Dec-21,30-Jul-21,126,mRNA,53,50 to 59
1187,female,CD,Anti-TNF Only,76716,positive,adult,,booster1,10-Jun-21,26-Nov-20,196,mRNA,43,40 to 49
1188,female,CD,Anti-TNF Only,39600,positive,adult,,booster1,25-Sep-21,06-Jul-21,81,mRNA,43,40 to 49
1189,female,CD,Anti-TNF Only,10123,positive,adult,,booster2,02-Jul-22,08-Apr-22,85,mRNA,44,40 to 49
1190,male,CD,Vedolizumab Only,19454,positive,adult,,pre_dose,18-Mar-21,19-Dec-20,89,mRNA,34,30 to 39
1191,male,CD,Vedolizumab Only,71340,ngative,adult,,booster1,02-Sep-21,14-Feb-21,200,mRNA,34,30 to 39
1192,male,CD,Vedolizumab Only,61574,positive,adult,,booster2,16-Feb-22,19-Oct-21,120,mRNA,35,30 to 39
1193,male,CD,Vedolizumab Only,44913,positive,adult,,booster1,21-Jul-21,05-Apr-21,107,mRNA,35,30 to 39
1194,male,CD,Vedolizumab Only,9928,ngative,adult,,booster1,08-Oct-21,30-Mar-21,192,mRNA,35,30 to 39
1195,male,CD,Vedolizumab Only,3691,positive,adult,,booster2,11-Mar-22,18-Dec-21,83,mRNA,36,30 to 39
1196,female,CD,Vedolizumab Only,8027,positive,adult,,pre_dose,08-Apr-21,21-Dec-20,108,vector,39,30 to 39
1197,female,CD,Vedolizumab Only,7892,positive,adult,,pre_dose,29-Jul-21,13-May-21,77,vector,39,30 to 39
1198,male,CD,Anti-TNF Only,12761,positive,elderly,,primary,15-Apr-21,28-Dec-20,108,mRNA,81,70+
1199,male,CD,Anti-TNF Only,70216,positive,elderly,146,booster1,27-May-21,12-Feb-21,104,mRNA,81,70+
1200,male,CD,Anti-TNF Only,56869,positive,elderly,,booster1,11-Sep-21,02-Apr-21,162,mRNA,82,70+
1201,male,CD,Anti-TNF Only,471,positive,elderly,,booster2,30-Dec-21,11-Jul-21,172,mRNA,82,70+
1202,male,CD,Anti-TNF Only,11218,positive,elderly,,booster2,04-Mar-22,05-Dec-21,89,mRNA,82,70+
1203,female,CD,Ustekinumab Only,24626,positive,adult,,primary,29-May-21,19-Mar-21,71,vector,28,18 to 29
1204,female,CD,Vedolizumab Only,8359,positive,elderly,,booster1,12-Mar-21,11-Nov-20,121,mRNA,65,60 to 69
1205,female,CD,Vedolizumab Only,35870,positive,elderly,,booster1,06-Oct-21,30-Jun-21,98,mRNA,66,60 to 69
1206,female,CD,Vedolizumab Only,19249,positive,elderly,,booster2,10-Feb-22,14-Sep-21,149,mRNA,66,60 to 69
1207,male,CD,Anti-TNF Only,170,ngative,adult,,pre_dose,02-Sep-21,14-Apr-21,141,mRNA,27,18 to 29
1208,male,CD,Ustekinumab Only,441,positive,adult,,pre_dose,28-Apr-21,29-Oct-20,181,mRNA,46,40 to 49
1209,male,CD,Ustekinumab Only,417,positive,adult,,booster1,03-Jul-21,14-May-21,50,mRNA,47,40 to 49
1210,male,CD,Ustekinumab Only,76858,positive,adult,,booster1,07-Oct-21,08-Jun-21,121,mRNA,47,40 to 49
1211,male,CD,Ustekinumab Only,63195,positive,adult,,booster2,11-Feb-22,15-Dec-21,58,mRNA,47,40 to 49
1212,male,CD,Ustekinumab Only,76652,positive,adult,,booster2,01-Jun-22,12-Feb-22,109,mRNA,47,40 to 49
1213,female,CD,Anti-TNF Only,14447,positive,adult,191,booster1,18-Aug-21,21-Mar-21,150,mRNA,22,18 to 29
1214,female,CD,Anti-TNF Only,76043,positive,adult,13,booster2,12-Feb-22,18-Oct-21,117,mRNA,22,18 to 29
1215,female,CD,Anti-TNF Only,57223,positive,adult,42,booster2,08-Apr-22,08-Feb-22,59,mRNA,22,18 to 29
1216,female,CD,Anti-TNF Only,52914,positive,adult,160,booster2,04-Aug-22,27-Feb-22,158,mRNA,23,18 to 29
1217,female,CD,Ustekinumab Only,994,positive,adult,337,primary,06-Jun-21,22-Dec-20,166,mRNA,29,18 to 29
1218,female,CD,Ustekinumab Only,65777,positive,adult,304,booster1,09-Jul-21,08-May-21,62,mRNA,29,18 to 29
1219,male,UC,Ustekinumab Only,14337,positive,adult,,pre_dose,10-Apr-21,28-Dec-20,103,mRNA,17,10 to 17
1220,male,UC,Ustekinumab Only,11373,positive,adult,,booster1,04-Aug-21,16-May-21,80,mRNA,18,18 to 29
1221,female,CD,Ustekinumab Only,1761,positive,adult,,booster1,05-Oct-21,23-Jul-21,74,vector,32,30 to 39
1222,female,CD,Ustekinumab Only,11625,positive,adult,,primary,28-May-21,25-Mar-21,64,vector,56,50 to 59
1223,female,CD,Anti-TNF Only,42710,positive,adult,,booster1,13-Oct-21,31-Mar-21,196,vector,56,50 to 59
1224,female,CD,Anti-TNF Only,115,ngative,adult,,booster2,02-Mar-22,08-Sep-21,175,vector,57,50 to 59
1225,female,CD,Anti-TNF Only,315,positive,adult,,booster2,20-Jul-22,04-Jan-22,197,vector,57,50 to 59
1226,female,CD,Vedolizumab Only,16644,positive,adult,,pre_dose,31-Mar-21,17-Dec-20,104,mRNA,36,30 to 39
1227,female,CD,Vedolizumab Only,16477,positive,adult,,primary,12-Jun-21,31-Mar-21,73,mRNA,37,30 to 39
1228,female,CD,Vedolizumab Only,78323,positive,adult,,booster1,01-Sep-21,14-Apr-21,140,mRNA,37,30 to 39
1229,female,CD,Vedolizumab Only,24343,positive,adult,,booster2,23-Feb-22,02-Dec-21,83,mRNA,37,30 to 39
1230,male,CD,Anti-TNF Only,125,ngative,adult,251,pre_dose,18-May-21,07-Nov-20,192,mRNA,42,40 to 49
1231,male,CD,Anti-TNF Only,53847,positive,adult,209,primary,29-Jun-21,30-Apr-21,60,mRNA,42,40 to 49
1232,male,CD,Anti-TNF Only,59614,ngative,adult,181,booster1,27-Jul-21,17-Feb-21,160,mRNA,42,40 to 49
1233,female,CD,Vedolizumab Only,5673,positive,adult,39,primary,05-Jun-21,15-Mar-21,82,mRNA,48,40 to 49
1234,female,CD,Vedolizumab Only,1028,positive,adult,120,booster1,25-Aug-21,03-Jul-21,53,mRNA,48,40 to 49
1235,male,CD,Anti-TNF Only,10208,positive,adult,,primary,16-May-21,23-Feb-21,82,mRNA,32,30 to 39
1236,male,CD,Anti-TNF Only,66208,positive,pediatric,,booster1,08-Aug-21,08-Apr-21,122,mRNA,1,00 to 09
1237,male,CD,Anti-TNF Only,84,ngative,pediatric,,booster2,30-Oct-21,02-Jun-21,150,mRNA,4,00 to 09
1238,male,CD,Anti-TNF Only,31301,positive,pediatric,,booster2,05-Feb-22,01-Oct-21,127,mRNA,7,00 to 09
1239,male,CD,Anti-TNF Only,36376,positive,pediatric,,booster2,17-Apr-22,23-Nov-21,145,mRNA,10,10 to 17
1240,male,CD,Anti-TNF Only,25412,positive,pediatric,,booster2,21-Jul-22,30-Mar-22,113,mRNA,4,00 to 09
1241,female,CD,Vedolizumab Only,3251,positive,pediatric,222,booster1,06-Apr-21,23-Dec-20,104,mRNA,3,00 to 09
1242,female,CD,Vedolizumab Only,31637,positive,pediatric,115,booster2,09-Mar-22,30-Dec-21,69,mRNA,6,00 to 09
1243,male,CD,Combination Therapy,10323,positive,pediatric,98,primary,02-Jun-21,21-Feb-21,101,mRNA,12,10 to 17
1244,male,CD,Combination Therapy,20608,positive,adult,213,booster1,25-Sep-21,06-Apr-21,172,mRNA,56,50 to 59
1245,male,CD,Combination Therapy,253,positive,pediatric,324,booster2,14-Jan-22,18-Jul-21,180,mRNA,2,00 to 09
1246,male,CD,Combination Therapy,36185,positive,pediatric,435,booster2,05-May-22,26-Jan-22,99,mRNA,2,00 to 09
1247,male,CD,Combination Therapy,36151,positive,pediatric,462,booster2,01-Jun-22,31-Jan-22,121,mRNA,13,10 to 17
1248,female,CD,Ustekinumab Only,35264,positive,pediatric,,booster1,09-Jun-21,29-Jan-21,131,mRNA,13,10 to 17
1249,female,CD,Ustekinumab Only,30537,positive,pediatric,,booster2,05-Jan-22,25-Oct-21,72,mRNA,1,00 to 09
1250,female,CD,Ustekinumab Only,623,positive,pediatric,,pre_dose,28-Apr-21,12-Nov-20,167,vector,5,00 to 09
1251,female,CD,Ustekinumab Only,1989,positive,pediatric,,primary,24-Jun-21,12-Feb-21,132,vector,12,10 to 17
1252,female,CD,Ustekinumab Only,73495,positive,pediatric,,booster1,06-Aug-21,16-May-21,82,vector,5,00 to 09
1253,female,CD,Ustekinumab Only,28491,positive,adult,,booster1,01-Mar-22,04-Dec-21,87,vector,50,50 to 59
1254,female,CD,Ustekinumab Only,2744,positive,adult,,booster2,30-Mar-22,15-Jan-22,74,vector,50,50 to 59
1255,female,CD,Ustekinumab Only,44377,positive,adult,,booster2,08-Jul-22,14-Apr-22,85,vector,51,50 to 59
1256,male,CD,Ustekinumab Only,11726,positive,adult,,pre_dose,01-May-21,20-Feb-21,70,vector,33,30 to 39
1257,female,CD,Ustekinumab Only,10048,positive,adult,,primary,25-May-21,29-Jan-21,116,mRNA,34,30 to 39
1258,female,CD,Ustekinumab Only,5429,positive,adult,,primary,14-Aug-21,09-Apr-21,127,mRNA,34,30 to 39
1259,female,CD,Ustekinumab Only,60470,positive,adult,,booster2,26-Jan-22,08-Nov-21,79,mRNA,34,30 to 39
1260,female,UC,Anti-TNF Only,52280,positive,adult,,primary,25-Sep-21,44402,62,vector,44,40 to 49
1261,male,CD,Combination Therapy,371,positive,adult,180,booster2,09-Nov-21,02-May-21,191,mRNA,22,18 to 29
1262,female,UC,Combination Therapy,14960,positive,adult,435,pre_dose,16-Mar-21,05-Jan-21,70,mRNA,35,30 to 39
1263,female,UC,Combination Therapy,12808,positive,adult,355,primary,04-Jun-21,29-Jan-21,126,mRNA,36,30 to 39
1264,female,UC,Combination Therapy,60396,positive,adult,319,booster1,10-Jul-21,14-Apr-21,87,mRNA,36,30 to 39
1265,female,UC,Combination Therapy,273,positive,adult,194,booster2,12-Nov-21,21-May-21,175,mRNA,36,30 to 39
1266,female,UC,Combination Therapy,502,positive,adult,83,booster2,03-Mar-22,20-Sep-21,164,mRNA,36,30 to 39
1267,female,UC,Combination Therapy,57695,positive,adult,27,booster2,28-Apr-22,16-Dec-21,133,mRNA,36,30 to 39
1268,female,CD,Combination Therapy,42654,positive,elderly,,booster1,15-May-21,19-Dec-20,147,mRNA,65,60 to 69
1269,female,CD,Combination Therapy,64545,positive,elderly,,booster1,02-Oct-21,30-Jul-21,64,mRNA,66,60 to 69
1270,female,CD,Combination Therapy,29495,positive,elderly,,booster2,10-Nov-21,26-Jun-21,137,mRNA,66,60 to 69
1271,female,CD,Combination Therapy,429,positive,elderly,,booster2,27-Apr-22,24-Oct-21,185,mRNA,66,60 to 69
1272,female,CD,Combination Therapy,357,positive,elderly,,booster2,21-Jul-22,10-Jan-22,192,mRNA,66,60 to 69
1273,female,CD,Vedolizumab Only,5817,positive,elderly,340,booster1,01-May-21,22-Nov-20,160,mRNA,79,70+
1274,female,CD,Vedolizumab Only,44236,positive,elderly,315,booster1,26-May-21,12-Nov-20,195,mRNA,79,70+
1275,female,CD,Vedolizumab Only,75618,positive,elderly,203,booster1,15-Sep-21,21-May-21,117,mRNA,79,70+
1276,female,CD,Vedolizumab Only,49529,positive,elderly,143,booster2,14-Nov-21,06-Sep-21,69,mRNA,80,70+
1277,female,CD,Anti-TNF Only,56257,positive,adult,,booster1,09-Sep-21,27-May-21,105,mRNA,36,30 to 39
1278,female,CD,Anti-TNF Only,45015,positive,adult,,booster2,04-Mar-22,23-Oct-21,132,mRNA,37,30 to 39
1279,female,CD,Anti-TNF Only,329,positive,adult,,booster2,20-Apr-22,06-Oct-21,196,mRNA,37,30 to 39
1280,male,CD,Anti-TNF Only,637,positive,adult,12,pre_dose,02-Feb-21,31-Aug-20,155,mRNA,27,18 to 29
1281,male,CD,Anti-TNF Only,403,positive,adult,68,pre_dose,30-Mar-21,30-Sep-20,181,mRNA,27,18 to 29
1282,male,CD,Anti-TNF Only,238,ngative,adult,,primary,15-Jun-21,06-Dec-20,191,vector,35,30 to 39
1283,female,UC,Vedolizumab Only,67627,positive,adult,,primary,23-Mar-21,27-Jan-21,55,mRNA,32,30 to 39
1284,female,UC,Vedolizumab Only,461,positive,adult,,primary,18-May-21,23-Nov-20,176,mRNA,32,30 to 39
1285,female,UC,Vedolizumab Only,10115,positive,adult,,booster1,02-Sep-21,11-May-21,114,mRNA,33,30 to 39
1286,female,CD,Anti-TNF Only,13338,positive,adult,103,pre_dose,27-Mar-21,19-Dec-20,98,mRNA,22,18 to 29
1287,female,UC,No Immunosuppressives,15612,positive,adult,87,primary,25-Feb-21,08-Nov-20,109,mRNA,45,40 to 49
1288,female,UC,No Immunosuppressives,58647,positive,adult,341,booster1,06-Nov-21,15-Jun-21,144,mRNA,46,40 to 49
1289,female,CD,Ustekinumab Only,484,positive,adult,,pre_dose,21-Apr-21,22-Oct-20,181,mRNA,56,50 to 59
1290,female,CD,Ustekinumab Only,46989,ngative,adult,,booster1,08-Sep-21,14-Mar-21,178,mRNA,56,50 to 59
1291,female,CD,Ustekinumab Only,54924,positive,adult,,booster2,25-Feb-22,03-Jan-22,53,mRNA,57,50 to 59
1292,female,CD,Anti-TNF Only,214,ngative,adult,,pre_dose,01-Apr-21,06-Oct-20,177,mRNA,23,18 to 29
1293,female,UC,Ustekinumab Only,507,positive,adult,,primary,27-Jun-21,09-Jan-21,169,mRNA,35,30 to 39
1294,female,UC,Ustekinumab Only,79225,positive,adult,,booster1,26-Jul-21,23-Mar-21,125,mRNA,35,30 to 39
1295,female,UC,Ustekinumab Only,19299,positive,adult,,booster2,22-Dec-21,15-Oct-21,68,mRNA,36,30 to 39
1296,female,UC,Ustekinumab Only,50606,positive,adult,,booster2,11-Apr-22,27-Dec-21,105,mRNA,36,30 to 39
1297,male,CD,Ustekinumab Only,150,ngative,adult,,pre_dose,09-Apr-21,16-Oct-20,175,vector,55,50 to 59
1298,male,CD,Ustekinumab Only,539,positive,adult,,primary,01-Jun-21,14-Dec-20,169,vector,55,50 to 59
1299,male,CD,Ustekinumab Only,14841,positive,adult,120,booster1,31-Dec-21,15-Sep-21,107,vector,56,50 to 59
1300,male,CD,Ustekinumab Only,39017,positive,adult,,booster2,09-Feb-22,21-Oct-21,111,vector,56,50 to 59
1301,male,CD,Ustekinumab Only,35029,positive,adult,,booster2,10-Jun-22,10-Apr-22,61,vector,56,50 to 59
1302,male,UC,Vedolizumab Only,19501,positive,adult,,pre_dose,09-Mar-21,30-Nov-20,99,mRNA,30,30 to 39
1303,male,CD,Combination Therapy,68804,positive,adult,,primary,18-Apr-21,20-Feb-21,57,mRNA,36,30 to 39
1304,male,CD,Combination Therapy,8507,positive,adult,,primary,02-Jul-21,16-Mar-21,108,mRNA,36,30 to 39
1305,male,CD,Combination Therapy,79703,ngative,adult,390,booster1,06-Aug-21,21-Feb-21,166,mRNA,36,30 to 39
1306,male,CD,Combination Therapy,16696,positive,adult,300,booster2,19-Jan-22,18-Aug-21,154,mRNA,37,30 to 39
1307,male,CD,Combination Therapy,16641,positive,adult,185,booster2,20-May-22,12-Mar-22,69,mRNA,37,30 to 39
1308,female,UC,Ustekinumab Only,19079,positive,adult,73,booster1,24-Jul-21,07-Apr-21,108,mRNA,24,18 to 29
1309,female,UC,Ustekinumab Only,55521,positive,pediatric,,booster2,22-Jan-22,24-Oct-21,90,mRNA,5,00 to 09
1310,female,UC,Ustekinumab Only,388,positive,pediatric,,booster2,05-Jun-22,30-Dec-21,157,mRNA,5,00 to 09
1311,male,CD,Anti-TNF Only,6612,positive,pediatric,28,pre_dose,29-Mar-21,04-Dec-20,115,mRNA,12,10 to 17
1312,female,CD,Ustekinumab Only,210,ngative,pediatric,,pre_dose,27-Mar-21,17-Sep-20,191,mRNA,5,00 to 09
1313,female,CD,Ustekinumab Only,324,positive,adult,,primary,22-May-21,01-Dec-20,172,mRNA,37,30 to 39
1314,female,CD,Ustekinumab Only,71973,ngative,adult,,booster1,31-Aug-21,19-Mar-21,165,mRNA,38,30 to 39
1315,female,CD,Ustekinumab Only,63667,positive,adult,,booster2,18-Feb-22,21-Oct-21,120,mRNA,38,30 to 39
1316,male,CD,Anti-TNF Only,10017,positive,adult,,pre_dose,31-Mar-21,29-Dec-20,92,vector,47,40 to 49
1317,male,CD,Anti-TNF Only,8577,positive,adult,,primary,12-Jun-21,19-Feb-21,113,vector,47,40 to 49
1318,male,CD,Anti-TNF Only,78794,positive,adult,,booster1,03-Aug-21,04-Mar-21,152,vector,47,40 to 49
1319,male,CD,Anti-TNF Only,33988,positive,adult,,booster1,31-Dec-21,31-Jul-21,153,vector,48,40 to 49
1320,male,CD,Anti-TNF Only,69120,positive,adult,,booster2,01-Feb-22,02-Dec-21,61,vector,48,40 to 49
1321,male,CD,Anti-TNF Only,59893,positive,adult,,booster2,07-May-22,03-Jan-22,124,vector,48,40 to 49
1322,female,CD,Anti-TNF Only,6851,positive,adult,,primary,14-Apr-21,29-Dec-20,106,mRNA,60,60 to 69
1323,female,CD,Anti-TNF Only,41930,positive,adult,,booster1,17-Jun-21,14-Apr-21,64,mRNA,60,60 to 69
1324,female,CD,Anti-TNF Only,48897,positive,adult,,booster1,17-Sep-21,12-Jul-21,67,mRNA,60,60 to 69
1325,female,CD,Anti-TNF Only,570,positive,adult,,booster2,04-Feb-22,21-Aug-21,167,mRNA,61,60 to 69
1326,female,CD,Anti-TNF Only,53734,positive,adult,,booster2,08-Apr-22,15-Feb-22,52,mRNA,61,60 to 69
1327,male,CD,Anti-TNF Only,5674,positive,adult,51,pre_dose,25-Feb-21,21-Oct-20,127,mRNA,46,40 to 49
1328,male,CD,Anti-TNF Only,5475,positive,adult,147,primary,01-Jun-21,22-Jan-21,130,mRNA,47,40 to 49
1329,male,CD,Anti-TNF Only,64485,ngative,adult,,booster1,27-Aug-21,26-Feb-21,182,mRNA,47,40 to 49
1330,male,CD,Anti-TNF Only,327,positive,adult,399,booster2,08-Feb-22,12-Sep-21,149,mRNA,47,40 to 49
1331,male,CD,Anti-TNF Only,23023,positive,adult,491,booster2,11-May-22,20-Mar-22,52,mRNA,48,40 to 49
1332,male,UC,Tofacitinib Only,138,ngative,adult,76,pre_dose,03-Mar-21,23-Sep-20,161,mRNA,37,30 to 39
1333,male,UC,Tofacitinib Only,21128,positive,adult,175,primary,10-Jun-21,01-Apr-21,70,mRNA,37,30 to 39
1334,male,UC,Tofacitinib Only,79290,positive,adult,271,booster1,14-Sep-21,20-Jun-21,86,mRNA,37,30 to 39
1335,female,CD,Ustekinumab Only,5805,positive,adult,,primary,05-May-21,19-Jan-21,106,mRNA,60,60 to 69
1336,female,CD,Ustekinumab Only,59428,ngative,adult,,booster1,19-Aug-21,03-Feb-21,197,mRNA,60,60 to 69
1337,female,CD,Ustekinumab Only,12532,positive,adult,,booster2,09-Feb-22,26-Nov-21,75,mRNA,61,60 to 69
1338,female,CD,Ustekinumab Only,667,positive,adult,,booster2,17-Jun-22,29-Dec-21,170,mRNA,61,60 to 69
1339,male,CD,Ustekinumab Only,312,positive,elderly,,pre_dose,08-Apr-21,10-Nov-20,149,mRNA,63,60 to 69
1340,male,CD,Ustekinumab Only,44864,positive,elderly,,booster1,03-Sep-21,08-May-21,118,mRNA,64,60 to 69
1341,male,CD,Ustekinumab Only,716,positive,elderly,,booster2,22-Feb-22,06-Oct-21,139,mRNA,64,60 to 69
1342,male,CD,Ustekinumab Only,36266,positive,elderly,,booster2,04-Jun-22,11-Jan-22,144,mRNA,64,60 to 69
1343,female,CD,Anti-TNF Only,880,positive,adult,412,primary,26-Feb-21,08-Oct-20,141,mRNA,30,30 to 39
1344,female,CD,Anti-TNF Only,,,adult,376,booster1,03-Apr-21,30-Jan-21,63,mRNA,30,30 to 39
1345,female,CD,Anti-TNF Only,65525,positive,adult,216,booster1,10-Sep-21,30-May-21,103,mRNA,30,30 to 39
1346,female,CD,Anti-TNF Only,36442,positive,adult,78,booster2,26-Jan-22,11-Nov-21,76,mRNA,31,30 to 39
1347,male,CD,Combination Therapy,19650,positive,adult,,pre_dose,03-Apr-21,06-Dec-20,118,mRNA,28,18 to 29
1348,male,CD,Combination Therapy,5002,positive,adult,223,primary,05-Jun-21,25-Jan-21,131,mRNA,17,10 to 17
1349,male,CD,Combination Therapy,45889,positive,adult,,booster1,23-Jul-21,02-Jun-21,51,mRNA,17,10 to 17
1350,female,CD,Combination Therapy,20421,positive,adult,,booster1,25-Aug-21,30-Apr-21,117,mRNA,20,18 to 29
1351,female,CD,Anti-TNF Only,20434,positive,adult,205,primary,17-Jun-21,12-Apr-21,66,mRNA,53,50 to 59
1352,female,CD,Anti-TNF Only,4938,positive,adult,151,booster1,10-Aug-21,22-May-21,80,mRNA,53,50 to 59
1353,female,CD,Anti-TNF Only,19049,positive,adult,35,booster1,12-Feb-22,08-Oct-21,127,mRNA,53,50 to 59
1354,female,CD,Anti-TNF Only,64586,positive,adult,62,booster2,11-Mar-22,15-Nov-21,116,mRNA,53,50 to 59
1355,female,CD,Anti-TNF Only,73037,positive,adult,152,booster2,09-Jun-22,13-Feb-22,116,mRNA,54,50 to 59
1356,female,UC,Vedolizumab Only,23510,positive,adult,19,primary,28-Feb-21,17-Dec-20,73,mRNA,43,40 to 49
1357,male,CD,Anti-TNF Only,301,positive,adult,121,pre_dose,30-Mar-21,16-Oct-20,165,mRNA,36,30 to 39
1358,male,CD,Anti-TNF Only,15238,positive,adult,213,primary,30-Jun-21,25-Apr-21,66,mRNA,36,30 to 39
1359,male,CD,Anti-TNF Only,45831,positive,adult,390,booster1,01-Jan-22,21-Aug-21,133,mRNA,37,30 to 39
1360,female,CD,Anti-TNF Only,11182,positive,adult,,pre_dose,30-Apr-21,08-Feb-21,81,mRNA,50,50 to 59
1361,female,CD,Anti-TNF Only,59325,positive,adult,,booster1,15-Jul-21,11-Jan-21,185,mRNA,50,50 to 59
1362,female,CD,Anti-TNF Only,19313,ngative,adult,,booster1,17-Jul-21,02-Jan-21,196,mRNA,50,50 to 59
1363,female,CD,Anti-TNF Only,39486,positive,adult,,booster2,20-Oct-21,15-Jun-21,127,mRNA,50,50 to 59
1364,female,CD,Anti-TNF Only,23660,positive,adult,,booster2,01-Mar-22,04-Jan-22,56,mRNA,50,50 to 59
1365,female,CD,Ustekinumab Only,188,ngative,adult,531,primary,25-Feb-21,14-Aug-20,195,mRNA,49,40 to 49
1366,female,CD,Ustekinumab Only,37897,positive,adult,470,booster1,27-Apr-21,06-Feb-21,80,mRNA,49,40 to 49
1367,female,CD,Ustekinumab Only,24218,positive,adult,274,booster2,09-Nov-21,19-Aug-21,82,mRNA,50,50 to 59
1368,female,CD,Ustekinumab Only,2609,positive,adult,193,booster2,29-Jan-22,25-Oct-21,96,mRNA,50,50 to 59
1369,female,CD,Ustekinumab Only,11641,positive,adult,300,booster2,14-May-22,24-Jan-22,110,mRNA,50,50 to 59
1370,male,CD,Ustekinumab Only,79309,ngative,adult,132,booster1,09-Sep-21,25-Feb-21,196,mRNA,33,30 to 39
1371,female,UC,Anti-TNF Only,972,positive,adult,329,pre_dose,17-Mar-21,21-Oct-20,147,mRNA,42,40 to 49
1372,female,CD,Anti-TNF Only,62497,positive,adult,320,booster1,10-Mar-21,10-Nov-20,120,mRNA,22,18 to 29
1373,female,CD,Anti-TNF Only,3834,positive,adult,238,booster1,31-May-21,24-Jan-21,127,mRNA,22,18 to 29
1374,female,CD,Anti-TNF Only,46868,positive,adult,87,booster2,29-Oct-21,11-Jul-21,110,mRNA,22,18 to 29
1375,female,CD,Anti-TNF Only,46,ngative,adult,11,booster2,04-Feb-22,05-Sep-21,152,mRNA,22,18 to 29
1376,female,CD,Combination Therapy,310,positive,adult,100,pre_dose,15-May-21,03-Dec-20,163,mRNA,49,40 to 49
1377,female,UC,Immunomodulator Only,411,positive,adult,,pre_dose,16-Mar-21,04-Sep-20,193,mRNA,53,50 to 59
1378,female,UC,Immunomodulator Only,318,positive,adult,,primary,04-May-21,14-Nov-20,171,mRNA,53,50 to 59
1379,female,UC,Immunomodulator Only,52910,positive,adult,185,booster1,02-Jul-21,26-Apr-21,67,mRNA,53,50 to 59
1380,female,UC,Immunomodulator Only,33562,positive,adult,,booster1,04-Sep-21,18-Mar-21,170,mRNA,54,50 to 59
1381,female,UC,Immunomodulator Only,62,ngative,adult,,booster2,18-Nov-21,01-Jun-21,170,mRNA,54,50 to 59
1382,female,UC,Immunomodulator Only,17086,positive,adult,,booster2,09-Feb-22,18-Dec-21,53,mRNA,54,50 to 59
1383,female,UC,Immunomodulator Only,70088,positive,adult,,booster2,29-Mar-22,16-Nov-21,133,mRNA,54,50 to 59
1384,female,UC,Immunomodulator Only,38870,positive,adult,,booster2,19-Jul-22,10-May-22,70,mRNA,54,50 to 59
1385,female,CD,Combination Therapy,14728,positive,adult,,primary,10-Mar-21,29-Dec-20,71,vector,38,30 to 39
1386,female,CD,Combination Therapy,12282,positive,adult,,booster1,08-Apr-21,02-Dec-20,127,vector,38,30 to 39
1387,female,CD,Combination Therapy,58444,positive,adult,,booster1,01-Oct-21,11-May-21,143,vector,39,30 to 39
1388,female,CD,Combination Therapy,68393,positive,adult,,booster2,13-Jul-22,22-Apr-22,82,vector,39,30 to 39
1389,male,UC,No Immunosuppressives,21249,positive,adult,73,primary,25-Feb-21,16-Dec-20,71,mRNA,27,18 to 29
1390,male,UC,No Immunosuppressives,41781,positive,adult,282,booster1,09-May-21,28-Oct-20,193,mRNA,27,18 to 29
1391,male,UC,No Immunosuppressives,20728,positive,adult,393,booster1,28-Aug-21,16-Apr-21,134,mRNA,28,18 to 29
1392,male,UC,No Immunosuppressives,51475,ngative,adult,525,booster1,07-Jan-22,28-Jun-21,193,mRNA,28,18 to 29
1393,male,UC,No Immunosuppressives,23412,positive,adult,634,booster2,26-Apr-22,04-Jan-22,112,mRNA,28,18 to 29
1394,female,CD,Ustekinumab Only,855,positive,adult,309,primary,08-Apr-21,22-Oct-20,168,mRNA,40,40 to 49
1395,female,CD,Ustekinumab Only,14693,positive,adult,253,booster1,03-Jun-21,04-Feb-21,119,mRNA,40,40 to 49
1396,female,CD,Ustekinumab Only,79109,positive,adult,155,booster1,09-Sep-21,02-May-21,130,mRNA,41,40 to 49
1397,female,CD,Ustekinumab Only,71310,positive,adult,70,booster2,03-Dec-21,02-Sep-21,92,mRNA,41,40 to 49
1398,male,UC,Anti-TNF Only,63395,positive,adult,,booster1,10-Aug-21,20-Mar-21,143,vector,32,30 to 39
1399,female,CD,Vedolizumab Only,464,positive,elderly,,primary,05-Mar-21,44065,195,vector,71,70+
1400,female,CD,Vedolizumab Only,75,ngative,elderly,,primary,20-Aug-21,44260,168,vector,71,70+
1401,female,CD,Anti-TNF Only,9920,positive,adult,,pre_dose,17-Mar-21,26-Nov-20,111,mRNA,47,40 to 49
1402,female,CD,Anti-TNF Only,36834,positive,adult,237,booster1,28-May-21,13-Dec-20,166,mRNA,47,40 to 49
1403,female,CD,Anti-TNF Only,64239,positive,adult,162,booster1,10-Sep-21,05-May-21,128,mRNA,48,40 to 49
1404,female,CD,Anti-TNF Only,174,ngative,adult,50,booster2,15-Dec-21,03-Jun-21,195,mRNA,48,40 to 49
1405,female,CD,Anti-TNF Only,184,ngative,adult,56,booster2,15-Mar-22,06-Sep-21,190,mRNA,48,40 to 49
1406,female,UC,No Immunosuppressives,10618,positive,adult,,pre_dose,23-Mar-21,04-Dec-20,109,mRNA,45,40 to 49
1407,female,UC,No Immunosuppressives,5858,positive,adult,,booster1,18-Nov-21,20-Sep-21,59,mRNA,46,40 to 49
1408,female,CD,Anti-TNF Only,61196,positive,adult,,booster1,27-Mar-21,03-Feb-21,52,mRNA,34,30 to 39
1409,female,CD,Anti-TNF Only,29852,positive,adult,,booster1,28-Sep-21,07-Apr-21,174,mRNA,34,30 to 39
1410,female,CD,Anti-TNF Only,21975,positive,adult,,booster2,18-Nov-21,16-Sep-21,63,mRNA,35,30 to 39
1411,female,CD,Anti-TNF Only,204,ngative,adult,,booster2,18-Feb-22,25-Aug-21,177,mRNA,35,30 to 39
1412,female,CD,Anti-TNF Only,29801,positive,adult,,booster2,19-Apr-22,28-Feb-22,50,mRNA,35,30 to 39
1413,female,CD,Ustekinumab Only,235,ngative,elderly,,pre_dose,29-Mar-21,29-Sep-20,181,mRNA,65,60 to 69
1414,female,CD,Ustekinumab Only,913,positive,elderly,,primary,12-May-21,22-Dec-20,141,mRNA,65,60 to 69
1415,female,CD,Ustekinumab Only,70751,positive,elderly,,booster1,15-Jul-21,31-Dec-20,196,mRNA,65,60 to 69
1416,female,CD,Ustekinumab Only,42317,positive,elderly,,booster2,12-Oct-21,03-Jun-21,131,mRNA,65,60 to 69
1417,female,CD,Ustekinumab Only,321,positive,elderly,,booster2,27-Jan-22,01-Aug-21,179,mRNA,66,60 to 69
1418,female,CD,Ustekinumab Only,491,positive,elderly,,booster2,01-Apr-22,29-Oct-21,154,mRNA,66,60 to 69
1419,female,CD,Ustekinumab Only,28533,positive,elderly,,booster2,02-Jul-22,18-Mar-22,106,mRNA,66,60 to 69
1420,male,CD,Anti-TNF Only,109,ngative,adult,100,pre_dose,28-Mar-21,07-Oct-20,172,mRNA,23,18 to 29
1421,male,UC,Anti-TNF Only,12823,positive,adult,,pre_dose,27-Apr-21,29-Jan-21,88,mRNA,60,60 to 69
1422,male,UC,Anti-TNF Only,20825,positive,adult,,booster1,15-Jun-21,18-Dec-20,179,mRNA,60,60 to 69
1423,male,UC,Anti-TNF Only,20183,positive,adult,,booster2,30-Nov-21,04-Oct-21,57,mRNA,61,60 to 69
1424,female,CD,Vedolizumab Only,110,ngative,adult,,pre_dose,09-Apr-21,17-Nov-20,143,mRNA,32,30 to 39
1425,female,CD,Vedolizumab Only,49135,positive,adult,,primary,03-Jun-21,04-Apr-21,60,mRNA,32,30 to 39
1426,male,CD,Ustekinumab Only,279,positive,elderly,22,pre_dose,05-Mar-21,26-Sep-20,160,mRNA,72,70+
1427,male,CD,Ustekinumab Only,71124,positive,elderly,83,primary,05-May-21,15-Mar-21,51,mRNA,72,70+
1428,male,CD,Ustekinumab Only,6876,positive,elderly,174,booster1,04-Aug-21,20-Apr-21,106,mRNA,72,70+
1429,male,CD,Ustekinumab Only,79943,positive,elderly,237,booster2,20-Nov-21,28-Aug-21,84,mRNA,72,70+
1430,male,CD,Ustekinumab Only,7429,positive,elderly,407,booster2,25-Mar-22,08-Nov-21,137,mRNA,73,70+
1431,male,CD,Ustekinumab Only,13033,positive,elderly,465,booster2,22-May-22,03-Mar-22,80,mRNA,73,70+
1432,male,UC,Immunomodulator Only,307,positive,adult,49,pre_dose,16-Apr-21,06-Oct-20,192,mRNA,27,18 to 29
1433,female,CD,Anti-TNF Only,22139,positive,adult,285,primary,31-Mar-21,22-Jan-21,68,mRNA,31,30 to 39
1434,female,CD,Anti-TNF Only,480,positive,adult,208,primary,16-Jun-21,16-Dec-20,182,mRNA,31,30 to 39
1435,female,CD,Anti-TNF Only,2424,positive,adult,180,booster1,14-Jul-21,04-Jan-21,191,mRNA,31,30 to 39
1436,female,CD,Anti-TNF Only,38231,positive,adult,24,booster1,03-Feb-22,09-Sep-21,147,mRNA,32,30 to 39
1437,female,CD,Anti-TNF Only,61791,positive,adult,99,booster2,19-Apr-22,18-Jan-22,91,mRNA,32,30 to 39
1438,female,CD,Ustekinumab Only,5976,positive,adult,,pre_dose,25-Mar-21,15-Nov-20,130,mRNA,59,50 to 59
1439,female,CD,Ustekinumab Only,376,positive,adult,162,primary,15-Jun-21,13-Jan-21,153,mRNA,60,60 to 69
1440,female,CD,Ustekinumab Only,22825,positive,adult,,booster1,01-Oct-21,13-Jun-21,110,mRNA,60,60 to 69
1441,female,CD,Ustekinumab Only,33956,positive,adult,,booster2,02-Nov-21,20-Aug-21,74,mRNA,60,60 to 69
1442,female,CD,Ustekinumab Only,70965,positive,adult,,booster2,01-Mar-22,28-Oct-21,124,mRNA,60,60 to 69
1443,female,CD,Ustekinumab Only,354,positive,adult,,booster2,05-May-22,04-Nov-21,182,mRNA,61,60 to 69
1444,male,CD,Vedolizumab Only,20594,positive,adult,,booster1,20-Mar-21,18-Oct-20,153,mRNA,50,50 to 59
1445,male,CD,Vedolizumab Only,56257,positive,adult,,booster1,24-Sep-21,14-May-21,133,mRNA,51,50 to 59
1446,male,CD,Vedolizumab Only,37548,positive,adult,,booster2,15-Feb-22,06-Nov-21,101,mRNA,51,50 to 59
1447,female,CD,Anti-TNF Only,19836,positive,adult,401,primary,20-Apr-21,11-Feb-21,68,mRNA,28,18 to 29
1448,female,CD,Anti-TNF Only,63464,positive,adult,338,booster1,22-Jun-21,30-Mar-21,84,mRNA,29,18 to 29
1449,female,CD,Anti-TNF Only,15055,positive,adult,,booster1,01-Sep-21,25-Apr-21,129,mRNA,29,18 to 29
1450,female,CD,Anti-TNF Only,38,ngative,adult,112,booster2,03-Feb-22,24-Aug-21,163,mRNA,29,18 to 29
1451,female,CD,Anti-TNF Only,64276,positive,adult,9,booster2,04-Jun-22,16-Feb-22,108,mRNA,30,30 to 39
1452,female,CD,Ustekinumab Only,36297,positive,adult,,booster1,02-Apr-21,09-Dec-20,114,mRNA,33,30 to 39
1453,female,CD,Ustekinumab Only,31671,positive,adult,,booster1,17-Sep-21,23-Apr-21,147,mRNA,33,30 to 39
1454,female,CD,Ustekinumab Only,46114,positive,adult,,booster2,24-Feb-22,14-Dec-21,72,mRNA,34,30 to 39
1455,female,CD,Anti-TNF Only,360,positive,adult,127,primary,28-May-21,10-Dec-20,169,mRNA,33,30 to 39
1456,female,CD,Anti-TNF Only,161,ngative,adult,112,booster2,22-Jan-22,01-Aug-21,174,mRNA,33,30 to 39
1457,female,CD,Anti-TNF Only,16338,positive,adult,153,booster2,04-Mar-22,04-Jan-22,59,mRNA,33,30 to 39
1458,male,UC,Anti-TNF Only,76137,positive,adult,177,booster2,21-Oct-21,18-Aug-21,64,mRNA,34,30 to 39
1459,male,CD,Anti-TNF Only,6936,positive,adult,,pre_dose,10-Apr-21,14-Jan-21,86,mRNA,39,30 to 39
1460,male,CD,Anti-TNF Only,13078,positive,adult,,primary,21-May-21,16-Mar-21,66,mRNA,39,30 to 39
1461,male,CD,Anti-TNF Only,12036,positive,adult,,booster1,14-Aug-21,28-Feb-21,167,mRNA,39,30 to 39
1462,male,CD,Anti-TNF Only,76892,positive,adult,,booster2,13-Jan-22,16-Oct-21,89,mRNA,39,30 to 39
1463,male,CD,Anti-TNF Only,58024,positive,adult,,booster2,07-Apr-22,28-Dec-21,100,mRNA,40,40 to 49
1464,male,CD,Anti-TNF Only,59672,positive,adult,,booster2,04-Jun-22,21-Feb-22,103,mRNA,40,40 to 49
1465,female,CD,Ustekinumab Only,898,positive,elderly,,primary,02-Jun-21,17-Dec-20,167,mRNA,63,60 to 69
1466,female,CD,Ustekinumab Only,6706,positive,elderly,,booster1,30-Sep-21,17-May-21,136,mRNA,63,60 to 69
1467,female,CD,Ustekinumab Only,33364,positive,elderly,,booster2,01-Dec-21,14-Sep-21,78,mRNA,64,60 to 69
1468,female,CD,Combination Therapy,22,ngative,adult,,pre_dose,31-Mar-21,23-Sep-20,189,mRNA,58,50 to 59
1469,female,CD,Combination Therapy,9,ngative,adult,,primary,21-May-21,08-Nov-20,194,mRNA,58,50 to 59
1470,female,CD,Combination Therapy,39097,positive,adult,,booster1,11-Aug-21,25-Mar-21,139,mRNA,58,50 to 59
1471,female,CD,Combination Therapy,238,ngative,adult,,booster2,29-Oct-21,03-May-21,179,mRNA,58,50 to 59
1472,female,CD,Combination Therapy,54390,positive,adult,,booster2,06-Mar-22,31-Dec-21,65,mRNA,59,50 to 59
1473,female,CD,Combination Therapy,638,positive,adult,,booster2,02-Apr-22,31-Oct-21,153,mRNA,59,50 to 59
1474,male,CD,Vedolizumab Only,490,positive,adult,482,pre_dose,27-Mar-21,01-Oct-20,177,mRNA,34,30 to 39
1475,female,UC,Ustekinumab Only,79560,positive,adult,126,booster1,01-Sep-21,09-Jun-21,84,vector,45,40 to 49
1476,female,UC,Ustekinumab Only,57121,positive,adult,99,booster2,14-Apr-22,13-Feb-22,60,vector,45,40 to 49
1477,female,UC,Ustekinumab Only,34388,positive,adult,155,booster2,09-Jun-22,27-Jan-22,133,vector,45,40 to 49
1478,male,CD,Anti-TNF Only,13412,positive,elderly,,pre_dose,31-Mar-21,10-Dec-20,111,mRNA,72,70+
1479,male,CD,Anti-TNF Only,25173,positive,elderly,,booster2,08-Feb-22,19-Oct-21,112,mRNA,72,70+
1480,male,UC,Ustekinumab Only,18442,positive,adult,,pre_dose,28-Mar-21,09-Jan-21,78,mRNA,38,30 to 39
1481,male,UC,Ustekinumab Only,51832,positive,adult,,booster1,16-Aug-21,22-Mar-21,147,mRNA,39,30 to 39
1482,male,CD,Ustekinumab Only,17853,positive,adult,297,pre_dose,23-Mar-21,19-Dec-20,94,mRNA,43,40 to 49
1483,male,CD,Ustekinumab Only,209,ngative,adult,224,primary,04-Jun-21,20-Nov-20,196,mRNA,43,40 to 49
1484,male,CD,Ustekinumab Only,78110,positive,adult,174,booster1,24-Jul-21,14-Apr-21,101,mRNA,43,40 to 49
1485,male,CD,Ustekinumab Only,667,positive,adult,20,booster2,25-Dec-21,29-Jul-21,149,mRNA,43,40 to 49
1486,male,CD,Ustekinumab Only,42253,positive,adult,76,booster2,31-Mar-22,18-Dec-21,103,mRNA,44,40 to 49
1487,male,CD,Ustekinumab Only,25461,positive,adult,132,booster2,26-May-22,28-Mar-22,59,mRNA,44,40 to 49
1488,female,CD,Ustekinumab Only,24643,positive,elderly,,primary,09-Apr-21,28-Jan-21,71,mRNA,64,60 to 69
1489,female,CD,Ustekinumab Only,9216,positive,elderly,,primary,23-May-21,04-Feb-21,108,mRNA,64,60 to 69
1490,female,CD,Ustekinumab Only,59655,positive,elderly,,booster1,21-Jul-21,27-Mar-21,116,mRNA,64,60 to 69
1491,female,CD,Ustekinumab Only,12163,positive,elderly,,booster1,18-Dec-21,11-Jul-21,160,mRNA,64,60 to 69
1492,female,CD,Ustekinumab Only,707,positive,elderly,,booster2,18-Jan-22,04-Aug-21,167,mRNA,65,60 to 69
1493,female,CD,Ustekinumab Only,284,positive,elderly,,booster2,10-May-22,16-Dec-21,145,mRNA,65,60 to 69
1494,male,UC,Anti-TNF Only,650,positive,adult,,pre_dose,17-Mar-21,15-Oct-20,153,mRNA,22,18 to 29
1495,male,UC,Anti-TNF Only,44421,positive,adult,,booster1,21-Jul-21,31-Mar-21,112,mRNA,22,18 to 29
1496,male,UC,Anti-TNF Only,39165,positive,adult,,booster2,07-Jan-22,03-Sep-21,126,mRNA,23,18 to 29
1497,male,UC,Anti-TNF Only,643,positive,adult,,booster2,01-Apr-22,28-Oct-21,155,mRNA,23,18 to 29
1498,female,UC,Ustekinumab Only,23687,positive,adult,377,booster1,04-May-21,03-Mar-21,62,mRNA,38,30 to 39
1499,male,CD,Ustekinumab Only,102,ngative,adult,341,primary,29-May-21,07-Dec-20,173,vector,51,50 to 59
1500,male,CD,Ustekinumab Only,8533,positive,adult,225,booster2,16-Feb-22,30-Nov-21,78,vector,52,50 to 59
1501,male,CD,Ustekinumab Only,302,positive,adult,169,booster2,30-Jun-22,21-Dec-21,191,vector,52,50 to 59
1502,male,CD,Anti-TNF Only,25169,positive,adult,,booster1,04-Sep-21,04-May-21,123,mRNA,56,50 to 59
1503,male,CD,Combination Therapy,16528,positive,adult,345,pre_dose,09-Apr-21,02-Jan-21,97,mRNA,28,18 to 29
1504,male,CD,Combination Therapy,8615,positive,adult,302,primary,02-Jun-21,19-Mar-21,75,mRNA,29,18 to 29
1505,male,CD,Combination Therapy,1790,positive,adult,187,booster1,27-Aug-21,18-May-21,101,mRNA,29,18 to 29
1506,male,CD,Combination Therapy,77924,positive,adult,,booster2,10-Feb-22,20-Oct-21,113,mRNA,29,18 to 29
1507,female,CD,Ustekinumab Only,28787,positive,elderly,,booster1,02-Sep-21,12-May-21,113,vector,64,60 to 69
1508,male,CD,Combination Therapy,17392,positive,adult,,pre_dose,13-Mar-21,02-Dec-20,101,mRNA,36,30 to 39
1509,male,UC,Anti-TNF Only,64193,positive,adult,225,booster1,18-Aug-21,17-May-21,93,mRNA,38,30 to 39
1510,male,CD,Combination Therapy,218,ngative,adult,,pre_dose,07-Apr-21,21-Sep-20,198,mRNA,57,50 to 59
1511,male,CD,Combination Therapy,47374,positive,adult,,booster1,24-Aug-21,23-May-21,93,mRNA,57,50 to 59
1512,male,CD,Combination Therapy,4909,positive,adult,,booster2,04-Nov-21,02-Aug-21,94,mRNA,57,50 to 59
1513,male,CD,Combination Therapy,43428,positive,adult,,booster2,04-Mar-22,07-Nov-21,117,mRNA,58,50 to 59
1514,male,CD,Combination Therapy,255,positive,adult,,booster2,04-Jun-22,31-Dec-21,155,mRNA,58,50 to 59
1515,male,CD,Ustekinumab Only,6812,positive,adult,,pre_dose,04-May-21,14-Jan-21,110,mRNA,42,40 to 49
1516,male,CD,Ustekinumab Only,59148,positive,adult,,booster1,24-Aug-21,28-Feb-21,177,mRNA,43,40 to 49
1517,male,CD,Ustekinumab Only,810,positive,adult,,booster2,25-May-22,18-Dec-21,158,mRNA,43,40 to 49
1518,male,CD,Immunomodulator Only,3809,positive,elderly,,primary,27-Apr-21,16-Dec-20,132,mRNA,73,70+
1519,male,CD,Immunomodulator Only,22582,positive,elderly,169,booster1,19-May-21,28-Feb-21,80,mRNA,73,70+
1520,male,CD,Immunomodulator Only,45907,ngative,elderly,,booster1,28-Aug-21,28-Feb-21,181,mRNA,73,70+
1521,male,CD,Immunomodulator Only,554,positive,elderly,,booster2,16-Nov-21,24-Jun-21,145,mRNA,74,70+
1522,male,CD,Immunomodulator Only,75067,positive,elderly,,booster2,04-Mar-22,30-Nov-21,94,mRNA,74,70+
1523,male,CD,Immunomodulator Only,415,positive,elderly,,booster2,22-Apr-22,25-Oct-21,179,mRNA,74,70+
1524,male,CD,Anti-TNF Only,67927,positive,elderly,,primary,04-May-21,12-Mar-21,53,mRNA,73,70+
1525,male,CD,Anti-TNF Only,75202,positive,elderly,,booster1,04-Jun-21,03-Apr-21,62,mRNA,73,70+
1526,male,CD,Anti-TNF Only,74984,ngative,elderly,,booster1,01-Jan-22,18-Jul-21,167,mRNA,73,70+
1527,male,UC,No Immunosuppressives,85,ngative,elderly,,primary,20-Apr-21,06-Nov-20,165,mRNA,72,70+
1528,male,UC,No Immunosuppressives,6436,positive,elderly,,booster1,09-Jun-21,07-Mar-21,94,mRNA,73,70+
1529,male,UC,No Immunosuppressives,24509,positive,elderly,,booster1,14-Sep-21,22-Jun-21,84,mRNA,73,70+
1530,male,UC,No Immunosuppressives,1058,positive,elderly,,booster2,18-Nov-21,07-Sep-21,72,mRNA,73,70+
1531,male,UC,No Immunosuppressives,36205,positive,elderly,,booster2,08-Feb-22,03-Dec-21,67,mRNA,73,70+
1532,male,UC,No Immunosuppressives,48701,positive,elderly,,booster2,05-Apr-22,29-Jan-22,66,mRNA,73,70+
1533,male,UC,No Immunosuppressives,40910,positive,elderly,,booster2,19-Jul-22,14-May-22,66,mRNA,74,70+
1534,male,UC,No Immunosuppressives,13864,positive,adult,,primary,03-Jul-21,19-Apr-21,75,mRNA,53,50 to 59
1535,male,UC,No Immunosuppressives,39459,ngative,adult,,booster1,20-Aug-21,04-Apr-21,138,mRNA,53,50 to 59
1536,male,UC,No Immunosuppressives,66270,ngative,adult,,booster1,04-Mar-22,15-Sep-21,170,mRNA,53,50 to 59
1537,male,UC,No Immunosuppressives,56640,positive,adult,,booster1,29-Jul-22,23-Mar-22,128,mRNA,54,50 to 59
1538,female,CD,Vedolizumab Only,5346,positive,elderly,,primary,28-Apr-21,16-Jan-21,102,mRNA,76,70+
1539,female,CD,Vedolizumab Only,48091,positive,elderly,345,booster1,23-Jun-21,16-Feb-21,127,mRNA,76,70+
1540,female,CD,Vedolizumab Only,38260,positive,elderly,,booster2,26-May-22,22-Jan-22,124,mRNA,77,70+
1541,female,UC,Anti-TNF Only,79846,positive,adult,306,booster1,24-Apr-21,02-Jan-21,112,mRNA,26,18 to 29
1542,female,UC,Anti-TNF Only,13675,positive,adult,106,booster2,10-Nov-21,02-Jul-21,131,mRNA,27,18 to 29
1543,male,UC,Ustekinumab Only,62839,positive,adult,,booster1,07-Aug-21,19-Feb-21,169,mRNA,54,50 to 59
1544,female,CD,Ustekinumab Only,303,positive,adult,429,primary,14-Apr-21,31-Oct-20,165,mRNA,23,18 to 29
1545,female,CD,Ustekinumab Only,1281,positive,adult,34,booster2,14-May-22,29-Jan-22,105,mRNA,24,18 to 29
1546,male,CD,Vedolizumab Only,28166,positive,elderly,,primary,24-Apr-21,17-Feb-21,66,mRNA,73,70+
1547,male,CD,Vedolizumab Only,74597,positive,elderly,,booster1,27-May-21,19-Feb-21,97,mRNA,73,70+
1548,male,CD,Vedolizumab Only,54899,positive,elderly,,booster1,18-Sep-21,15-May-21,126,mRNA,73,70+
1549,male,CD,Vedolizumab Only,34700,positive,elderly,302,booster2,13-Nov-21,12-Sep-21,62,mRNA,73,70+
1550,male,CD,Vedolizumab Only,20040,positive,elderly,,booster2,04-May-22,31-Dec-21,124,mRNA,74,70+
1551,male,CD,Ustekinumab Only,69380,positive,adult,359,primary,24-Mar-21,30-Jan-21,53,mRNA,47,40 to 49
1552,male,CD,Ustekinumab Only,5916,positive,adult,209,primary,21-Aug-21,22-Apr-21,121,mRNA,48,40 to 49
1553,male,CD,Ustekinumab Only,36408,positive,adult,113,booster2,25-Nov-21,04-Aug-21,113,mRNA,48,40 to 49
1554,male,CD,Ustekinumab Only,75999,positive,adult,4,booster2,22-Mar-22,11-Dec-21,101,mRNA,48,40 to 49
1555,male,CD,Combination Therapy,107,ngative,adult,,pre_dose,22-Apr-21,02-Nov-20,171,mRNA,49,40 to 49
1556,male,CD,Combination Therapy,2803,positive,adult,,primary,21-May-21,11-Jan-21,130,mRNA,49,40 to 49
1557,male,CD,Combination Therapy,20956,positive,adult,,booster1,08-Jul-21,06-Feb-21,152,mRNA,49,40 to 49
1558,male,CD,Combination Therapy,79298,positive,adult,,booster1,24-Sep-21,15-May-21,132,mRNA,49,40 to 49
1559,male,CD,Combination Therapy,882,positive,adult,187,booster2,30-Oct-21,14-Jun-21,138,mRNA,49,40 to 49
1560,male,CD,Combination Therapy,148,ngative,adult,,booster2,25-Feb-22,01-Sep-21,177,mRNA,50,50 to 59
1561,female,UC,Anti-TNF Only,72166,positive,elderly,,booster1,06-Jul-21,24-Feb-21,132,mRNA,65,60 to 69
1562,female,UC,Anti-TNF Only,72191,positive,elderly,,booster1,08-Sep-21,10-Jul-21,60,mRNA,65,60 to 69
1563,female,UC,Anti-TNF Only,35801,positive,elderly,,booster2,07-Oct-21,20-Jun-21,109,mRNA,65,60 to 69
1564,female,UC,Anti-TNF Only,432,positive,elderly,,booster2,24-Feb-22,16-Aug-21,192,mRNA,66,60 to 69
1565,female,UC,Anti-TNF Only,426,positive,elderly,,booster2,19-Apr-22,10-Oct-21,191,mRNA,66,60 to 69
1566,female,CD,Ustekinumab Only,52143,positive,elderly,,primary,15-May-21,16-Mar-21,60,mRNA,74,70+
1567,female,CD,Ustekinumab Only,7535,ngative,elderly,,booster1,07-Nov-21,14-Jun-21,146,mRNA,75,70+
1568,female,CD,Ustekinumab Only,795,positive,elderly,,booster2,18-Feb-22,07-Sep-21,164,mRNA,75,70+
1569,female,CD,Ustekinumab Only,393,positive,elderly,,booster2,24-May-22,01-Dec-21,174,mRNA,75,70+
1570,male,CD,Anti-TNF Only,6344,positive,adult,268,primary,23-Apr-21,26-Dec-20,118,mRNA,41,40 to 49
1571,male,CD,Anti-TNF Only,28103,positive,adult,164,booster1,05-Aug-21,10-Apr-21,117,mRNA,41,40 to 49
1572,male,CD,Anti-TNF Only,4022,positive,adult,72,booster1,05-Nov-21,22-Aug-21,75,mRNA,41,40 to 49
1573,male,CD,Anti-TNF Only,47052,ngative,adult,31,booster1,16-Feb-22,14-Aug-21,186,mRNA,42,40 to 49
1574,male,CD,Anti-TNF Only,72207,positive,adult,53,booster1,10-Mar-22,08-Jan-22,61,mRNA,42,40 to 49
1575,female,CD,Vedolizumab Only,350,positive,adult,,pre_dose,13-Apr-21,29-Sep-20,196,vector,38,30 to 39
1576,female,CD,Vedolizumab Only,14112,positive,adult,,primary,28-May-21,04-Mar-21,85,vector,38,30 to 39
1577,female,CD,Vedolizumab Only,15146,positive,adult,,booster1,21-Aug-21,26-May-21,87,vector,38,30 to 39
1578,female,CD,Vedolizumab Only,31955,positive,adult,,booster1,03-Aug-22,09-Mar-22,147,vector,39,30 to 39
1579,female,CD,Ustekinumab Only,70693,positive,adult,,primary,25-Jun-21,02-May-21,54,mRNA,56,50 to 59
1580,female,CD,Ustekinumab Only,49828,positive,adult,,booster1,21-Aug-21,17-May-21,96,mRNA,56,50 to 59
1581,female,CD,Ustekinumab Only,78294,positive,adult,,booster1,15-Dec-21,10-Aug-21,127,mRNA,57,50 to 59
1582,female,CD,Ustekinumab Only,535,positive,adult,,booster2,25-May-22,16-Dec-21,160,mRNA,57,50 to 59
1583,male,CD,No Immunosuppressives,14628,positive,elderly,,primary,27-Apr-21,17-Feb-21,69,mRNA,74,70+
1584,male,CD,No Immunosuppressives,61741,positive,elderly,,booster1,21-May-21,03-Nov-20,199,mRNA,74,70+
1585,male,CD,No Immunosuppressives,30013,positive,elderly,,booster1,18-Sep-21,14-Mar-21,188,mRNA,74,70+
1586,male,CD,No Immunosuppressives,119,ngative,elderly,,booster2,14-Jan-22,28-Aug-21,139,mRNA,75,70+
1587,male,CD,No Immunosuppressives,147,ngative,elderly,,booster2,12-Apr-22,06-Oct-21,188,mRNA,75,70+
1588,male,CD,No Immunosuppressives,73507,positive,elderly,,booster2,31-May-22,02-Mar-22,90,mRNA,75,70+
1589,female,CD,Anti-TNF Only,17763,positive,adult,,pre_dose,22-Mar-21,08-Jan-21,73,mRNA,59,50 to 59
1590,female,CD,Anti-TNF Only,73944,positive,adult,,booster1,29-Aug-21,05-Jul-21,55,mRNA,60,60 to 69
1591,female,CD,Anti-TNF Only,75387,positive,adult,,booster2,10-Nov-21,03-Jul-21,130,mRNA,60,60 to 69
1592,female,CD,Anti-TNF Only,76976,positive,adult,,booster2,26-Jan-22,31-Oct-21,87,mRNA,60,60 to 69
1593,female,CD,Anti-TNF Only,162,ngative,adult,,booster2,24-May-22,14-Nov-21,191,mRNA,60,60 to 69
1594,male,CD,Anti-TNF Only,364,positive,adult,277,pre_dose,15-Apr-21,02-Oct-20,195,mRNA,52,50 to 59
1595,male,CD,Anti-TNF Only,342,positive,adult,221,primary,10-Jun-21,08-Jan-21,153,mRNA,53,50 to 59
1596,male,CD,Anti-TNF Only,35555,positive,adult,165,booster1,05-Aug-21,14-Mar-21,144,mRNA,53,50 to 59
1597,male,CD,Anti-TNF Only,2276,positive,adult,53,booster1,25-Nov-21,23-Jul-21,125,mRNA,53,50 to 59
1598,male,CD,Anti-TNF Only,20488,positive,adult,29,booster2,15-Feb-22,12-Oct-21,126,mRNA,53,50 to 59
1599,male,CD,Anti-TNF Only,429,positive,adult,,booster2,25-May-22,23-Nov-21,183,mRNA,54,50 to 59
1600,male,CD,No Immunosuppressives,13771,positive,adult,,primary,19-Jun-21,16-Apr-21,64,mRNA,35,30 to 39
1601,male,CD,No Immunosuppressives,56787,positive,adult,,booster1,21-Jul-21,04-Feb-21,167,mRNA,35,30 to 39
1602,male,CD,No Immunosuppressives,23540,positive,adult,,booster1,25-Dec-21,17-Sep-21,99,mRNA,35,30 to 39
1603,male,CD,No Immunosuppressives,35843,positive,adult,,booster2,21-Jan-22,25-Sep-21,118,mRNA,35,30 to 39
1604,male,CD,No Immunosuppressives,73530,positive,adult,,booster2,11-Jun-22,25-Mar-22,78,mRNA,36,30 to 39
1605,male,UC,No Immunosuppressives,331,positive,elderly,,primary,09-May-21,07-Dec-20,153,mRNA,68,60 to 69
1606,male,UC,No Immunosuppressives,19077,positive,elderly,,booster1,06-Jul-21,01-Mar-21,127,mRNA,68,60 to 69
1607,male,UC,No Immunosuppressives,52214,ngative,elderly,,booster1,16-Oct-21,11-Apr-21,188,mRNA,68,60 to 69
1608,male,UC,No Immunosuppressives,14850,positive,elderly,,booster2,06-Jan-22,01-Oct-21,97,mRNA,69,60 to 69
1609,male,UC,No Immunosuppressives,64197,positive,elderly,,booster2,20-Apr-22,31-Jan-22,79,mRNA,69,60 to 69
1610,male,UC,No Immunosuppressives,53,ngative,elderly,,booster2,14-Jun-22,22-Dec-21,174,mRNA,69,60 to 69
1611,female,CD,Ustekinumab Only,175,ngative,adult,,pre_dose,14-Apr-21,11-Oct-20,185,mRNA,49,40 to 49
1612,female,CD,Ustekinumab Only,74394,positive,adult,,primary,09-Jun-21,20-Apr-21,50,mRNA,49,40 to 49
1613,female,CD,Ustekinumab Only,24418,positive,adult,,booster1,06-Aug-21,16-Jun-21,51,mRNA,49,40 to 49
1614,female,CD,Ustekinumab Only,73367,positive,adult,,booster2,24-Nov-21,26-Jul-21,121,mRNA,50,50 to 59
1615,female,CD,Ustekinumab Only,3224,positive,adult,,booster2,11-Feb-22,30-Nov-21,73,mRNA,50,50 to 59
1616,female,CD,Ustekinumab Only,238,ngative,adult,,booster2,21-Jun-22,11-Dec-21,192,mRNA,50,50 to 59
1617,female,UC,Vedolizumab Only,70309,positive,adult,,booster1,30-Mar-21,16-Oct-20,165,mRNA,35,30 to 39
1618,female,UC,Vedolizumab Only,76354,positive,adult,,booster1,24-Nov-21,22-Sep-21,63,mRNA,35,30 to 39
1619,female,UC,Vedolizumab Only,32,ngative,adult,,booster2,01-Mar-22,30-Aug-21,183,mRNA,36,30 to 39
1620,male,CD,Ustekinumab Only,5131,positive,adult,383,pre_dose,24-Apr-21,11-Dec-20,134,mRNA,47,40 to 49
1621,male,CD,Ustekinumab Only,18746,positive,adult,327,primary,19-Jun-21,15-Mar-21,96,mRNA,47,40 to 49
1622,male,CD,Ustekinumab Only,63965,positive,adult,271,booster1,14-Aug-21,15-May-21,91,mRNA,47,40 to 49
1623,male,CD,Ustekinumab Only,47036,positive,adult,166,booster2,27-Nov-21,03-Aug-21,116,mRNA,48,40 to 49
1624,male,CD,Ustekinumab Only,42736,positive,adult,48,booster2,25-Mar-22,22-Nov-21,123,mRNA,48,40 to 49
1625,male,CD,Ustekinumab Only,139,ngative,adult,299,pre_dose,25-Mar-21,16-Oct-20,160,mRNA,48,40 to 49
1626,male,CD,Ustekinumab Only,14310,positive,adult,242,primary,21-May-21,20-Jan-21,121,mRNA,48,40 to 49
1627,male,CD,Ustekinumab Only,4227,positive,adult,139,booster1,01-Sep-21,25-Feb-21,188,mRNA,48,40 to 49
1628,male,CD,Ustekinumab Only,413,positive,adult,59,booster2,20-Nov-21,13-Jun-21,160,mRNA,48,40 to 49
1629,male,CD,Ustekinumab Only,9136,positive,adult,,booster2,11-Mar-22,19-Nov-21,112,mRNA,49,40 to 49
1630,male,CD,Ustekinumab Only,72293,positive,adult,130,booster2,28-May-22,20-Mar-22,69,mRNA,49,40 to 49
1631,male,CD,Combination Therapy,9766,positive,adult,,primary,19-May-21,14-Feb-21,94,mRNA,56,50 to 59
1632,male,CD,Combination Therapy,42099,positive,adult,,booster1,14-Aug-21,03-Apr-21,133,mRNA,57,50 to 59
1633,male,CD,Combination Therapy,319,positive,pediatric,,booster2,01-Feb-22,19-Aug-21,166,mRNA,8,00 to 09
1634,male,CD,Combination Therapy,62560,positive,pediatric,,booster2,18-May-22,08-Mar-22,71,mRNA,15,10 to 17
1635,male,UC,Vedolizumab Only,7396,positive,pediatric,,primary,22-Jul-21,12-Mar-21,132,vector,12,10 to 17
1636,male,UC,Vedolizumab Only,20274,positive,pediatric,,booster1,08-Aug-21,29-Apr-21,101,vector,2,00 to 09
1637,male,UC,Vedolizumab Only,59009,ngative,adult,,booster1,06-Jan-22,20-Jun-21,200,vector,33,30 to 39
1638,male,UC,Vedolizumab Only,7421,positive,adult,,booster2,23-Jun-22,25-Feb-22,118,vector,33,30 to 39
1639,male,UC,Vedolizumab Only,8775,positive,adult,,primary,28-May-21,08-Mar-21,81,mRNA,39,30 to 39
1640,male,UC,Vedolizumab Only,7882,positive,adult,328,booster1,25-Jun-21,27-Apr-21,59,mRNA,39,30 to 39
1641,male,UC,Vedolizumab Only,29025,positive,adult,211,booster2,20-Oct-21,25-Jul-21,87,mRNA,40,40 to 49
1642,male,UC,Vedolizumab Only,8594,positive,adult,83,booster2,25-Feb-22,09-Nov-21,108,mRNA,40,40 to 49
1643,male,UC,Vedolizumab Only,56907,positive,adult,55,booster2,25-Mar-22,24-Nov-21,121,mRNA,40,40 to 49
1644,male,UC,Vedolizumab Only,39816,positive,adult,22,booster2,10-Jun-22,02-Feb-22,128,mRNA,40,40 to 49
1645,male,CD,Ustekinumab Only,0,ngative,adult,220,primary,09-Jun-21,21-Nov-20,200,mRNA,36,30 to 39
1646,male,CD,Ustekinumab Only,74737,positive,adult,106,booster1,01-Oct-21,14-Jun-21,109,mRNA,36,30 to 39
1647,male,CD,Anti-TNF Only,8575,positive,elderly,232,primary,01-Jun-21,24-Feb-21,97,mRNA,65,60 to 69
1648,male,CD,Anti-TNF Only,54629,positive,elderly,151,booster1,21-Aug-21,28-Apr-21,115,mRNA,65,60 to 69
1649,male,CD,Anti-TNF Only,74346,positive,elderly,,booster2,18-Nov-21,12-Sep-21,67,mRNA,65,60 to 69
1650,male,CD,Anti-TNF Only,303,positive,elderly,16,booster2,04-Feb-22,12-Aug-21,176,mRNA,65,60 to 69
1651,male,UC,Combination Therapy,19,ngative,adult,,pre_dose,30-Mar-21,05-Oct-20,176,mRNA,59,50 to 59
1652,male,UC,Combination Therapy,62300,positive,adult,,booster1,31-Aug-21,26-Apr-21,127,mRNA,60,60 to 69
1653,male,UC,Combination Therapy,51187,positive,adult,,booster2,28-Jun-22,26-Apr-22,63,mRNA,61,60 to 69
1654,male,UC,Vedolizumab Only,52781,positive,adult,,booster1,24-Jul-21,01-May-21,84,vector,60,60 to 69
1655,male,UC,Anti-TNF Only,64857,positive,elderly,,booster1,19-Aug-21,08-Apr-21,133,mRNA,68,60 to 69
1656,male,UC,Anti-TNF Only,72726,positive,elderly,,booster2,09-Mar-22,20-Oct-21,140,mRNA,69,60 to 69
1657,male,UC,Vedolizumab Only,51948,ngative,adult,279,booster1,31-Jul-21,03-Feb-21,178,mRNA,62,60 to 69
1658,male,UC,Vedolizumab Only,67277,positive,elderly,97,booster2,29-Jan-22,20-Nov-21,70,mRNA,62,60 to 69
1659,male,UC,Vedolizumab Only,67833,positive,elderly,,booster2,21-May-22,22-Feb-22,88,mRNA,63,60 to 69
1660,male,UC,Anti-TNF Only,387,positive,elderly,,primary,21-May-21,22-Dec-20,150,mRNA,65,60 to 69
1661,male,UC,Anti-TNF Only,570,positive,elderly,,booster2,01-Feb-22,28-Aug-21,157,mRNA,66,60 to 69
1662,male,UC,Anti-TNF Only,167,ngative,elderly,,booster2,26-Apr-22,30-Oct-21,178,mRNA,66,60 to 69
1663,male,UC,Anti-TNF Only,6404,positive,elderly,,booster2,10-Jun-22,03-Mar-22,99,mRNA,66,60 to 69
1664,male,CD,Ustekinumab Only,7795,positive,adult,,primary,20-Apr-21,11-Jan-21,99,vector,61,60 to 69
1665,male,CD,Ustekinumab Only,24811,positive,adult,,booster1,13-Jul-21,17-Apr-21,87,vector,62,60 to 69
1666,male,CD,Ustekinumab Only,38172,positive,elderly,,booster1,24-Dec-21,07-Oct-21,78,vector,62,60 to 69
1667,male,CD,Ustekinumab Only,74268,positive,elderly,,booster2,02-Feb-22,05-Dec-21,59,vector,62,60 to 69
1668,male,CD,Ustekinumab Only,403,positive,elderly,,booster2,26-May-22,11-Nov-21,196,vector,62,60 to 69
1669,female,UC,Anti-TNF Only,2681,positive,adult,,pre_dose,09-Apr-21,30-Nov-20,130,mRNA,31,30 to 39
1670,female,CD,Ustekinumab Only,15994,positive,adult,,primary,10-Jun-21,30-Mar-21,72,vector,53,50 to 59
1671,female,CD,Ustekinumab Only,32818,positive,adult,,booster1,07-Aug-21,09-Feb-21,179,vector,54,50 to 59
1672,female,CD,Ustekinumab Only,69731,positive,adult,,booster1,21-Nov-21,04-Jul-21,140,vector,54,50 to 59
1673,female,CD,Ustekinumab Only,40236,positive,adult,,booster2,15-Dec-21,14-Sep-21,92,vector,54,50 to 59
1674,female,CD,Ustekinumab Only,21138,positive,adult,,booster2,12-Apr-22,22-Dec-21,111,vector,54,50 to 59
1675,female,CD,Ustekinumab Only,22889,positive,adult,,booster2,18-May-22,13-Feb-22,94,vector,54,50 to 59
1676,male,UC,Corticosteroids,57354,positive,elderly,400,booster1,30-Mar-21,30-Dec-20,90,mRNA,62,60 to 69
1677,male,UC,Corticosteroids,14625,positive,elderly,281,booster1,27-Jul-21,22-Mar-21,127,mRNA,63,60 to 69
1678,male,UC,Corticosteroids,387,positive,elderly,155,booster2,30-Nov-21,19-May-21,195,mRNA,63,60 to 69
1679,male,UC,Corticosteroids,45967,positive,elderly,,booster2,04-Feb-22,06-Nov-21,90,mRNA,63,60 to 69
1680,male,UC,Corticosteroids,56120,positive,elderly,8,booster2,26-Apr-22,07-Dec-21,140,mRNA,63,60 to 69
1681,female,CD,Anti-TNF Only,15083,positive,elderly,,booster1,15-Jun-21,23-Apr-21,53,mRNA,64,60 to 69
1682,female,CD,Anti-TNF Only,76423,positive,elderly,,booster1,24-Sep-21,02-Aug-21,53,mRNA,64,60 to 69
1683,female,CD,Anti-TNF Only,686,positive,elderly,,booster2,04-Jan-22,09-Aug-21,148,mRNA,64,60 to 69
1684,female,CD,Anti-TNF Only,471,positive,elderly,,booster2,16-Apr-22,29-Oct-21,169,mRNA,65,60 to 69
1685,female,CD,Anti-TNF Only,173,ngative,elderly,,booster2,25-Jun-22,21-Dec-21,186,mRNA,65,60 to 69
1686,female,CD,Combination Therapy,65629,positive,elderly,,primary,25-May-21,03-Apr-21,52,vector,65,60 to 69
1687,female,CD,Combination Therapy,44557,positive,elderly,,booster1,20-Jul-21,23-Apr-21,88,vector,65,60 to 69
1688,female,CD,Combination Therapy,4368,positive,elderly,,booster2,09-Dec-21,22-Aug-21,109,vector,65,60 to 69
1689,male,CD,Vedolizumab Only,16463,positive,elderly,,primary,22-May-21,27-Feb-21,84,mRNA,69,60 to 69
1690,male,CD,Vedolizumab Only,17432,positive,elderly,,booster1,23-Jun-21,22-Mar-21,93,mRNA,69,60 to 69
1691,male,CD,Vedolizumab Only,35476,positive,elderly,,booster2,09-Nov-21,26-Jul-21,106,mRNA,70,70+
1692,male,CD,Vedolizumab Only,727,positive,elderly,,booster2,23-Feb-22,25-Sep-21,151,mRNA,70,70+
1693,male,CD,Vedolizumab Only,5878,positive,elderly,,booster2,06-May-22,15-Mar-22,52,mRNA,70,70+
1694,female,CD,Anti-TNF Only,9489,positive,adult,,primary,25-May-21,21-Feb-21,93,vector,50,50 to 59
1695,female,CD,Anti-TNF Only,26947,positive,adult,,booster1,06-Jul-21,04-Mar-21,124,vector,50,50 to 59
1696,female,CD,Anti-TNF Only,26324,positive,adult,,booster1,16-Oct-21,31-Jul-21,77,vector,51,50 to 59
1697,female,CD,Anti-TNF Only,14647,positive,adult,,booster2,22-Jan-22,03-Dec-21,50,vector,51,50 to 59
1698,female,UC,Ustekinumab Only,975,positive,adult,,primary,12-Jun-21,29-Dec-20,165,mRNA,62,60 to 69
1699,female,UC,Ustekinumab Only,28621,positive,adult,,booster1,20-Jul-21,12-Apr-21,99,mRNA,62,60 to 69
1700,female,UC,Ustekinumab Only,413,positive,elderly,355,booster2,09-Dec-21,07-Jun-21,185,mRNA,62,60 to 69
1701,female,UC,Ustekinumab Only,338,positive,elderly,232,booster2,30-Mar-22,11-Nov-21,139,mRNA,63,60 to 69
1702,female,UC,Ustekinumab Only,10958,positive,elderly,,booster2,24-May-22,16-Feb-22,97,mRNA,63,60 to 69
1703,female,CD,Corticosteroids,348,positive,elderly,,primary,04-May-21,28-Oct-20,188,mRNA,76,70+
1704,female,CD,Corticosteroids,47593,positive,elderly,,booster1,06-Aug-21,22-May-21,76,mRNA,76,70+
1705,female,CD,Corticosteroids,423,positive,elderly,,booster2,17-Nov-21,16-May-21,185,mRNA,76,70+
1706,female,CD,Corticosteroids,144,ngative,elderly,,booster2,22-Apr-22,12-Nov-21,161,mRNA,77,70+
1707,male,CD,Anti-TNF Only,15697,positive,adult,,booster1,01-Sep-21,17-Apr-21,137,mRNA,54,50 to 59
1708,female,CD,Vedolizumab Only,8150,positive,elderly,,primary,24-Jun-21,13-Mar-21,103,mRNA,67,60 to 69
1709,female,CD,Vedolizumab Only,79242,positive,elderly,355,booster1,15-Jul-21,18-Feb-21,147,mRNA,67,60 to 69
1710,female,CD,Vedolizumab Only,53092,positive,elderly,,booster1,27-Nov-21,05-Jun-21,175,mRNA,67,60 to 69
1711,female,CD,Vedolizumab Only,66987,positive,elderly,,booster2,27-May-22,12-Jan-22,135,mRNA,68,60 to 69
1712,female,CD,Combination Therapy,13737,positive,elderly,,primary,27-May-21,11-Mar-21,77,mRNA,70,70+
1713,female,CD,Combination Therapy,1627,positive,elderly,,booster1,28-Aug-21,10-Apr-21,140,mRNA,70,70+
1714,female,CD,Combination Therapy,25719,positive,elderly,,booster2,19-Nov-21,19-Jul-21,123,mRNA,71,70+
1715,female,CD,Combination Therapy,488,positive,elderly,,booster2,10-Mar-22,09-Sep-21,182,mRNA,71,70+
1716,male,UC,Vedolizumab Only,70765,positive,adult,,primary,28-May-21,05-Apr-21,53,mRNA,62,60 to 69
1717,male,UC,Vedolizumab Only,3116,positive,adult,,booster1,06-Aug-21,30-Apr-21,98,mRNA,62,60 to 69
1718,male,UC,Vedolizumab Only,74916,positive,elderly,,booster1,24-Nov-21,01-Aug-21,115,mRNA,62,60 to 69
1719,male,UC,Vedolizumab Only,18191,positive,elderly,232,booster2,26-Feb-22,14-Oct-21,135,mRNA,62,60 to 69
1720,male,UC,Vedolizumab Only,33,ngative,elderly,,booster2,29-Apr-22,23-Oct-21,188,mRNA,63,60 to 69
1721,male,CD,Vedolizumab Only,16055,positive,adult,,primary,15-May-21,14-Feb-21,90,mRNA,56,50 to 59
1722,male,CD,Vedolizumab Only,27401,positive,adult,,booster1,10-Jul-21,13-Apr-21,88,mRNA,56,50 to 59
1723,male,CD,Vedolizumab Only,20,ngative,adult,,booster2,30-Oct-21,19-Apr-21,194,mRNA,56,50 to 59
1724,male,CD,Vedolizumab Only,104,ngative,adult,,booster2,16-Apr-22,21-Oct-21,177,mRNA,56,50 to 59
1725,female,CD,Anti-TNF Only,3369,positive,adult,,primary,26-Jun-21,17-Feb-21,129,mRNA,23,18 to 29
1726,female,CD,Anti-TNF Only,65322,positive,adult,,booster1,24-Jul-21,06-Mar-21,140,mRNA,23,18 to 29
1727,female,CD,Anti-TNF Only,498,positive,adult,,booster2,05-Mar-22,17-Sep-21,169,mRNA,24,18 to 29
1728,female,CD,Anti-TNF Only,299,positive,adult,,booster2,07-Apr-22,23-Sep-21,196,mRNA,24,18 to 29
1729,female,CD,No Immunosuppressives,457,positive,elderly,,primary,06-May-21,26-Nov-20,161,mRNA,64,60 to 69
1730,female,CD,No Immunosuppressives,29167,positive,elderly,,booster1,22-Jul-21,09-Jan-21,194,mRNA,64,60 to 69
1731,female,CD,No Immunosuppressives,75858,positive,elderly,,booster1,01-Jan-22,04-Nov-21,58,mRNA,64,60 to 69
1732,female,CD,No Immunosuppressives,50140,positive,elderly,,booster2,05-Feb-22,01-Dec-21,66,mRNA,64,60 to 69
1733,female,CD,No Immunosuppressives,28923,positive,elderly,,booster2,24-May-22,29-Jan-22,115,mRNA,65,60 to 69
1734,male,UC,Immunomodulator Only,900,positive,adult,,primary,05-Jun-21,18-Jan-21,138,vector,57,50 to 59
1735,male,UC,Immunomodulator Only,75108,positive,adult,,booster1,19-Aug-21,10-Apr-21,131,vector,57,50 to 59
1736,male,UC,Immunomodulator Only,79,ngative,adult,,booster2,11-Feb-22,10-Aug-21,185,vector,58,50 to 59
1737,male,UC,Immunomodulator Only,786,positive,adult,,booster2,23-Apr-22,14-Nov-21,160,vector,58,50 to 59
1738,male,CD,Corticosteroids,905,positive,adult,,pre_dose,07-Apr-21,01-Nov-20,157,mRNA,55,50 to 59
1739,male,CD,Corticosteroids,60,ngative,adult,,primary,20-May-21,09-Nov-20,192,mRNA,55,50 to 59
1740,male,CD,Corticosteroids,58709,ngative,adult,,booster1,08-Jul-21,31-Dec-20,189,mRNA,55,50 to 59
1741,male,CD,Corticosteroids,22009,positive,adult,,booster2,15-Oct-21,23-Aug-21,53,mRNA,56,50 to 59
1742,male,CD,Corticosteroids,29143,positive,adult,,booster2,16-Mar-22,22-Jan-22,53,mRNA,56,50 to 59
1743,male,CD,Corticosteroids,64244,positive,adult,,booster2,18-Jun-22,17-Mar-22,93,mRNA,56,50 to 59
1744,male,CD,Combination Therapy,72097,positive,adult,44,primary,21-May-21,29-Mar-21,53,mRNA,36,30 to 39
1745,male,CD,Combination Therapy,9402,positive,adult,,primary,04-Jul-21,30-Mar-21,96,mRNA,36,30 to 39
1746,female,UC,Tofacitinib Only,15376,positive,adult,,primary,10-Jun-21,24-Feb-21,106,mRNA,25,18 to 29
1747,female,UC,Tofacitinib Only,70320,positive,adult,,booster1,05-Aug-21,17-Mar-21,141,mRNA,25,18 to 29
1748,female,UC,Tofacitinib Only,29650,positive,adult,,booster1,05-Jan-22,11-Nov-21,55,mRNA,26,18 to 29
1749,female,UC,Tofacitinib Only,71016,positive,adult,,booster2,15-Feb-22,07-Dec-21,70,mRNA,26,18 to 29
1750,male,UC,Anti-TNF Only,78856,ngative,elderly,,booster1,10-Jun-21,26-Nov-20,196,mRNA,68,60 to 69
1751,male,UC,Anti-TNF Only,18399,ngative,elderly,,booster1,30-Sep-21,19-Apr-21,164,mRNA,69,60 to 69
1752,male,UC,Anti-TNF Only,842,positive,elderly,,booster2,19-Mar-22,08-Oct-21,162,mRNA,69,60 to 69
1753,female,CD,Vedolizumab Only,320,positive,adult,396,primary,30-Jun-21,14-Jan-21,167,mRNA,38,30 to 39
1754,female,CD,Vedolizumab Only,867,positive,adult,229,booster2,14-Dec-21,26-Jul-21,141,mRNA,39,30 to 39
1755,female,CD,Vedolizumab Only,74000,positive,adult,117,booster2,05-Apr-22,31-Jan-22,64,mRNA,39,30 to 39
1756,female,UC,Anti-TNF Only,,,elderly,,primary,11-May-21,02-Mar-21,70,mRNA,65,60 to 69
1757,female,UC,Anti-TNF Only,28049,positive,elderly,,booster1,13-Jul-21,19-Mar-21,116,mRNA,65,60 to 69
1758,female,UC,Anti-TNF Only,12566,positive,elderly,,booster2,13-Jan-22,16-Sep-21,119,mRNA,66,60 to 69
1759,female,UC,Anti-TNF Only,51565,positive,elderly,,booster2,12-May-22,18-Feb-22,83,mRNA,66,60 to 69
1760,male,CD,Ustekinumab Only,467,positive,elderly,,primary,05-Aug-21,16-Mar-21,142,vector,62,60 to 69
1761,female,UC,Immunomodulator Only,9002,positive,adult,,primary,15-Jun-21,24-Mar-21,83,mRNA,24,18 to 29
1762,female,UC,Immunomodulator Only,77166,positive,adult,,booster1,03-Aug-21,14-Apr-21,111,mRNA,24,18 to 29
1763,female,UC,Immunomodulator Only,65227,positive,adult,,booster1,27-Nov-21,05-Aug-21,114,mRNA,25,18 to 29
1764,female,CD,Combination Therapy,11571,positive,adult,,primary,18-May-21,14-Feb-21,93,mRNA,59,50 to 59
1765,female,CD,Combination Therapy,2853,positive,adult,,booster1,10-Aug-21,19-Mar-21,144,mRNA,59,50 to 59
1766,female,CD,Combination Therapy,415,positive,adult,,booster2,21-Jan-22,10-Jul-21,195,mRNA,59,50 to 59
1767,female,CD,Ustekinumab Only,12681,positive,adult,300,booster1,21-May-21,28-Nov-20,174,mRNA,24,18 to 29
1768,female,CD,Ustekinumab Only,20365,positive,adult,182,booster1,16-Sep-21,29-Mar-21,171,mRNA,25,18 to 29
1769,male,CD,Combination Therapy,67226,positive,adult,,primary,11-Jun-21,16-Apr-21,56,mRNA,55,50 to 59
1770,male,CD,Combination Therapy,36376,positive,adult,79,booster1,21-Jul-21,25-May-21,57,mRNA,55,50 to 59
1771,male,CD,Combination Therapy,344,positive,adult,133,booster2,18-Feb-22,30-Aug-21,172,mRNA,55,50 to 59
1772,male,CD,Combination Therapy,46359,positive,adult,259,booster2,24-Jun-22,19-Feb-22,125,mRNA,56,50 to 59
1773,male,CD,Combination Therapy,55815,ngative,adult,,booster1,11-Jul-21,18-Jan-21,174,mRNA,33,30 to 39
1774,male,CD,Combination Therapy,58758,positive,adult,,booster1,03-Oct-21,29-May-21,127,mRNA,33,30 to 39
1775,female,CD,Combination Therapy,321,positive,adult,,primary,25-Jun-21,28-Dec-20,179,vector,23,18 to 29
1776,female,CD,Combination Therapy,29275,ngative,adult,,booster1,20-Aug-21,29-Mar-21,144,vector,23,18 to 29
1777,female,CD,Anti-TNF Only,37367,positive,elderly,341,booster1,11-May-21,12-Nov-20,180,mRNA,81,70+
1778,male,CD,Vedolizumab Only,69225,positive,elderly,,booster1,06-May-21,02-Mar-21,65,mRNA,78,70+
1779,male,CD,Vedolizumab Only,4074,positive,elderly,,booster1,22-Oct-21,14-Aug-21,69,mRNA,78,70+
1780,female,UC,No Immunosuppressives,76380,positive,adult,,primary,26-May-21,06-Apr-21,50,mRNA,50,50 to 59
1781,female,UC,No Immunosuppressives,61111,positive,adult,,booster1,31-Jul-21,12-May-21,80,mRNA,50,50 to 59
1782,female,CD,Anti-TNF Only,38164,positive,adult,,booster1,14-Jul-21,12-Jan-21,183,mRNA,53,50 to 59
1783,female,CD,Anti-TNF Only,1392,positive,adult,,booster2,19-Oct-21,30-Jun-21,111,mRNA,54,50 to 59
1784,female,CD,Anti-TNF Only,672,positive,adult,,booster2,04-Feb-22,10-Sep-21,147,mRNA,54,50 to 59
1785,female,CD,Anti-TNF Only,181,ngative,adult,,booster2,11-May-22,06-Nov-21,186,mRNA,54,50 to 59
1786,male,CD,Ustekinumab Only,14441,positive,adult,,primary,05-Jun-21,22-Feb-21,103,vector,60,60 to 69
1787,male,CD,Ustekinumab Only,71357,ngative,adult,,booster1,11-Aug-21,23-Jan-21,200,vector,60,60 to 69
1788,male,CD,Ustekinumab Only,13760,ngative,adult,,booster1,01-Dec-21,30-May-21,185,vector,61,60 to 69
1789,male,CD,Ustekinumab Only,162,ngative,adult,,booster2,02-Apr-22,02-Nov-21,151,vector,61,60 to 69
1790,male,CD,Ustekinumab Only,684,positive,adult,,booster2,01-Jun-22,10-Jan-22,142,vector,61,60 to 69
1791,male,CD,No Immunosuppressives,2720,positive,adult,,booster1,05-May-22,07-Feb-22,87,mRNA,38,30 to 39
1792,male,CD,Corticosteroids,173,ngative,adult,,primary,25-May-21,28-Nov-20,178,vector,31,30 to 39
1793,male,CD,Corticosteroids,61771,positive,adult,,booster1,15-Jun-21,20-Apr-21,56,vector,31,30 to 39
1794,male,CD,Corticosteroids,68568,positive,adult,,booster2,14-Oct-21,23-Aug-21,52,vector,32,30 to 39
1795,male,CD,Corticosteroids,205,ngative,adult,,booster2,20-Jan-22,13-Jul-21,191,vector,32,30 to 39
1796,male,CD,Corticosteroids,8759,positive,adult,,booster2,08-Jun-22,26-Jan-22,133,vector,32,30 to 39
1797,female,CD,Ustekinumab Only,15765,positive,adult,292,primary,03-Jun-21,17-Mar-21,78,mRNA,56,50 to 59
1798,female,CD,Ustekinumab Only,,,adult,229,booster1,05-Aug-21,30-May-21,67,mRNA,56,50 to 59
1799,female,CD,Ustekinumab Only,19759,positive,adult,,booster1,04-Nov-21,17-Jun-21,140,mRNA,56,50 to 59
1800,female,CD,Ustekinumab Only,321,positive,adult,,booster2,24-Feb-22,05-Sep-21,172,mRNA,57,50 to 59
1801,female,CD,Anti-TNF Only,564,positive,adult,,primary,09-Jun-21,02-Jan-21,158,mRNA,34,30 to 39
1802,female,CD,Anti-TNF Only,36409,positive,adult,,booster1,29-Jul-21,23-Jan-21,187,mRNA,34,30 to 39
1803,female,CD,Anti-TNF Only,15785,positive,adult,,primary,01-Jun-21,27-Jan-21,125,mRNA,39,30 to 39
1804,female,CD,Anti-TNF Only,64945,positive,adult,,booster1,25-Aug-21,20-Jun-21,66,mRNA,40,40 to 49
1805,female,CD,Anti-TNF Only,304,positive,adult,,booster2,08-Feb-22,01-Aug-21,191,mRNA,40,40 to 49
1806,female,CD,Anti-TNF Only,26946,positive,adult,,booster2,25-Jun-22,02-May-22,54,mRNA,40,40 to 49
1807,male,CD,Ustekinumab Only,54362,positive,adult,,booster1,06-Jul-21,02-May-21,65,mRNA,20,18 to 29
1808,male,CD,Ustekinumab Only,841,positive,adult,,booster2,23-Feb-22,06-Sep-21,170,mRNA,20,18 to 29
1809,female,UC,Vedolizumab Only,32985,positive,adult,,booster1,02-Jun-21,14-Dec-20,170,mRNA,58,50 to 59
1810,female,UC,Vedolizumab Only,19297,ngative,adult,,booster1,30-Sep-21,22-Apr-21,161,mRNA,58,50 to 59
1811,female,UC,Vedolizumab Only,18661,positive,adult,,booster2,30-Jun-22,06-Mar-22,116,mRNA,59,50 to 59
1812,male,UC,Vedolizumab Only,30467,positive,adult,,booster1,04-Jun-21,08-Feb-21,116,mRNA,33,30 to 39
1813,male,UC,Vedolizumab Only,27966,ngative,adult,,booster1,19-Oct-21,01-Jun-21,140,mRNA,34,30 to 39
1814,female,CD,Combination Therapy,702,positive,adult,,primary,27-May-21,02-Jan-21,145,mRNA,28,18 to 29
1815,female,CD,Combination Therapy,25823,positive,adult,85,booster1,20-Aug-21,11-Feb-21,190,mRNA,28,18 to 29
1816,male,CD,Ustekinumab Only,739,positive,adult,,primary,26-Jun-21,07-Feb-21,139,mRNA,44,40 to 49
1817,male,CD,Ustekinumab Only,49939,positive,adult,,booster1,29-Sep-21,12-Jul-21,79,mRNA,44,40 to 49
1818,male,CD,Ustekinumab Only,67,ngative,adult,,booster2,06-Apr-22,26-Sep-21,192,mRNA,45,40 to 49
1819,female,CD,Anti-TNF Only,56060,positive,adult,,booster1,02-Jun-21,03-Feb-21,119,mRNA,32,30 to 39
1820,female,CD,Anti-TNF Only,50244,positive,adult,,booster1,06-Oct-21,16-Jul-21,82,mRNA,33,30 to 39
1821,female,CD,Anti-TNF Only,14325,positive,adult,,booster1,07-Aug-21,02-Apr-21,127,mRNA,51,50 to 59
1822,female,CD,Anti-TNF Only,71836,ngative,adult,,booster1,13-Nov-21,28-Jun-21,138,mRNA,51,50 to 59
1823,female,CD,Anti-TNF Only,9104,positive,adult,,booster2,11-Mar-22,31-Oct-21,131,mRNA,52,50 to 59
1824,female,CD,Anti-TNF Only,487,positive,adult,,booster2,14-Jul-22,19-Feb-22,145,mRNA,52,50 to 59
1825,female,CD,Anti-TNF Only,55430,positive,adult,,booster1,12-Jun-21,03-Mar-21,101,vector,54,50 to 59
1826,female,CD,Anti-TNF Only,32,ngative,adult,,booster2,23-Oct-21,05-May-21,171,vector,55,50 to 59
1827,female,CD,Anti-TNF Only,17846,positive,adult,269,primary,22-May-21,22-Feb-21,89,mRNA,22,18 to 29
1828,female,CD,Anti-TNF Only,46057,positive,adult,223,booster1,07-Jul-21,18-May-21,50,mRNA,22,18 to 29
1829,male,CD,Anti-TNF Only,12946,positive,adult,,primary,03-Jun-21,44280,70,vector,34,30 to 39
1830,male,CD,Anti-TNF Only,607,positive,adult,,primary,28-Sep-21,44303,164,vector,35,30 to 39
1831,male,CD,Ustekinumab Only,7932,positive,adult,,primary,04-Jun-21,31-Jan-21,124,mRNA,58,50 to 59
1832,male,CD,Ustekinumab Only,58962,positive,adult,,booster1,13-Aug-21,23-Feb-21,171,mRNA,58,50 to 59
1833,male,CD,Ustekinumab Only,44283,positive,adult,,booster2,21-Jan-22,10-Oct-21,103,mRNA,59,50 to 59
1834,male,CD,Ustekinumab Only,153,ngative,adult,,booster2,28-Apr-22,23-Nov-21,156,mRNA,59,50 to 59
1835,female,CD,Anti-TNF Only,71280,positive,adult,31,primary,04-May-21,14-Mar-21,51,mRNA,30,30 to 39
1836,female,CD,Anti-TNF Only,218,ngative,adult,60,primary,02-Jun-21,03-Dec-20,181,mRNA,30,30 to 39
1837,female,CD,Anti-TNF Only,73691,positive,adult,157,booster1,07-Sep-21,25-Jun-21,74,mRNA,30,30 to 39
1838,female,CD,Anti-TNF Only,58274,positive,adult,236,booster1,25-Nov-21,11-Jun-21,167,mRNA,30,30 to 39
1839,female,CD,Anti-TNF Only,56682,positive,adult,,booster2,25-Feb-22,26-Dec-21,61,mRNA,31,30 to 39
1840,male,CD,Anti-TNF Only,316,positive,adult,,primary,25-Jun-21,28-Dec-20,179,mRNA,57,50 to 59
1841,male,CD,Anti-TNF Only,61198,positive,adult,,booster1,04-Aug-21,05-Feb-21,180,mRNA,57,50 to 59
1842,male,CD,Anti-TNF Only,19613,positive,adult,,booster2,11-Dec-21,08-Oct-21,64,mRNA,57,50 to 59
1843,male,CD,Anti-TNF Only,356,positive,adult,,booster2,02-Mar-22,29-Aug-21,185,mRNA,57,50 to 59
1844,female,CD,Combination Therapy,73626,positive,adult,55,primary,14-Apr-21,15-Feb-21,58,mRNA,27,18 to 29
1845,male,CD,Combination Therapy,402,positive,elderly,,primary,06-May-21,18-Nov-20,169,vector,64,60 to 69
1846,male,CD,Combination Therapy,18693,positive,elderly,,primary,10-Jun-21,08-Feb-21,122,vector,64,60 to 69
1847,male,CD,Combination Therapy,17827,positive,elderly,,booster1,07-Aug-21,12-Jun-21,56,vector,64,60 to 69
1848,male,CD,Combination Therapy,53399,positive,elderly,,booster2,08-Oct-21,30-Jul-21,70,vector,64,60 to 69
1849,male,CD,Combination Therapy,378,positive,elderly,,booster2,22-Jan-22,11-Jul-21,195,vector,65,60 to 69
1850,male,CD,Combination Therapy,24415,positive,elderly,,booster2,11-Mar-22,11-Dec-21,90,vector,65,60 to 69
1851,male,CD,Combination Therapy,62632,positive,elderly,,booster2,01-Jul-22,18-Apr-22,74,vector,65,60 to 69
1852,female,CD,Ustekinumab Only,321,positive,adult,219,primary,22-Jun-21,14-Jan-21,159,mRNA,32,30 to 39
1853,female,CD,Ustekinumab Only,41248,positive,pediatric,184,booster1,27-Jul-21,17-May-21,71,mRNA,1,00 to 09
1854,female,CD,Ustekinumab Only,19798,ngative,pediatric,75,booster1,12-Apr-22,13-Nov-21,150,mRNA,2,00 to 09
1855,female,CD,Anti-TNF Only,75774,positive,elderly,237,booster1,11-Sep-21,29-Apr-21,135,mRNA,65,60 to 69
1856,female,CD,Anti-TNF Only,26520,positive,elderly,40,booster2,15-Jun-22,08-Feb-22,127,mRNA,66,60 to 69
1857,male,UC,Vedolizumab Only,39729,positive,elderly,,booster1,05-Jun-21,04-Feb-21,121,mRNA,68,60 to 69
1858,male,UC,Vedolizumab Only,12806,positive,elderly,,booster1,24-Sep-21,05-Aug-21,50,mRNA,68,60 to 69
1859,male,UC,Vedolizumab Only,277,positive,elderly,,booster2,19-Nov-21,09-May-21,194,mRNA,68,60 to 69
1860,male,UC,Vedolizumab Only,46022,positive,elderly,,booster2,12-Feb-22,26-Aug-21,170,mRNA,68,60 to 69
1861,male,UC,Vedolizumab Only,273,positive,elderly,,booster2,13-May-22,19-Nov-21,175,mRNA,69,60 to 69
1862,male,CD,Combination Therapy,16957,positive,pediatric,101,primary,10-Jul-21,22-Mar-21,110,mRNA,3,00 to 09
1863,male,CD,Combination Therapy,26749,positive,pediatric,155,booster1,02-Sep-21,16-May-21,109,mRNA,12,10 to 17
1864,male,CD,Combination Therapy,24509,positive,pediatric,211,booster1,28-Oct-21,06-Aug-21,83,mRNA,15,10 to 17
1865,male,CD,Combination Therapy,51984,positive,pediatric,272,booster1,28-Dec-21,01-Oct-21,88,mRNA,12,10 to 17
1866,female,CD,Anti-TNF Only,106,ngative,pediatric,110,primary,01-Jun-21,14-Jan-21,138,mRNA,1,00 to 09
1867,female,CD,Anti-TNF Only,30933,positive,pediatric,161,booster1,22-Jul-21,16-Feb-21,156,mRNA,2,00 to 09
1868,female,CD,Anti-TNF Only,163,ngative,pediatric,273,booster2,11-Nov-21,18-May-21,177,mRNA,3,00 to 09
1869,female,CD,Anti-TNF Only,5604,positive,pediatric,,booster2,03-Mar-22,04-Jan-22,58,mRNA,4,00 to 09
1870,female,CD,Anti-TNF Only,878,positive,pediatric,,primary,02-Jun-21,15-Jan-21,138,mRNA,5,00 to 09
1871,female,CD,Anti-TNF Only,58147,positive,pediatric,,booster1,11-Aug-21,26-Feb-21,166,mRNA,6,00 to 09
1872,female,CD,Anti-TNF Only,41357,ngative,pediatric,,booster1,21-Oct-21,31-May-21,143,mRNA,7,00 to 09
1873,female,UC,Vedolizumab Only,74270,positive,pediatric,316,booster1,20-Apr-21,27-Oct-20,175,mRNA,8,00 to 09
1874,female,UC,Vedolizumab Only,558,positive,pediatric,29,booster2,31-Mar-22,27-Oct-21,155,mRNA,9,00 to 09
1875,male,UC,Corticosteroids,74695,positive,elderly,257,primary,24-May-21,03-Apr-21,51,mRNA,63,60 to 69
1876,male,UC,Corticosteroids,63949,positive,elderly,155,booster1,03-Sep-21,25-May-21,101,mRNA,63,60 to 69
1877,male,UC,Corticosteroids,15427,positive,elderly,76,booster2,21-Nov-21,30-Sep-21,52,mRNA,63,60 to 69
1878,male,UC,Corticosteroids,582,positive,elderly,36,booster2,13-Mar-22,26-Sep-21,168,mRNA,64,60 to 69
1879,female,UC,Vedolizumab Only,52365,positive,elderly,,booster1,04-Sep-21,08-Mar-21,180,mRNA,79,70+
1880,female,UC,Vedolizumab Only,16111,positive,elderly,,booster2,19-Feb-22,19-Nov-21,92,mRNA,80,70+